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Primary fatty acid amides in mammalian tissues: Isolation and analysis by
HPTLC and SPE in conjunction with GC/MS

Abstract of a Dissertation at Duquesne University
Dissertation supervised by Professor Mitchell E. Johnson

Primary fatty acid amides (PFAM’s) are a novel class of bio-active lipids present in
mammals in trace level. Selective isolation of PFAM’s from lipid extracts is crucial for
obtaining them in pure and concentrated form for interference-free instrumental
detection and analysis.

Synthesis of these commercially unavailable lipids is also

important for method development and quantitative analysis by instrumental means. In
this study a wide variety of long chain saturated and unsaturated primary fatty acid
amides were synthesized and characterized.

This list includes the positional and

geometrical isomers of naturally abundant PFAM’s. Two isotopically enriched PFAM’s
were also synthesized which are important for establishing the fragmentation patterns of
the amides by mass-spectral analysis as well as for use as internal standards in
quantitative analysis. The separation of saturated and some unsaturated amides was
obtained using a non polar HP-5MS column. A more polar column, BPX70, was
employed for the separation of the geometric and positional isomers of the unsaturated
amides.
Two methods for the isolation of PFAM’s from lipid extracts were developed
and validated. First method is a high performance thin layer chromatography (HPTLC),
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which was found to be efficient in quick profiling of different lipid classes present in a
total lipid extract. Any lipid class of choice can also be further analyzed by scraping it
off the HPTLC plates.

The second method is a solid-phase extraction (SPE) for

selectively extracting the amides in a single fraction by a specific elution solvent from a
normal phase column.

This fraction can be dried and brought to the desired

concentration for further instrumental analysis. Lowest mass of amides to be loaded and
recovered by SPE was also optimized. Both HPTLC and SPE amide isolation methods
were validated using the total lipids extracted from N18TG2 mouse neuroblastoma cell
line. The detection limits of the amides by gas chromatography/mass spectrometry
(GC/MS) were found to be in the order of 5-30 pg. PFAM’s isolated from rabbit brain
and heart tissues by these methods were identified as palmitamide, stearamide and
oleamide. Trace amounts of linoleamide and eicosenoamide were also observed in brain
tissues.
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Chapter 1
Review of lipids and fatty acid amide analysis

1.1 Introduction
Lipid analysis is one of the most investigated topics by bio-analytical/bio-chemists due
to the diverse structures, nature and the activity of lipids in biological systems. One of
the lipid classes, fatty acid amides, is long known for their hormone-like activities.
They attracted recent attention when anandamide was identified as an endogenous
cannabinoid or endocannabinoid.

Anandamide is a twenty carbon fatty acid

ethanolamine with four point of unsaturation (cis,cis,cis,cis-5,8,11,14 eicosatetraenoyl
ethanolamine).

It was first identified to be produced in brain and to bind to the

cannabinoid receptor (CB1). It was also found to mimic all the activities of delta-9tetrahydrocannabinol (∆9 THC) [1]. It is necessary to point out here that ∆9 THC is the
compound that is responsible for all the pharmacological activity of marijuana and is an
exogenous cannabinoid [2, 3]. Cannabinoids are involved in so called retrograde or
backward signaling that can change the regular neurotransmission. It has also been
found that three specific neurotransmitters glutamate, dopamine and acetylcholine that
play key roles in neuronal activities, initiate the synthesis and release of
endocannabinoids [see Ref. 4 for review]. Therefore this fatty acid amide class (N-acylethanolamides) faced intensive study over the last decade.
The other groups of fatty acid amide, the primary fatty acid amides, have not
been found to show any affinity for CB1 receptor but are catabolically related to the

cannabinoid receptor class fatty acid amides. One such primary amide, oleamide, was
extracted from the cerebrospinal fluid of sleep-deprived cats and hence was thought to
be involved in neurobehavioral activities in brain. Oleamide and other primary amides
have therefore been also studied along with the endocannabinoids. These extensive
studies include their synthesis, biochemical studies, isolation from tissues and cells etc.
and moreover, their characterization by instrumental means.
The instruments that are most often used in lipid analyses includes nuclear
magnetic resonance (NMR), high performance liquid chromatography (HPLC), liquid
chromatography coupled with tandem mass spectrometry (LC/MS/MS), gas
chromatography/mass
ionization/time-of-flight

spectrometry

(GC/MS),

(MALDI/TOF).

matrix-assisted
High

laser

performance

desorption
thin

layer

chromatography/thin layer chromatography (HPTLC/TLC) and solid phase extraction
(SPE) are often used for sample preparation. In this chapter the analyses of fatty acid
amides by instrumental means, including the techniques used in sample preparation will
be reviewed. The main target of this chapter is to recognize the work that has been
done and to approach what could further be done in order to isolate and analyze the
fatty acid amides free of interaction from other lipid classes. Some basic information
about lipids and lipid analyses will also be provided as introduction.

1.2 Lipid definition
The term lipid refers to the substances that are soluble in organic solvents and are
insoluble in water. This is rather a book definition that avoids the fact that many nonlipid substances are also soluble in organic solvents and some lipids show more affinity
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for water than organic solvents.

Lipids can be defined as the molecules that are

synthesized by biological systems and can be extracted from the biological samples by
dissolution into organic solvents. The word ‘fat or oil’ previously used for lipids
mainly refers to one class of lipid (triacylglycerol), which is the major stored form of
energy in animals and plant seeds [5, 6]. Classification of lipids is described in detail in
the section below.

1.3 Lipid classification
These important biochemical molecules range from low molecular weight fatty acids to
high molecular weight complex phospho- and glyco-lipids. The two main branches of
lipid are storage lipids (which do not contain any polar head groups) and membrane
lipids (which contain polar head groups attached to the lipid backbone). Storage lipids
are mainly relatively non-polar triacylglycerols containing glycerol backbones esterified
with saturated or unsaturated fatty acids. Waxes are another kind of storage lipids,
which are mainly the esters of long chain fatty acid with long chain alcohols. They also
have water repellent properties and firm consistency.

Membrane lipids are called

structural lipids because they form the structure of the cell membrane. Membrane lipids
can be phospholipids, glycolipids or sterols. Based on the backbone, phospholipids are
classified as glycerophospholipids (containing glycerol backbone) or sphingolipids
(containing sphingosine backbone). All the phospholipids have a polar head group
attached to the glycerol or the sphingosine backbones through a phosphodiester linkage,
whereas all the glycolipids have a simple sugar or complex oligosaccharide attached to
the sphingoshine backbone. Some membrane lipids have fatty acids attached through
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either ether or vinyl ether bonds at the other end of the glycero or phosphoglycero
backbone. These are called ether lipids or plasmalogens. Sterols, another class of
membrane lipids, contain a steroid nucleus of four fused rings. There are other lipids
that are present in much smaller amount and are synthesized as necessary. These are
the metabolites and the messenger lipids such as eicosanoids, steroids, free fatty acids
and the fatty acid amides. Some of the phospholipids and plasmalogens also serve as
metabolites and second messengers.

These types of lipids play crucial roles in

numerous biological activities. Fatty acids and sterols serve as the precursors for these
biologically important classes of lipids [7, 8].

lipids

storage
lipids

tri-acylglycerols
and waxes

membrane
lipids

phospholipids,
glycolipids and
sterols

metabolites
and messenger
lipids

eicosanoids,
steroids, free fatty
acids, fatty acid amides
sphingomyelin
ceramide

Scheme 1.1: Relational diagram of lipid classes.
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Scheme 1.1 gives basic idea about the lipid classes possible even though there
are many in between classes discussion of which is beyond the limit of this review.

1.4 Basic structure and biological importance of each lipid class
1.4.1 Storage lipids
1.4.1.1 Triacylglycerols
1

H 2C

2

HC

3

H 2C

O

R1

O

R2

O

R3

R1, R2 and R3 represent saturated or unsaturated fatty acids

In vertebrates, energy consumption occurs continuously.

Triacylglycerols

(TAG) serve as the stored form of energy in specialized cells called adipocytes. These
lipids serve this purpose best because they occupy less volume per calorie of stored
chemical energy than carbohydrate and protein. Adipocytes contain a large amount of
triacylglycerols (more than 80% of the mass) that almost fills the cell. 12-14% of
normal body weight in male and more than 25% of that in female is adipose tissue or
fat. In most eukaryotic cells, TAGs float as oily droplets in the aqueous cytosol, serving
as metabolic fuel. TAGs are also stored as oils in the seeds of many plants, proving
energy as needed. When fuel is required at a particular body site, the enzyme TAG
lipase expressed in adipocytes and seeds catalyzes the hydrolysis of TAG, releasing free
fatty acids and sending them to that site to be used as fuel through β-oxidation.
Therefore, these fat cells maintain a stable supply of energy by synthesizing TAG from
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carbohydrates to be stored and again hydrolyzing them to be used as fuels as necessary
[8, 9]. Mono or diacylglycerols (MAG or DAG) are formed when any two or any one
of the OH groups on the glycerol backbone respectively remains un-esterified. MAG
and DAG have profound biological activities as metabolites and messengers.
1.4.1.2 Waxes
O
R1

C O R2

Fatty acid

long chain alcohol

Biological waxes are the esters of long-chain fatty acid with long chain alcohols.
The chain length varies from 14 to 36 carbons. These waxes are secreted by different
insects, birds and animals and have significant importance for them as well as to
humans.

The water-repellent property of waxes helps not only to keep the body

waterproof but also to keep water from evaporating. It also protects the body against
outside attack. Due to its firm consistence property it is extracted from animal and
plants, and used in manufacturing industries for various purposes such as in the
manufacture of lotions, ointments and polishes [8].

1.4.2 Membrane lipids
1.4.2.1 Phospholipids and glycolipids
Glycerophospholipids are similar in structure as the TAGs except for an H or a polar
head group is attached to the sn-3 position of the glycerol backbone via a
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phosphodiester linkage. In sphingolipids, fatty acids are joined by amide linkages
rather than ester linkages to the sphingoshine backbone. Phosphosphingolipids have a
phosphate group attached between the sphingosine backbone and the polar head group.
O
O HC
2
R2

C

O C R1

OCH
H2C

O
O P O X
O

Glycerophospholipid

OH
O
R C

H HC HC CH (CH ) CH
2 12
3
N

CH
H2C O X

Sphingolipids
X = H or a polar head group

Glycolipids are sphingolipids that lack the phosphate group but have a simple
sugar or a complex oligosaccharide attached as the head group. Membrane lipids
constitute the 5-10% of the dry mass of most cells and play important roles in the cell
structure.

They form an impermeable barrier that surrounds cells and cellular

compartments.

They are mainly amphipathic with a hydrophobic backbone and a

hydrophilic polar head group. Sphingolipids play a significant role in cell biology and
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cellular functions ranging from intercellular signaling as a second messenger in cellular
apoptosis to membrane structural functions [6].
1.4.2.2 Plasmalogens

O H2C
R2

C

O

OCH
H2C

CH

O H2C

CHR1
O

R2

C

O

CH
CHR1

OCH
H2C

CR3

O

O

O
P

O X

O

Non-polar plasmalogen

Polar plasmalogen

R1, R2 and R3 here represent long alkyl chains

Plasmalogens are another kind of phospholipids that are also called vinyl-ether lipids
and can be non-polar or polar in nature. Non-polar plasmalogens are glycerol esters of two
fatty acids with a vinyl ether group in position 1; whereas polar plasmalogens are phospholipids
consisting of polar head group (X) in position 3, fatty acid ester in position 2 and vinyl ether
bond in position1.

Usually the highest proportion of the plasmalogen form is in the

phosphatidylethanolamine class with little or no other phospholipids. In phosphatidylcholine, a
larger proportion is in the alkyl ether form rather than vinyl ether form, except in heart lipids,
where it is reversed. Based on the distribution and properties of plasmalogens in various cell
types and changes that occur in plasmalogen metabolism in certain mutant cells, it is suspected
that plasmalogens may have a number of other functions in addition to being structural
components of cell membranes. They may serve as a store of poly-unsaturated fatty acids
(PUFA) that can be released by specific stimulant molecules, may act as intracellular signaling
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compounds, may have a role as antioxidants, and are implicated in aging and various
degenerative diseases [10].
1.4.2.3 Sterols

CH3
H3C

H3C

CH3

H3C

HO
Cholesterol

Sterols are another class of membrane lipids that constitute the cell membrane.
They also serve as precursors for various biologically active hormones and other
signaling molecules. The characteristic sterol structure consists of one five carbon and
three six carbon fused rings.

1.4.3 Metabolites and messenger lipids
1.4.3.1 Eicosanoids
Eicosanoids are derivatives of fatty acid and they act on cells near the point of
synthesis. They are all derived from 5,8,11,14-eicosatetraenoic acid (20:45,8,11,14) and
therefore are called eicosanoids. The eicosanoids are known to be involved in a variety
of activities in cells. Some of the examples are stimulation of muscle contraction,
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regulation of blood flow and wake-sleep cycle, induction of inflammation and pain
(prostaglandins), formation of blood clots as well as the reduction of blood flow at the
site of clot (thromboxanes), induction of muscle contractions in lungs causing asthmatic
attack (leukotrienes) [8].
1.4.3.2 Steroids
Steroids are derivatives of sterols and they travel through blood stream from the point of
synthesis to act on different target tissues. They have very high affinity for their
receptors and therefore are potent signaling hormones.

They can act against

eicosanoids by sending the signal for the reduction of their synthesis thereby acting as
anti inflammatory and anti-asthmatic medicine.
1.4.3.3 Free fatty acids

O
R

OH

Fatty acids are the structural components of almost all the lipids and serve as
body energy through β-oxidation. They also act as second messengers.
1.4.3.4 Fatty acid amides
O
R

CH2
NH

O
OH

R

CH2

NH2

Primary fatty acid amides

N-acylethanolamine
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Fatty acid amides belong to an important bio-regulatory group of lipids that act
as messenger lipids. N-acylethanolamines and primary fatty acid amides are the two
most well recognized classes of this group. They are mainly the derivatives of long
chain saturated and unsaturated fatty acids. Primary fatty acid amides (PFAM’s) can be
formed via amidation of the corresponding acid in vitro and from N-acylglycine in vivo
[11].

N-acylethanolamines can be synthesized by the hydrolysis of N-acyl

phosphatidylethanolamine (N-acyl PE) in vivo [12].
1.4.3.5 N-acylglycines

O
OH
R

NH
O
N-acylglycine

N-acylglycines (NAG) are metabolite lipids that are recently shown to be
substrates for PAM (peptidylglycine α-amidating monooxygenase) in PFAM
biosynthesis [11, also see Scheme 1.2]. Short chain N-acyglycines are produced by the
action of acyl-CoA:glycine N-acyltranferase (ACGNAT; found in liver and kidney) on
acyl-CoA thioesters and glycines.

Because acyl-CoA thioesters with acyl chains

containing more that 10 carbon atoms has very low V/K values, it is very unlikely that
long chain NAG synthesis is catalyzed by ACGNAT. But the identification of long
chain NAGs in mammals and insects indicate the presence of an enzyme that catalyzes
their synthesis. Very recently Merkler et al. [13] have found that N18TG2 cells grown in
14

C oleic acid under the conditions known to stimulate PAM expression increases
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oleamide production and in presence of a PAM inhibitor produces 14C N-oleoylglycine
(14C NOG). Their findings therefore strongly support NAG as a substrate for PAM in
primary fatty acid amide biosynthesis in vivo.

1.5 Biological significance of fatty acid amides (ethanolamines and primary
amides)
O
OH
NH

Arachidonyl ethanolamine (anandamide)

O
NH2

cis-9-octadecenoamide (oleamide)

The biological significance of fatty acid amides have been reviewed in detail in
references 4 and 14. Kuehl et al. [15] has first shown that N-palmitoylethanolamine
extracted from soybean, peanut oil and egg yolk is a naturally occurring antiinflammatory agent. Palmitoylethanolamine was also shown by Ganley et al. [16, 17]
to have anti- inflammatory and anti- anaphylactic properties and was discovered by
Bachur et al. [18] as endogenous products of brain, liver and skeletal muscles of fasted

12

rats and guinea pigs, brain containing the highest amount (they also found the presence
of stearoylethanolamine 3-10% of the total palmitoylethanolamine). In 1992, Raphael
Mechoulam and his coworkers [1] discovered another endogenous fatty acid amide Narachidonyl ethanolmaine (anandamide) in porcine brain.

It was found to bind

cannabinoid receptor (CB1), and mimic all the activities of ∆9 THC. As described
earlier, ∆9 THC was previously found to bind to rat CB1 receptor [2].
Receptors are small proteins found in almost all cell membranes, including
neurons. Specific molecules bind to specific receptors resulting in the changes in cells.
Cannabinoid receptors are the specific brain membrane receptors that are coupled to the
G-proteins.

The compounds that have the affinity for these receptors are called

cannabinoids or cannabinoid receptor-active.

Those cannabinoids which are

synthesized endogenously are termed endogenous cannabinoids or endocannabinoids.
The two types of cannabinoid receptors discovered are CB1 found in brain and spinal
cord and CB2 found in peripheral tissue. CB1 is one of the most abundant G-protein
coupled receptors in brain.

It is found in high densities in cerebral cortex,

hippocampus, hypothalamus, cerebellum, basal ganglia, brainstem, spinal cord, and
amygdala [19-21]. It was found by Mackie, Freund, and coworkers [22, 23] that
cannabinoid receptors occurred only in very specific position of certain neurons that
release the inhibitory neurotransmitter GABA (gamma-aminobutyric acid). The reason
it was densely packed on the GABA releasing neurons is that the CB1 receptors can be
activated by retrograde (backward) signaling and therefore can reduce or terminate the
release of GABA, changing the regular neurotransmission. Even though most of the
physiological roles of the cannabinoid (CB1) receptors and hence those of the
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cannabinoids are still not known, their presence in the parts of the brain that are
responsible

for

psychoactive

power

(cerebral

cortex),

memory

impairment

(hippocampus), pain reduction and vomiting reflex (brain stem and spinal cord),
appetite (hypothalamus), emotional responses (amygdale), etc. associate them with
those kinds of activities. CB2 is known to be involved in the immune system. Besides
anandamide, four other ethanolamines γ-linolenoylethanolamine, docosatetraenoylethanolamine, docosahexaenoylethanolamine and eicosatrienoylethanolamine were also
found to be endocannabinoids [24-27]. 2-arachidonylglycerol (2-AG) has been recently
discovered as an endocannabinoid, which binds to both CB1 and CB2 [28, 29]. It was
found that three specific neurotransmitters glutamate, dopamine and acetylcholine can
induce the synthesis and release of endocannabinoids in specific regions of brain [4].
Because the activation of the CB1 receptors virtually inhibits the secretion of these
neurotransmitters neuronal functions can very well be regulated by fatty acid
ethanolamines [30].
Between the late 1950’s and early 1970’s palmitoylethanolamine was identified
as an inhibitory agent of inflammation, traumatic shock, and toxic effects of anti-cancer
drugs and ethanol [14, 31-39]. Long chain N-acylethanolamines were found to affect
heart and liver mitochondrial functional parameters. In heart mitochondria they can
inhibit the release of Ca+2, which are usually accumulated by the action of some Ca+2
releasing agents.

This accumulation of Ca+2 inside the mitochondria occurs via

induction of increased permeability of the inner mitochondrial membrane by these
releasing agents [40]. After anandamide was identified as a brain natural product that
mimics the activities of marijuana, a number of other activities of this fatty acid amide
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were discovered. Stein et al. [41] found that anandamide injection causes rapid increase
of bradycardia by its direct action on the blood vessels and subsequent lowering of
blood pressure by its inhibition of the secretion of noradrenaline by nerves in the hearts
and blood vessels [42-43]. Very recently this so called antinociceptive and possible
neuroprotective agent has also been found to have affinity for other targets especially
for vanilloid (TRPV1) receptors [reviewed in Ref. 44]. The author pointed that the
efficacy of anandamide as a TRPV1 agonist is influenced by several factors such as
receptor reserve, phosphorylation, metabolism and uptake, CB1 receptor activation,
voltage, temperature, pH and bovine serum albumin. The endocannabinoid system may
play a role in the modulation of TRPV1 receptor activation, which might have potential
implications in the treatment of inflammatory, respiratory and cardiovascular disorders.
Therefore, the diverse effect of anandamide in bio-regulation is still not completely
understood.
Biosynthesis of ethanolamines was investigated long before their affinity for CB
receptor was discovered. Their biosynthesis is catalyzed by an enzyme transacylase
that synthesizes N-acylphosphatidylethanolamine (NAPE) from phosphatidylethanolamines (PE) [45] and by the action of a second phospholipase D type enzyme
(phosphodiesterase) that hydrolyzes NAPE to N-acylethnolamine (NAE) [12]. The
liver, brain, and kidney mitochondria, microsomes and cytosols were found to be the
main points of their synthesis even though the synthesis of anandamide is most active in
brain cytosol.

The enzyme transacylase was first identified by the abnormal

accumulation of NAPE and hence NAE in damaged dog-heart mitochondria [46-50]
and phosphodiesterase was first characterized in rat heart membrane and was later
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found to be present in almost all rat tissues examined with higher amounts present in
young rat brains [reviewed in ref 51]. Schmid and co-workers [50, 52] while studying
these endogenous cannabinoids first discovered that these compounds are hydrolyzed
into free fatty acids and ethanolamines by a specific enzyme.

The enzyme that

hydrolyzes anandamide to arachidonic acid was named anandamide amidohydrolase
and was characterized by a number of scientists. This membrane bound enzyme, now
called fatty acid amido hydrolase (FAAH), was also found to catalyze the hydrolysis of
a series of N-acylethanolamines with similar catalytic activities [53-56].
While the functions and metabolic pathways of NAEs are well established [51,
57-60] very little is known about the biosynthesis and biodegradation pathways of
PFAM’s. They were first identified in human luteal phase plasma [61] and came to
major attention when oleamide was isolated from the cerebrospinal fluid of sleepdeprived cats. In 1995 Cravatt et al. [62] separated oleamide from the cerebrospinal
fluid of sleep deprived cats and characterized it as a sleep-inducing lipid. Even though
no evidence has been found so far that oleamide is also an endocannabinoid, it was
found to be catabolically related to the endocannabinoids [reviewed in Ref. 51].
Oleamide is also known to modulate serotonin neurotransmissions [63], increase
affinity of GABA for its receptors [64] and inhibit lymphocyte proliferation [65], to
prevent gap junction communication in osteoblastic and glial cells [66-68], to increase
food intake in rats upon injection [69], to inhibit synovial fluid phospholipase A2, [70],
to possess seizure limiting properties in mice [71, 72], as well as to modulate memory
in rat [73].

Of the other amides, erucamide may simulate angiogenesis [74] and

regulate fluid imbalance [75]; arachidonamide inhibits human synovial phospholipase
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A2 [70] and inhibits leukotriene biosynthesis [76]; linoleamide increases Ca2+ flux [77]
and inhibits erg current in pituitary cells [78]. Even though the actions of most of the
other amides are yet not known, it is almost certain that fatty acid amides have
interesting biological activity in mammals.

O

Acyl CoA : glycine
N-acyl transferase

SCoA
Oleyl CoA

Gly
CoA

O
ΟΗ
N
H

PAM

O

Oleyl glycine

O
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NH2
O

Oleamide

OH
Oleic acid
Scheme1.2: Biosynthetic pathway of PFAM’s proposed by Merkler et al. [11].
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In search for answers to the biosynthesis and degradation pathways of PFAM’s,
a number of pathways have been proposed. The most recognized pathway involves the
production of N-acylglycines (NAG) from acyl-CoA and glycine by the enzyme called
acyl-CoA: glycine N-acyltransferase followed by the PAM (peptidylglycine αamidating monooxygenase) catalyzed reduction of NAG to primary fatty acid amides
[11, also see Scheme1.2]. The amides are then hydrolyzed by the action of FAAH (able
to hydrolyze anandamide and a wide variety of fatty acid amides) [reviewed in Ref. 79],
which is probably why the concentration of amides found in mammals is very low [8082]. PAM has also been known to catalyze the oxidation of many neural and endocrine
peptide hormones to amides [83, 84]. One model cell line that is used to study oleamide
biosynthesis is N18TG2 mouse neuroblastoma cell because of its ability to express PAM.
These cells not only express PAM but also show dramatic increase in PAM expression
upon cellular differentiation [85]. However, questions were raised about the above
pathway when

14

C oleamide was found to be produced by N18TG2 cells grown in

14

C

oleic acid [86]. The authors pointed that because the levels of oleamide were not
significantly influenced by stimulation with ionomycin, but were slightly increased by
incubation with FAAH inhibitor, N18TG2 cell membranes may contain an enzymatic
activity catalyzing the synthesis of oleamide from oleic acid and ammonia. They
argued that these data suggest that a reverse FAAH-like enzyme may be responsible for
the formation of oleamide in cell-free preparations but not in whole cells. Very recently
Merkler et al. [13] have found that N18TG2 cells grown in

14

C oleic acid under the

conditions known to stimulate PAM expression increases oleamide production and
under the conditions known to inhibit PAM activity produces 14C N-oleoylglycine (14C
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NOG). Their findings that oleamide can also be generated from the cells grown in
NOG strongly support NOG as an intermediate and PAM as a catalyst in oleamide
biosynthesis in vivo.
N-acylethanolamine

(NAE)

and

its

biosynthetic

precursor

N-acyl

phosphatidylethanolamine (NAPE) can be found in almost all vertebrate tissues, cells,
body fluids, invertebrates, and plants [87-91]. It has been found that both NAE and
NAPE can accumulate in injured areas [92-97], which suggests that cellular levels of
both NAE and NAPE are tightly regulated under physiological conditions. They tend to
accumulate highly in response to stress, cellular and tissue degeneration and membrane
degradation. The types of NAEs that are observed in these cases are mainly the
saturated and monounsaturated NAE, suggesting these amides have profound action in
preventing tissue damage and stabilizing membranes [51]. The inhibitory activity of
NOE in lipid peroxidation in rat heart mitochondria [98, 99] and the inhibitory activity
of NPE (N-palmitoylethanolamine) in the glutamate induced excitotoxic death of the
cerebellar granule neurons suggest that these cannabinoid receptor inactive amides may
prevent or delay the breakdown of the cannabinoids by competing for their degradation
by the hydrolyzing enzyme FAAH [100, 101]. It was also claimed that the NAEs may
also inhibit or compete for the anandamide transporter by increasing the availability of
the endocannabinoid for interaction with the CB1 receptors [102]. These theories might
also be true for the primary fatty acid amides. Because oleamide was detected in
N18TG2 mouse neuroblastoma cells about 80 times higher than the reported anandamide
level in the same cells [86], it is possible that oleamide may be a biological enhancer of
anandamide activity. Leggett et al. [103] have very recently presented data indicating
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oleamide as an agonist for CB1 receptor in vitro but in vivo data reported so far is
conflicting with this finding [104] and therefore is inconclusive.
The synthesis of both of these cannabinoid receptor active and inactive
bioregulators in vitro, the research on their biochemical and pharmacological properties,
and their quantification in numerous biological samples has led us to the understanding
of their various activities so far. In this paper our main goal is to review the analysis of
fatty acid amides by instrumental means with special attention paid to the sample
preparation.

1.6 Instrumental analysis
The techniques used over the years for lipid analysis are mainly gas chromatography
(GC), liquid chromatography (LC) and capillary electrophoresis (CE) coupled with
various types of detectors. Ultraviolet-visible absorption (UV-vis), fluorescence (F),
diode-array UV-vis, flame ionization (FID), laser induced fluorescence (LIF) detection,
and electron ionization (EI) or chemical ionization (CI) by a mass spectrometer (MS)
are the common detection techniques of which the latter is the most widely used for
many years. Due to the nonvolatile nature of lipids derivatization is usually required in
order to make them volatile and thermally stable to be analyzed by gas chromatography.
The other advantages of derivatization are better resolution, improved detector response
and peak shape. This situation led researchers to find numerous techniques for lipid
derivatizations, most of which works fine, but the formation of artifacts makes the
techniques complicated for identifying the target itself. Derivatization in LC is also
often required in order to improve (i) detectability, (ii) resolution and selectivity of
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analytes, (iii) analyte identity in a complex matrix, (iv) chromatographic behavior as
well as (v) stability of analytes under study. One example is that fluorescence tagging
is required for improving the detectability of the PFAM’s by LC/UV. Even though
unlike GC the majority of the compounds can be analyzed by LC without prior
derivatization, one advantage of GC over LC is its higher peak capacity due to the
availability of the longer column length. In recent years the newly developed ionization
techniques such as electrospray ionization (ESI) and matrix-assisted laser desorption
ionization (MALDI) have been the choice of lipid chemists due to their ability to form
directly gas phase molecular ions for simple as well as complex lipids. CE is another
technique that has not been widely applied to the lipid analyses but provides great hope
for amide analysis.

1.6.1 Liquid chromatography-mass spectrometry (LC/ESI/APCI/MALDI-MS)
High performance liquid chromatography (HPLC) is a separation technique that has
advantages over gas chromatography due to its ability to analyze nonvolatile and
thermally fragile molecules. LC can be applied for the separation of a wide range of
chemically and biologically significant molecules such as small metabolites to large
proteins. The basic HPLC system consists of mobile phase reservoirs, a pump for
solvent delivery, an injector, a column and detectors of choice.
The most used HPLC separation techniques are normal-phase (NP) and
reversed-phase (RP) HPLC. The adsorption in NP occurs by the interaction of polar
functional groups of the solute with discrete sites on the stationary phases. Depending
on the strength of these polar interactions, NP chromatography selectively separates
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solutes with different number of electronegative atoms or with different functional
group. This type of chromatography is therefore suited for class separation. Of the two
types of LC stationary phases, silica is used more due to its high sample capacity and
less catalytic activity than alumina. Because bare silica can strongly retain some of the
very polar compounds, bonded silica stationary phases (diol, cyanopropyl or amino
propyl bonded) are used in their separation. Using these less polar phases it is easier to
clean the column and the presence of water in mobile phases creates less of a problem
in the retention time reproducibility. The drawback of NP chromatography is that
separation selectivity cannot be achieved by varying the particle size or shape.
Selectivity in this case depends primarily on varying the mobile phases. Reversedphase chromatography utilizes non polar stationary phase with polar mobile phases,
which is reverse of the case of NP chromatography. In RP, retention of solutes occurs
through nonspecific hydrophobic interactions with the stationary phases. Therefore the
most polar solutes in this case have the least retention time. The advantage of RP over
NP is that the individual compounds in a class can be separated in this chromatography.
The stationary phase in RP can be bonded silica or different polymeric phases, although
bonded silica being the most widely used. Variation in retention and selectivity can be
achieved somewhat by using different RP columns, but varying the mobile phase
composition provides the greatest selection in separation as in the case of NP [105].
The types of detectors used in conjunction with LC are refractive index, UV-vis,
fluorescence, diode-array UV-vis and mass spectrometer (MS). All of them provide
spectral data in the form of signal as a function of time whereas the latter provides
signal as a function of mass to charge ratio (m/z) as well. The most used LC/MS
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ionization involves the ionization of the analyte molecules at atmospheric pressure and
the common sources of ionization are electrospray ionization (ESI), atmospheric
pressure chemical ionization (APCI) and atmospheric pressure photoionization (APPI).
In ESI the analyte in appropriate solution is sprayed into a chamber in the presence of a
strong electrostatic force and heated dry N2 gas at atmospheric pressure and therefore
dissociated into gas phase ions. These gas phase ions are attracted through a dielectric
capillary entrance and enter into the mass analyzer. In APCI, the sample in appropriate
solvent is sprayed through a heated vaporizer at atmospheric pressure resulting in the
formation of gas-phase solvent molecules, which in tern are then ionized by electrons
discharged from a corona needle. The charges on the solvent molecules are then
transferred to the analyte molecules through chemical reactions and the analyte ions
thus enter into the mass analyzer through the dielectric capillary entrance. In the
relatively new technique APPI, the sample in appropriate solution is converted into gas
phase molecules, which are then ionized by photons of narrow range ionization energies
generated from a discharge lamp. The advantage of APPI is that the carefully chosen
ranges of photon energies allow the formation of as many analyte ions as possible
minimizing the ionization of the solvent molecules. The ions formed then enter in the
mass analyzer the same way as ESI and APCI [106]. The other most popular ionization
technique that creates direct gas phase molecular ions is the matrix-assisted laser
desorption ionization (MALDI). MALDI was first introduced by Tanaka et al. [107]
for which, he was awarded the 2002 Nobel Prize in chemistry. In MALDI, the analyte
is co-crystallized with a matrix (usually 1:1000 molar ratio of analyte to matrix), which
absorbs in the laser region (337 nm for a N2 laser, for example). The matrix is ionized
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upon bombardment of the mixture with short duration pulses of UV light from a
nitrogen laser. The analyte is ionized by energy transfer from the matrix to the analyte
rather than by direct laser ionization. The ions produced then are guided to the mass
analyzer by applying a high potential electric field.
The most common types of mass analyzers used are ion trap, quadrupole, timeof-flight (TOF) and fourier transform-ion/cyclotron-resonance (FT/ICR or FT/MS). In
ion trap mass analyzer the ions entering into the ion trap chamber are trapped by
electromagnetic fields and selectively ejected by another field.

Ion trap has an

advantage of performing multiple stages of mass spectrometry without additional mass
analyzers. The simplest and the least expensive mass analyzer is the quadrupole mass
analyzer, which consists of four parallel rods arranged in squares. When the analytes
enter the quadrupole, the electromagnetic fields generated by applying voltages to these
rods detects which mass-to-charge ions can pass through the filter at a given time. TOF
mass analyzer consists of a flight tube through which the entering ions are allowed to
accelerate by the application of a uniform electromagnetic force. Because the lighter
ions travel faster, the mass-to-charge ratios of the ions are determined by the time
required by the ions to reach the top of the flight tube and reflect back to the detector.
The most expensive mass analyzer, FT/MS, operates in ion trapping mechanism where
the ions entering the analyzer are trapped in circular orbits by powerful electrical and
magnetic fields. The ions excited by a radio-frequency (RF) electrical field generate a
time dependent current, which is converted to orbital frequencies corresponding to the
mass-to-charge ratios of the ions by fourier transform. Even though the relatively soft
ionization techniques discussed above are able to form gas phase molecular ions and are
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more suitable for nonvolatile lipid analysis then the previously used techniques such as
EI or CI, they are only capable of generating few fragment ions which are not enough to
achieve structural information. The most powerful analytical tool developed in recent
years is the collision-induced decomposition (CID) of the molecular ions, which can
provide molecular weight information as well as create more fragmentation, allowing
the elucidation of structural details [106].
Liquid chromatography has been widely used over the years for the analysis of
lipids due to its ability to handle nonvolatile substances, which is a crucial factor in lipid
chemistry. The native structures of complex phospholipids can be precisely obtained
using MALDI and ESI which was impossible with electron impact MS. On-line HPLC
and tandem MS with its capability to separate and identify complex lipids occurring as a
mixture in natural products and biological samples is a significant analytical tool for
lipidomics. A number of authors have reviewed lipid analysis over the years. These
reviews include but are not limited to those by Kim et al. [108], Careri et al. [109],
Murphy et al. [110], Volin et al. [111], Byrdwell [112, 113], Schiller et al. [114], and
Griffiths [115]. Our discussion will be in the light of these reviews as well as recent
papers, with special attention paid to the fatty acid amides.
1.6.1.1 Liquid chromatography (LC) of lipids
In lipid analysis high-performance liquid chromatography (HPLC) has become a great
importance not only for separation of individual lipid classes but also for the sample
preparation. Usually after the Folch-pi type of lipid extraction from any tissue/cells,
HPLC is employed for further extraction into individual lipid classes. Separation of
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each lipid within the classes can also be achieved before mass-spectral analysis. Both
the normal phase (NP) and reverse phase (RP) HPLC can be used for the separation of
lipids. Phospholipids, for example, are the mostly studied lipid classes by LC. In
normal phase HPLC (silica) phospholipids are separated by the polarity of head group,
i.e., the neutral phospholipid classes elute first and phosphocholine-phospholipids elutes
later.

Therefore NP is mostly for the separation of lipids by individual classes.

Whereas RP can be used to separate individual components within classes provided that
the separation of each class was achieved by NP prior to RP. The reason behind that is,
in RP, elution is largely depended on the fatty acyl chain rather than on the polar head
group resulting in the co-elution of molecules within different classes. For simplicity
NP is employed for their separation by classes followed by MS for further identification
of each species. One disadvantage of using silica-based column though is the issue with
the reproducibility of the retention time if water is present in the solvent system, which
can change the affinity of phospholipids for silica. The typical NP mobile phases are
hexane/alcohol mixtures whereas typical RP mobile phases are acetonitrile/alcohol
mixtures modified depending on the lipids to be separated [reviewed in Ref 116]. For
the separation of fatty acids RP is most widely used. Because of the absorptivity of the
carboxyl group at low UV region, fluorescent tagging is often required to form
derivatives, which fluoresces in the UV region for peak monitoring. Another example
is the analysis of eicosanoid which requires concentration in order to increase sensitivity
for RPLC analysis. A limitation in their MS analysis is that some isomers produce
identical spectra, therefore it is necessary to chromatographically separate all the
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isomers before hand. Separation of PFB esters of eicosaniods on a NP column is also
useful before MS study [for review see Ref. 117].
1.6.1.2 ESI/APCI/MS
1.6.1.2.1 ESI/APCI/MS of storage lipids

The identification as well as the determination of the acyl position is a crucial factor for
the analysis of the lipids. Even though triacylglycerols (TAG) are the most volatile of
the complex lipids, derivatization is required for their analysis by GC/MS. Separation
and identification is somewhat limited due to the present of numerous different TAG
species containing different fatty acyl chain along the sn-1, 2 and 3 position of the
glycerol backbone. The advantage of ESI or APCI to form direct gas phase ions has
made the analysis of intact TAG species easier. ESI yields [M+Na]+, [M+NH4]+,
[M+K]+ ions for the monoacylglycerols (MAG) diacylglycerols (DAG) or the
triacylglycerols [118, 119]. The alkali adduct ion formation is usually facilitated by the
addition of those corresponding ions to the electrospray buffers. One problem in these
cases appears to be the relation of the absolute abundance of these ions to the total
number of double bonds in the acyl chains of these lipid species. The lipid containing
saturated acyl chain results in poor yields of the adduct ion, whereas the one containing
unsaturated acyl chain result in higher yields. Further CID of these adduct ions provide
information about the location of the acyl group as well as the location of the double
bonds. For example, Cheng et al. [120] revealed the complete structure of the TAG by
the high energy CID studies of the NH4 and the Na adduct ions. APCI of TAG also
results in the formation of [M+H]+ ions but poor yield of these ions of the TAG species
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with saturated acyl chain remains to be the problem [119]. Silver ion HPLC along with
APCI detection was reported for the separation and detection of numerous TAG species
in a number of different oil samples [121].
1.6.1.2.2 ESI/APCI/MS for phospholipids

Analysis of glycerophospholipids is somewhat more challenging if the identification of
the position of the two acyl chains is required. Even though field desorption-MS was
first used [122] to analyze glycerophospholipids, fast atomic bombardment (FAB)-MS
was most widely used due to the useful information that could be found from the FAB
generated molecular ions [123-131].

The disadvantage of the FAB was the

considerable variation in the ion yields for the different classes of the phospholipids,
which seemed to be taken care of by the use of ESI-MS [132-135]. In these studies
[M+H]+ and [M+ alkali metal]+ ions were reported to be the abundant ions. These
parent ions were further fragmented by collision induced decomposition (CID) yielding
significant information about the polar head group as well as the diglyceride ions
resulting from the neutral loss of the head groups. [M-H]- ions were also yielded by
glycerophospholipids and were successfully used in the analysis of these species in
biological samples [136-137]. Analysis of glycerophospholipids as their [M + acetate]+
ions is also possible by using acetate buffers for ESI. Additional ion found to be
abundant was [M-15]-, which resulted from the CID of the [M + acetate]+ ions during
tandem quadrupole MS [138].

The formation of carboxylate ions from

glycerophospholipids by CID in the negative ion ESI mode offers identification of the
acyl chains esterified in the sn-1and sn-2 position even though the sn-1 carboxylate ions
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predominate [139]. Collisional activation of the negative molecular ions [M-H]- can
also yield ions corresponding to the loss of polar head groups [140].
The sphingolipids also have a polar head group, except ceramides, which lack
the polar head group. This group also forms abundant [M+H]+ ions using both ESI and
APCI [141, 142]. The CID of this molecular ion yields ions corresponding to the loss
of water as well to the cleavage of the amide link. Negative ions are also generated
during ESI yielding [M+Cl]- ions which upon CID form Cl- ion at m/z 35 [143].
Sphingomyelin also derive [M+H]+ ions as well as [M-15]- ions specific to
phosphocholine lipids. CID of the molecular ions but not the [M-15]- ions yield the
abundant ion for phosphocholine head group at m/z 184 [131]. Formation of [M+Li]+
ion in ESI-tandem mass spectrometer was described by Hsu et al.. [144] where CID was
found to yield [M+Li-183]+ and [M+Li-183-18]+ ions corresponding to the loss of
phosphocholine headgroup and water respectively. Fatty acyl chains and the base could
be identified from the less abundant ions, but this analysis is not very promising. As
said before, membrane lipids are the most complex lipids and a challenge for the
analytical techniques available due to presence of acyl chains as well as varied polar
head groups to the glycerol or to the sphingosine backbone. APCI seemed to be more
successful in the acyl chain analysis in sphingomyelin than ESI due to the yield of
several product ions such as the one [M-N(CH3)3-H2O+H]+ due to the abundant loss of
N(CH3)3 and water as well as the loss of ceramide-specific ions [145, also see Figure
1.1]. APCI and ESI were both used to analyze sphingolipids in brain and human
plasma [146, 147].

Rather complex glycosphingolipids containing a carbohydrate

linked to the ceramide base instead of a polar head group are more difficult to analyze.
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Successful use of ESI, MALDI and FAB were reported for the analysis of these lipids
[148-163].

FIGURE 1-1: Positive ions from sphingomyelin (d18:1/18:0) obtained by A) ESI and
B) APCI. Reproduced from Ref.110.

1.6.1.2.3 ESI/APCI/MS of metabolites and messenger lipids

Free acids are the mostly studied lipid class by the highest number of various
instrumental techniques. Negative ion ESI of saturated fatty acids yield [M-H-H2O]-
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ions whereas unsaturated fatty acid shows additional ions derived from the bond
cleavage at the α- and γ-position of the unsaturation [164]. APCI/MS of fatty acids
mostly produces M+ peak but in case of the hydroxy fatty acids, [M-H2O+H]+ was
observed as a base peak. The other peaks observed were the protonated molecular ion
peaks, which were prominent if the hydroxy group were located near the carboxylate
end [112]. Eicosanoids produce abundant carboxylate anion under ESI. Due to the
complexity of the eicosanoids, CID is generally used to reveal further fragmentation
information. The detection limit of various eicosanoids using unique CID product ions
could be as little 1.6 ng/mL. ESI of steroids yield [M+H]+ ions as well as additional
ions corresponding to the loss of one and two water molecules. APCI on the other hand
yields only [M+H]+ or [M+H]- ions. Femtomole level detection was achieved in the
analysis of several steroids even though the low yield of the ions is a serious drawback
in their analysis. The analysis of steroid conjugates is more successful as the yields of
the product ions are higher and further fragment ions from CID can be monitored
selectively for quantitation in femtomole level [for review see Ref. 110].
1.6.1.3 MALDI/MS
Even though MALDI is used mainly for the analysis of water-soluble compounds and
proteins, the interest in lipid analysis by MALDI is currently increasing. MALDI has
been used successfully for the analysis of lipids in various samples including vegetable
oils [165, 166, 167-170], crude tissue extracts [171-185], extracts of body fluids and
cells [186-196] and it has been well established that quantification with reproducible
results can be obtained by MALDI/TOF given adequate sample preparation and
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homogeneity of the analyte and matrix. The use of a specific matrix to absorb the laser
energy as well as to keep the analyte from cluster formation makes lipid analysis
feasible. The use of 2,5-dihydroxybenzoic acid (DHB) is suitable in the lipid analysis
because it does not tend to form cluster. Also very low yield of matrix ions are
generated which is a plus point for analysis of complex compounds. Sinapinic acid, a
common matrix used in MALDI should be avoided in lipid analysis because it tends to
undergo polymerization, resulting in the saturation of detector [197, 198]. Because
lipid and the matrix are both organic compounds, it is very easy to make a homogenous
mixture of analyte and the matrix. In MALDI, a solid sample rather then an analyte in
solution is required, which calls for minimal sample preparation.

Another main

advantage in MALDI is that singly charged ions predominate, therefore less
complication is expected. Even though multiply charged molecules are also generated,
they show a higher tendency toward neutralization, leaving the stable singly charged
ions easily detectable [199]. The extraction of lipid prior to analysis gives better results
than applying the sample without extraction. DHB as a matrix requires quick drying of
the sample on the MALDI plate after mixing with the matrix in order to obtain small
and homogeneous analyte/matrix co-crystals. The ions that are observed in the lipid
analysis are mainly [M+Na]+, [M+K]+ and [M+H]+. The first two cations [Na+ and K+]
are typically found in the lipid extracts and [M+H]+ arises from the addition of TFA
[~0.1%] to the matrix. The adduct pattern is strongly influenced by applied laser
intensity as well as the ion composition of the applied solvent.
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1.6.1.3.1 MALDI of storage lipids

Analysis of diacylglycerols by MALDI-MS was reported using 2,5-dihydroxy benzoic
acid (DHB) as a matrix [162] where [M+Na]+ ions appeared to result in better yields.
MALDI was able to identify TAG as [M+Na]+ ions in olive and cod liver oil without
prior separation using R-cyno-4-hydroxy-cinnamic acid as a matrix [165, 200]. The
analysis of vegetable oil samples were possible by MALDI-TOF [166] due to the
simplicity of the adduct formation (mostly Na+ adduct were visible). In MALDI, DAG
and TAG show very little fragmentation of the stable [M+Na]+ ion adduct. For DAG,
formation of carbenium ions has been observed due to the loss of NaOH [201]. For
TAG, loss of the Na salt of a fatty acid residue results in fragment patterns which might
be also the case in DAG but is less pronounced due to the interference with the peaks
from matrix.

The fatty acid composition also has an effect on the fragmentation

behavior. For TAG and DAG, the formation of Na+ adduct is more prominent than the
H+ adduct, which is due to the different tendencies of the Na+ ion and H+ ions to bind to
the glycerol backbone than to the polar head groups.
1.6.1.3.2 MALDI of membrane lipids

Cholesterol esters behave the same way as TAG and DAG, giving the [M+Na]+ adduct
whereas cholesterol gives an [M+H-H2O]+ ion due to the loss of water and its high
affinity for H+ ion. For phospholipids the intensity of [M+H]+ adduct is typically
stronger than the alkali adduct in MALDI spectra. Because the adduct pattern strongly
depends on the solvent composition and the applied laser intensity, enhanced signal for
alkali adduct can be generated by increasing laser intensity. Sphingolipids can be
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analyzed as intact molecules and can yield several peaks due to the heterogeneity in the
sphingosine or the acyl chain. One of the most prominent peaks is that derived from the
sphingosine residue at m/z 264.0. Analysis of complex glycerophospholipids in human
neutrophils by MALDI/TOF with DHB containing 1% TFA as a matrix resulted in the
formation of [M+H]+ and [M + alkali]+ ions [197]. MALDI was also used along with
FT/ICR [202] for the analysis of these lipids using DHB as a matrix and both [M+H]+
and [M-H]- ions as well as [M+ Na]+ ions were observed as abundant ions. CID of the
negative molecular ions yielded abundant carboxylate ions of which sn-2 carboxylate
found to be predominant.

Using MALDI it is possible to profile a mixture of

sphingolipids and glycolipids by their Na+ adducts [203].

In order to avoid

complication, sample preparation with TLC prior to MALDI is recommended [204].
1.6.1.3.3 MALDI of metabolites and messenger lipids

Free fatty acids can be analyzed by MALDI with low detection limit due to their low
molecular weight. Saturated free fatty acids were found to form Na+ adduct of the
sodium salt of the free fatty acid but the presence of unsaturated ones shifted the
molecular weight by +14 for all the fatty acids in a mixture [114]. Use of MALDI has
not been quite occurred yet in the analysis of eicosanoids or steroids, but can be of great
importance. Providing the development of appropriate matrices, application of MALDI
with tandem MS can provide more advanced identification of complex eicosanoids.

1.6.2 Gas Chromatography/mass-spectrometry (GC/MS)
Gas chromatography (GC) is a unique and versatile technique used with many types of
samples with little or no sample modification. It was developed for the analysis of
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volatile compounds and from there it has been expanded for the chemical separation
and analyses of gaseous samples, liquid solutions and volatile solids. Typical GC
system consists of an oven (which controls the temperature of the column), an injection
port and a detector connected to the column. The columns employed usually vary in
phase polarity depending on the nature of the compounds to be analyzed. If there is no
interaction between the column phase and the analyte no retention occurs, therefore the
non polar compounds are analyzed by non polar columns (95-100% dimethyl
polysiloxane phase) and polar compounds by polar columns (14-100% polar group
substituted dimethyl polysiloxane phase). Column length (l), internal diameter (r) and
film thickness (df) are the factors that are usually taken into consideration while
choosing a capillary column. The regular values for these parameters are r: 0.1 mm to
0.5 mm; l: 30-100 m; and df: 0.10 µm to 5.0 µm. It is ideal that the column be as short
as possible to keep the analysis time and cost low. The chromatographic resolution and
the analysis time depend on the value of r. Usually at constant df , the lower the r the
higher the resolution and better the separation between critical pairs. If MS is used as a
detector, 0.32 is the maximum value of r used. The combination of the values of r and
df should be so chosen that the value of the column phase ratio is higher for better
separation.
A number of different types of detectors are used in conjunction with GC of
which the most frequently reported ones for lipid analysis are the flame ionization
detector (FID) and the electron impact or chemical ionization mass spectrometry
(EI/CI/MS). With FID the analytes are burned in a hydrogen flame and thus are
ionized. The negative potential of the jet results in the neutralization of the positive

35

ions and the electrons are captured by an electrode to produce a signal current. In FID
only substances with at least one C-C or C-H bond are detected and as a universal
technique FID is not well suited for the trace analysis in complex matrices. FID is also
not suitable for the analysis of the highly chlorinated or brominated substances [205].
In the MS mode, two different ionizations electron impact ionization (EI) or chemical
ionization (CI) can be used. EI is the most frequently used ionization process in all
GC/MS systems. EI involves the interaction between an energy-rich electron beam
with the outer electron of the analyte molecule giving rise to the formation of the
molecular ion [M+•]. The excitation in the rotational and vibrational level of the M+• ion
by excess kinetic energy impacted by the electron beam produces further fragmentation.
Because the typical ionization potential used in most EI processes is 70 eV, which is
almost 5 times higher than the potential required to ionize the organic molecules,
sometimes in EI daughter or granddaughter ions are observed instead of the M+• ions.
Therefore in EI, determination of molecular weight is sometimes troublesome and the
application of CI is necessary. In CI, a reagent gas is used for the ionization of the
analyte molecules instead of a beam of electrons. The two step reaction involves the
formation of a reagent gas cluster through electron bombardment followed by the
reaction between the cluster and the analyte molecule in order to form protonated
molecular ion. CI can be used in either positive or negative mode depending on the
need of a particular analysis and because it uses considerably less ionization potential,
little or no fragmentation of the molecular ion occurs, providing important information
about the molecule itself. The data can be monitored by selecting either the total ion
mode (TIM) or the selected ion mode [SIM] in most GC/MS systems.
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The main disadvantage of gas chromatography in lipid analysis is its
incapability of direct analysis of the larger nonvolatile lipid molecules. Even though
recently commercialized modified columns are suitable for free fatty acid and amides
analysis, most of the lipids needed to be derivatized to a suitable volatile molecule prior
to injection. Another disadvantage of GC/MS is the lower sensitivity for trace analysis
and the analysis of compounds in complex matrices. Conjunction of GC/MS with TLC
and SPE is more preferable for the purification and preconcentration of the analytes of
interest.
1.6.2.1 GC/MS of storage lipids
Triacylglycerols (TAG) are probably the mostly studies lipids by GC/MS. In studies,
that require the quantification of total fat content in food, transesterifiction under
acidic/basic condition is usually done and the fatty acids are analyzed as their methyl
ester (FAME). Almost all FAME can be separated on a relatively polar column giving
the analyst an idea of available types. EI spectra of TAG usually produces [M-RnCO2]+,
[RnCO+128]+, [RnCO+74]+ and [RnCO]+ ions, providing information about carbon
chain and the number of double bonds. But the studies that require identifying the
location of the acyl chain in glycerol backbone as well as the position of the double
bonds in acyl chain are quite challenging. ESI/APCI are mostly employed for such
tasks. Separation and detection of MAG is much simpler and can be conveniently
carried out by GC/MS due to the presence of only one acyl chain. Analysis and
quantification of DAG is also a sensitive technique by GC coupled with negative ion
CI. They can be separated and detected as their pentafluorobenzyl (PFB) ester, even
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though the derivatization technique results in the migration of the acyl groups into
stable 1, 3 positions. The detection limit was found to be 30 fmol of an endogenous
DAG species extracted from human basophils [115, 206-210].
1.6.2.2 GC/MS of membrane lipids
Whereas LC/ESI/MS is the most widely used technique for the analysis phospholipids
and sphingolipids, use of GC/MS has also been employed for a long period of time for
their analysis. Numerous amount of work have been reported in this regard which
requires suitable derivatization techniques but none are adequate for the complete
structural details. For example, hydrolysis of ceramide followed by GC/MS analysis
provides no more information than the identity of the fatty acyl chain and the bases.
Ceramides can also be analyzed in intact form as their trimethylsilyl (TMS) or
methylated derivatives. The analysis of the methylated glycosphingolipids from human
and mouse body organs shows that ceramides separate according to the chain length of
the fatty acids but co-elution of some ceramides under each GC peak was observed.
Separation in subclasses by TLC or SPE before GC/MS is usually helpful in this type of
situation [163, 211-219].
1.6.2.3 GC/MS of metabolites and messenger lipids
Gas chromatographic separation and EI/CI detection can be carried out for the
identification of the fatty acids after derivatizing them into a suitable volatile ester,
typically the methyl ester [220-223, also see Figure 1-2]. Due to the presence of
numerous different species in biological samples this type of analysis is difficult in
clarifying the individual origin of the too many fragment ions formed. Optimized
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analysis conditions such as sample clean up and select ion monitoring usually improve
this situation [224-225].

FIGURE 1-2: Separation of C4 to C24 fatty acid methyl esters on restek Rt-2560
column. Reproduced from Restek website (www.restekcorp.com ).

One example is the analysis of the arachidonyl containing phospholipids in
human histiocytic lymphoma U937 cell line by negative ion CI/MS as their PFB ester
[131].

The predominant carboxylate anions were monitored for the assay of the

arachidonic acids in this case. Methylation conditions were optimized by Park et al.
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[226] for the quantitative analysis of the isomers of conjugated linoleic acids (CLA) in
various lipid samples. They found that methylations only under different conditions are
suitable for different types of CLA and GC was not suitable for the analysis of samples
containing low amounts of CLA. Quantitation of eicosanoids by GC/MS requires
different derivatization and purification procedures for different eicosaniods, which is
complicated and time consuming [227-236]. Use of suitable derivatization agent and
careful sample preparation can solve these problems. For example, the analysis of
eicosaniods after solid phase extraction (SPE) and derivatization with tert-butyl
dimethylsilyl ether (t-BDMS) was reported by Tsukamoto et al. [237]. Use of one
internal standard per eicosanoid and SIM provided the assay of six different eicosanoids
from cultured cells. Their method was found to be linear from 10 pg to 100 ng.

1.6.3 CE-LIF/CE-MS
Capillary electrophoresis (CE) is a novel analytical tool which can provide selectivity
and higher chromatographic resolution for a wide variety of samples. The high voltage
separation and the narrow capillary zone offer fast and efficient separation. It also has
an advantage of low sample and solvent consumption over other analytical techniques.
Capillary electrophoresis, (CE), was introduced by Jorgenson and Lukacs [238-242] in
the early 1980's. CE coupled with various detectors offers the automated analytical
equipment, fast analysis times and on-line detection of the separated peaks.

The

possible CE modes are capillary zone electrophoresis, micellar electrokinetic capillary
chromatography, capillary gel electrophoresis, capillary isoelectric focusing, and
capillary isotachophoresis with various detection systems such as UV-Vis, fluorescence,
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Raman, and laser induced fluorescence (LIF) [243]. The separation based on size and
charge differences between analytes is termed capillary zone electrophoresis (CZE) or
free solution CE (FSCE); separation of neutral compounds using surfactant micelles is
refereed as micellar electrokinetic capillary chromatography (MECC); sieving of
solutes through a gel network is termed as capillary gel electrophoresis (GCE); and
separation of zwitterionic solutes within a pH gradient is called capillary isoelectric
focusing (CIEF).

Capillary electrochromatography (CEC) is an associated

electrokinetic separation technique which involves applying voltages across capillaries
filled with silica gel stationary phases. Separation selectivity in CEC is a combination
of both electrophoretic and chromatographic processes. FSCE and MECC are the most
frequently used separation techniques in pharmaceutical analysis. GCE and CIEF are of
importance for the separation of biomolecules such as DNA and proteins, respectively,
and are becoming of increasing importance as development of biotechnology derived
drugs is becoming more frequent. So far most of the work done by CE/LIF / CE/MS
focused on the analysis of mainly peptides and proteins. A very few papers on lipid
analysis by CE have been published most of which focused on the separation of the
fatty acids [151, 244-261].

1.6.4 Fatty acid amide analysis
1.6.4.1 Sample preparation
1.6.4.1.1 Lipid extraction

Lipid extraction is the first step of lipid analysis and is the most important task. FolchPi and Bligh/Dyer [262-263] extractions are the two types of techniques that are widely
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being used and modified. Usually a 20 fold volume of chloroform:methanol (2:1, v/v)
is added to the tissue/cell for homogenization. The volume of a tissue sample is
computed on the assumption that the specific gravity of tissue is the same as that of
water. After homogenization the sample is filtered and 20% water (or aqueous salt
solution) is added to the total volume of filtrate. The mixture separates into two phases:
the lower phase (chloroform:methanol:water; 86:14:1, v/v/v) containing lipids and the
upper phase (chloroform:methanol:water, 3:48:47, v/v/v) containing non lipid
contaminants. The upper phase is then discarded and lower phase is dried under N2 to
be dissolved in a suitable solvent [262]. Modifications of this method are allowed
providing the required ratio of tissue/cell to solvent is maintained. Modification also
depends on the types of lipid classes to be extracted. For example, centrifugation can
be used instead of filtration, but 20% methanol needs to be added to the homogenate in
order to lower its specific gravity. Therefore, after centrifugation, twice the amount of
chloroform must be added to the supernatant in order to have a 2:1 chloroform to
methanol ratio. Also the Folch solvent can be replaced by suitable solvents such as
isopropanol instead of methanol or dichloromethane instead of chloroform, etc. One
disadvantage of the Folch process is that the gangliosides remain entirely soluble in the
upper aqueous phase. If gangliosides are to be extracted, dialysis of the upper phase to
remove ions and other low molecular weight compounds followed by lyophilisation is
done. Fatty acid amides being only moderately polar can be extracted readily with the
total lipid using the conventional Folch-Pi extraction.
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1.6.4.1.2. Sample clean-up/ derivatization

Before analyzing the sample by the choice of instrument, it is common practice use
TLC or SPE to separate target analyte or analytes. The pure and concentrated analyte is
then injected into the GC/MS or LC/MS system in order to increase the sensitivity and
detactibility (see Section 1.7, Chapter 2 and Chapter 3 for more detail on sample cleanup by TLC and SPE). As discussed above, if the analyte is non volatile, or has
absorptivity only in the low UV region, derivatization is often required. Fatty acid
amides are one such lipid class that possess both the characteristics and hence need to
be derivatized for instrumental analysis.

Even though amides can be successfully

analyzed in GC polysiloxane columns without derivatization, severe tailing due to the
NH2 group hinders trace analysis of amides. This is especially true when analyzing
amides from biological samples, which contain numerous other species. Sample clean
up is therefore an important part of amide analysis. HPLC analysis of amides is also
troublesome due to the abosoptivity of amide group in low UV region (`210 nm).
Fluorescent tagging is required for the formation of fluorophore which fluoresces in the
UV region allowing peak monitoring (see Chapter 6 for more information on
derivatization for GC analysis).
1.6.4.2 Chromatography methods
Gas chromatography (GC) is the most widely applied technique in the separation of
fatty acid amides. As mentioned in the earlier section, volatile derivative formation
is usually required for GC analyses. Even though the analysis of underivatized fatty
acid amides can be performed in polysiloxane columns, quantitation at trace level is
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troublesome due to the severe tailing from the NH2 group [264].

N-acyl

ehanolamines were detected in both derivatized (O-acetyl or TMS) and underivatized
forms using SE-30 GC and DV-5 columns [1, 18]. Separation of a mixture of low
molecular weight fatty acids, PFAM’s and NAEs using a chromosorb-101 column
was also achieved [265]. Separation of C12-C22 NAEs as their O-acetyl analogs
showed that the unsaturated ones eluted right before their saturated analog on OV1/OP-15 columns [266].

Schmid and co-workers [267, 268-270] reported the

analyses of N-acyl PE (precursors of NAEs) and NAEs as their tertbutyldimethylchlorosilyl (t-BDMS) derivatives by a HP-5MS column. The use of a
similar column (BP5) for the separation of NAE and their precursors without prior
derivatization was also achieved [271]. Primary fatty acid amides were analyzed
without derivatization [272-274] using 3% Dexil 300/CP-Sil 5 CB/BP1 columns but
only oleamide, stearamide and erucamide were separated. In 1985 Arafat et al.
reported [61] the extraction of five long chain saturated and unsaturated PFAM’s
from human luteal phase plasma and their analysis as trimethylsilyl (TMS)
derivatives by an HP-5MS column. Separation of TMS derivatives of C2-C20 fatty
acid amides (both saturated and unsaturated) was also shown on a Supelco
Simplicity-5TM column by Gee et al. [275]. They found that the peak intensity was
largely dependent on the silylating agent used.

Use of BSTFA (bis-

trimethylsilyltrifluoroacetmide) and MSTFA (N-methyl-N-trimethylsilyltrifluoroacetmide) provided the most complete reactions and the derivatized amides with
these two reagents produced largest peak areas. They also studied the derivatization
of amides by TMSCl (chlorotrimethylsilane) which is usually used as a catalytic
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element for selectively derivatizing lipids. No derivatization occurred when TMSCl
was used alone. Presence of TMSCl was found to prevent the reaction between
MSTFA and amides. The extent of the reaction of amides with BSTFA was found to
be reduced in presence of TMSCl.

BSTFA was chosen over MSTFA as a

derivatizing agent because of the greatest signal-to-noise and signal-to-background
ratios in the former case. Toluene was used as a solvent because (i) amides as well
as the silylated amides are soluble in toluene, (ii) reaction in toluene and ethyl
acetate produced maximal peak areas for the silylated amides, and (iii) reaction in
toluene gave rise to higher signal-to-noise and signal-to-background ratios than in
ethyl acetate. They also optimized the temperature and time for the derivatization of
oleamide in BSTFA-toluene. HP-5MS was used to study the both derivatized and
underivatized oleamide which showed that N-trimethylsilyl oleamide and N-tbutyldimethylsilyl oleamide had better detection limit then the oleamide itself [264].
Even though the detection limit improves upon derivatization, one should not
discount the possibility of artifact formation. Vosmann et al. [276] reported that the
derivatization of lipid mixture containing primary fatty acid amides and NAEs with
trimethylsulfonium hydroxide [TMSH] led to the formation of N- and /or Omethylated derivatives which can result in faulty conclusion.

It is therefore

necessary to use the judgement where derivatization is actually required. Detection
limits need to be determined for derivatized and underivatized amides.

If the

amounts of amides in a sample fall above the quantitation limit for underivatized
amides, derivatization should be avoided.
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If it is absolutely necessary to use

derivatization, the optimum conditions must be used so that as low as possible
derivatization agent can be used under mildest conditions.
Liquid chromatography (LC) is the other technique used in fatty acid amide
analyses even though it has not been as widely employed as GC. LC is usually used
for oxidized, highly branched or relatively polar samples (e.g., phospholipids). One
advantage of LC over GC is that the derivatization is not required.

But the

absorptivity of the -CONH2 group in low UV region (~210 nm) gives rise to poor
sensitivity [277].

In order to increase sensitivity, fluorescence tagging is often

required with compounds that fluoresce in the UV region. Carpenter et al. [277]
studied the separation of a series of N-acylglycines (NAG) and PFAM’s (C2-C12)
using a Phenomenex Luna C8 column. The mobile phases for NAG were 50 mM
sodium phosphate (pH 6.0): acetonitrile as gradient and those for PFAM’s was
water: acetonitrile as gradient followed by isocratic elution. The separation of long
chain PFAM’s (C12-22) were achieved using a Waters C18 column and water:
methanol as gradient. They (Carpenter et al.) mentioned that a longer run time (over
25 min) for the separation of saturated and unsaturated amides was required. C18
Reversed-phase HPLC was also used to assay PAM activity for the conversion of Nacylglycine to the primary fatty acid amides by Carpenter et al. They achieved the
separation of N-oleoylglycine, oleamide and oleic acid on a Phenomenex Luna C18
column using acetonitrile : methanol as a gradient. Carpenter and co-workers has
also optimized the conditions for APCI using a C18 column for PFAM’s. In order to
analyze unsaturated and longer chain PFAM's, (C ≥ 22) using this technique (for
both reversed and normal phase columns), the gradient of mobile phase needs to be
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optimized. HPLC separation of PFAM’s was also carried out on a Nuclesil-100
column by Jasperse [278] and separation of caprylamide, capramide, lauramide,
myristamide, palmitamide, oleamide, stearamide and arachidamide was reported.
Reverse phase HPLC using a Nova-pak-C18 column was able to resolve 5 separate
NAEs based on the chain length and the degree of unsaturation. The co-eluting
NAEs were furthered resolved using a free fatty acid HP column from Waters [266].
The separation of anandamide, N-palmitoylethanolamine, and N-oleoylethanolamine
in biological samples was also achieved on a C18 Hypersil column [279]. Koga et
al. [280] used TSKgel C18 80TM / TSKgel silica-60 columns for the determination
of N-acylethanolamides.

Using their method, separation and quantification of

anandamide and other NAEs in rat brain and peripheral tissues was possible.
Normal phase HPLC using evaporating light scattering detection for the screening of
the lipid classes found in food packaging materials established the separation of 12
different lipid classes including erucamide on a LiChrospher Diol column [281].
From the literature review it is clear that the resolution largely depends on the nature
and the gradient of the mobile phase used. It is therefore might be possible to
separate wide range of co-eluting fatty acid amides with careful selection of mobile
phases and their gradient.
The analysis of fatty acid amides by capillary electrophoresis (CE) can be of
great importance because the high sensitivity and best resolution is required for these
compounds. Separated of free fatty acids by non-aqueous CE with near infrared
fluorescence detection was reported [247, 248]. Feng et al. [282] were the first to
investigate the separation of amidated amino acid by MECC/LIF after selective
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fluorescence derivatization. The same group has also shown [283] that CE/LIF can
be a very sensitive and efficient method for analyzing the PFAM's. The amides can
be converted to corresponding amines through Hofmann rearrangement [284, 285],
and the amines are then derivatized with an amine-reactive probe. Fluorescein
isothiocyanate (FITC) and fluorescein succinimidyl ester (FSE) were used as the
reactive probe but were not found to be useful in methanolic CE due to the lack of
charge in methanol. Even though the use of CE/MS for determination of peptides
and proteins is common, its application towards lipids analysis has not been reported
to date but can be of significant importance.
1.6.4.3 Detection method
Mass spectrometry is the main detection technique usually employed in fatty acid
amide analysis with GC and LC.

The common ionization techniques used for

GC/MS analysis of amides are electron ionization (EI) and chemical ionization (CI).
Devane et al. [1] had characterized anandamide by GC/MS as both underivatized and
TMS- derivatized conditions. Direct exposure CI (isobutene-DCI) gave rise to the
protonated molecular [M+H]+ ions (m/z = 348) which under CID produced
significant fragments at m/z 287, 62 and 44 due to the formation of [M+HC2H7NO]+, most abundant protonated ethanolamine ions [HOCH2CH2NH3+] and
due to the formation of dehydrated protonated ethanolamine ([HOCH2CH2NH3H2O]+) respectively. The TMS derivative of anandamide gave rise to M+ ion at m/z
419 and [M-CH3]+ adduct ion at m/z 404.

Upon CID of m/z 404, two major

fragments were observed due to the formation of Me2Si+OCH2CH2NH2 (m/z 118)
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and Me2Si+OCH2CH2NHCOCH=CH2 (m/z 172) respectively. The EI mass spectral
patterns of O-acetyl-NAEs showed [266] the formation of M+ ions as well as the
common ions formed due to McLafferty rearrangement (m/z 85 and m/z 145) and
due to gamma cleavage (m/z 98 and 158). Schmid et al. [267] reported detection
limits for tert-butyldimethylchlorosilyl (t-BDMS) derivatives for NAEs. Limits for
saturated NAEs were found to be 0.1 ng and those for unsaturated NAEs were found
to be 1 ng (anandamide) under single ion monitoring mode (SIM, m/z = M-57].
Primary fatty acid amides were also analyzed by GC/FID and GC/MS as slip agents
in plastics [272-274]. Detection limits of palmitamide, stearamide, oleamide and
erucamide from various polymeric matrices using GC-FID and/or GC/MS were
found to be less than 50 ppb [273]. Trimethylsilyl (TMS) derivatives of long chain
saturated and unsaturated amides by EI/MS showed characteristic molecular [M]+
ions; [M-15] + ions due to the loss of -CH3 at the aliphatic end and formation of a
ketene; [M-71] + ions due to the loss of -C5H11 also at the aliphatic end and m/z 59
and m/z 72 ions due to McLafferty rearrangement [61]. Similar patterns were also
observed for erucamide and oleamide isolated from blood plasma and bacterial cells
respectively [75, 286].

The underivatized amides on the other hand showed

characteristics M+ ions; [M-17]+ ions due to the loss of NH3 and formation of a
ketene; [M-43]+ ions due to the loss of -C3H4 at the aliphatic end; m/z 59 and m/z 72
ions due to McLafferty rearrangement; fragment ion due to the allylic cleavage
between C7-C8, followed by rearrangement and the fragment ions due to the C6-C7
and C5-C6 cleavage of the ketene [86]. BSTFA derivatized fatty acid amide analysis
using an ion trap analyzer was carried out by Gee et al. [275].
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The amides

separation was achieved for ethanamide to eicosanamide in the total ion mode and
for the positional isomers of C18 unsaturated amides in the single ion mode. The
detection limit was found to be in the order of 1 pmol and quantitation limit was
between 1 to 10 pmol. The fragmentation pattern in this case was different from that
observed by Arafat et al., which was attributed to the use of a different mass analyzer
(Arafat et al. used a quadrupole mass analyzer). The mass spec patterns observed in
the case of Gee et al. included the [M-71]+ ions due to the loss of a pentyl group
(unsaturated amides having double bond position closer to the cleavage site C13-C14
did not show this peak) as well as the m/z 59 and m/z 72 ions formed by McLafferty
rearrangement. No M+ or [M-15]+ peaks were observed. These patterns were further
confirmed using the fragmentation patterns of isotopically labeled amides [287].
Quadrupole mass analyzer was also used for the determination of underivatized,
TMS, nitrile, and N-t-BDMS derivatized oleamide [264]. Mass spectral patterns of
derivatized and underivatized oleamide are shown in Figure 1-3.
The common ionization techniques used for LC/MS in fatty acid amide
analysis are electrospray ionization (ESI) and atmospheric pressure chemical
ionization (APCI). The major ions observed in negative ion ESI/MS for NAPE
(precursors of NAEs) was deprotonated [M-H]- ions which upon CID gave further
fragmentation and information for identifying the N-acyl group attached to the
NAPE. The detection limit was found to be 0.1 ng (100 fmol) per injection [288,
289]. The major ions observed in positive ion ESI/MS of NAEs [279] are [M+H]+
and [M+Na]+. Koga et al. [280] have used APCI for the determination of NAEs.
The NAEs were detected as [M+H]+ ions and detection limit was found to be about
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200 pmol per injection for all the NAEs. The drift voltage was found to have an
inverse effect on the intensity of the [M+H]+ ion and a directly propotional effect on
the [M+H-H2O]+ ion. For all the NAEs the maximum intensity of the [M+H]+ ions
were found to be maximum at a drift voltage of 20 V with a nebulizer temperature of
200 ºC.

FIGURE 1-3: EI/MS of A) underivatized, B) nitrile derivatized, C) TMS derivatized,
and D) N-t-BDMS derivatized oleamide. Lower levels of M+ and [M-17]+ ions (m/z
281 and m/z 264 respectively) are observed in A and the improvement of M+ ions is
observed in B upon nitrile derivatization. Predominant fragment peaks are found at
lower m/z where the peak interference from biological sample might be substantial
but converting oleamide to TMS or N-t-BDMS ester yields high sensitivities for the
m/z 338, which can be used for reliable quantitation. Reproduced from Ref. 264.
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Cravatt et al. [290] in 1996 published the structural determination of
oleamide by mass spectrometry after it was discovered to appear and disappear upon
sleep deprivation and resting respectively in cat cerebrospinal fluid. High resolution
FAB/MS provided [M+Na]+ ion at m/z 304.2614 for oleamide and tandem ESI/MS
produced [M+H]+ parent ions (m/z 282) as well as further fragmentation providing
detailed structural information. ESI/MS of oleamide from rat cerebrospinal fluid
yielded the [M+H]+ ion which upon CID gave rise to further fragmentation but was
found to be too complicated to predict due to the presence of numerous signals even
in the blank [264].
Together all these outcome points toward the fact that quite a large number of
instrumentation techniques are available for the analysis of fatty acid amides but have
their own drawbacks. Sensitivity is a critical issue because sample matrices of interest
are mostly biological tissues or cultured cells. Sample preparation for amides prior to
the analysis is essential for increased detector lifetime, lower detection limit/higher
sensitivity, which usually results in quantitative data with good percent recovery for
these types of samples.

1.7 Sample clean-up in lipid analysis
Thin layer chromatography (TLC)/High performance thin layer chromatography
(HPTLC) and solid-phase extraction (SPE) are the two main sample preparation
techniques frequently used by analytical chemists. Use of TLC and SPE in lipid
separation has also been explored. TLC/HPTLC can be used for easy profiling of the
lipid classes and the separated samples can be scraped off the plates and analyzed by the
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instrument of choice without any interference from the other classes. A number of
authors [177, 291-304] have reported such analyses with successful TLC separation of
various lipid classes followed by instrumental analyses. Similar sample preparation
which is very recently being explored is SPE and the separations of different lipid
classes from various types of samples by different SPE columns have been performed
and the advantages and disadvantages have been reviewed [305-318].

The most

popular SPE columns for the extraction of various lipid classes are the silica and the
aminopropyl bonded phase. Due to the highly polar nature of the silica it can adsorb
polar lipids and different classes can then be eluted by mobile phase with increasing
polarity. The aminopropyl column is more popular then silica because it is a little bit
less polar, which is advantageous for the complete recovery of the polar lipids. Another
advantage of the aminopropyl column is that it can also be used as an ion exchange
column. Details of TLC/HPTLC and SPE studies will be discussed in the introduction
sections of the chapters three and four respectively.

1.8 Conclusions
The object of this chapter is to introduce the instrumental analysis done in lipid
chemistry in brief with especial attention in fatty acid amide class analysis and to
provide an idea of the objective of this thesis. We are interested particularly in primary
fatty acid amides (PFAM’s) because this fatty acid amide subclass has not been
explored as extensively as the N-acyl ethanolamides (NAEs).

The idea that they

possess significant bio-regulatory activities and hormonal behavior as the NAEs besides
being catabolically related to them is still to be explored. Careful study is needed to
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identify their specific action, which requires sole isolation, identification and
quantitation of these species from biological samples. The presence of a huge number
of different lipids in the sample matrix makes it difficult to analyze any particular class
without interaction from other classes. A method for the isolation of amides before
instrumental analysis is therefore very crucial. As pointed out in the earlier sections
that a set of standards as well as the use of deuterated amides as internal standard is
required for the quantitative analysis of the amides. Before instrumental analysis,
amides need to be extracted from the total lipid fractions so that other lipid classes do
not interfere with the particular amide analysis conditions. In Chapter 2 of this thesis,
we will present the synthesis and purification of the long chain PFAM’s including the
geometric and positional isomers.

Synthesis of deuterated standards will also be

discussed. This chapter will also focus on the separation of the amides by a HP-5MS
column and its incapability of separating cis/trans and positional isomers.

The

synthesized standards will then be used for the method development of the amide
isolation from total lipid extract and amide analysis. Chapter 3 will focus on the total
lipid profiling of the N18TG2 mouse neuroblastoma cells by HPTLC followed by the
isolation and analysis of cell amides. Chapter 4 will be mainly on the solid-phase
extraction of amides from standard lipid mixture followed by method validation with
N18TG2 cell lipids.

Application of both methods for the analysis of PFAM’s in

mammalian tissues will be discussed in Chapter 5.

Chapter 6 will focus on the

separation of the co-eluting amides using argentation HPTLC as well as GC using a
BPX-70 column.
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Chapter 2
Small-scale synthesis and characterization of naturally abundant and
isotopically enriched primary fatty acid amides

2.1 Abstract
A simple procedure for the synthesis of commercially unavailable primary fatty acid
amides (PFAM’s) and isotopically labeled PFAM’s in small scale has been successfully
established. Synthesized amides can be used as standards and the isotopically enriched
amides can be used as internal standards for their analysis, especially for the analysis of
biologically active amides, in cell and tissue samples by instrumental means. The
amides were synthesized from corresponding acids, thionyl chloride and anhydrous
ammonia. Deuterated or 13C labeled acids were employed in the synthesis of deuterated
or

13

C labeled amides respectively.

All the precursors used in the synthesis are

available commercially. The two step synthesis requires 1 h reflux for the 1st step and
~30 min at around 100 ºC for the 2nd step. The product was highly pure yielding 6798% depending on the nature of the amide. No other impurities besides a small amount
of corresponding acids in some cases were observed. Purity of the products and their
structures were confirmed by gas chromatography/mass spectrometric (GC/MS)
analysis. 1H NMR was used for the characterization of the geometric isomers (cis/trans)
of the unsaturated amides. The products were found to be very stable over a period of
three years inside desiccators at room temperature.
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2.2 Introduction
It was not until Cravatt et al. [1] published report on the biological activity of primary
fatty acid amides (PFAM’s) that they caught attention as mammalian hormones.
PFAM’s were mainly used as slip additives in plastic industries before then. Slip
additives, added during the formulation of plastics, provide useful surface properties to
the plastic by gradually blooming to the surface. These properties include lubrication,
prevention of films from sticking together to molds and to each other and reduction of
static charge [2]. The primary amides that are used in various types of plastic as slip
additives are mainly oleamide, erucamide, palmitamide and stearamide [2-4].
In 1989 Arafat et al. [5] had reported the identification of 5 saturated and
unsaturated long chain primary fatty acid amides (palmitamide, palmitoleamide,
oleamide, elaidamide and linoleamide) in human luteal phase plasma, but their function
was not attributed. They also reported a synthetic procedure for the amides. It was
shown by Wakamatsu et al. [6] in 1990 that erucamide in bovine mesentery is an
angiogenic factor. Its angiogenic activity was also shown in regenerating skeletal
muscle but erucamide significantly did not show any proliferative activity in
endothelium, muscle and connective tissue [6, 7].
In 1995 isolation of oleamide from the cerebrospinal fluid of sleep-deprived cat
and induction of physiological sleep in rats upon injection of synthetic oleamide turned
attention to the fact that primary fatty acid amides might be an unrecognized class of
important bioregulators [1]. Since then primary fatty acid amides, especially oleamide
was widely studied and various activities of oleamide as well as other amides have been
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identified [6-21]. Bisogno et al. [22] have reported the production of oleamide by
N18TG2 mouse neuroblastoma cells and pointed out that oleamide might be synthesized
in vivo from oleic acid. This is contradictory to the fact that oleamide is produced in
vivo by the catalytic activity of PAM on N-oleoylglycine [23].
Recently Merkler et al. [24] have found that N18TG2 cells grown in

14

C oleic

acid under the conditions known to stimulate PAM expression show increased oleamide
production and under the conditions known to inhibit PAM activity produces

14

C N-

oleoylglycine (14C NOG). Their findings that oleamide can also be generated from the
cells grown in NOG, strongly support NOG as an intermediate and PAM as a catalyst in
oleamide biosynthesis in vivo. In order to carry out such studies, quantitation is a crucial
factor for complete understanding of these bio-regulators. Unfortunately, primary fatty
acid amides are not found commercially and they must be synthesized to be used as
standards for any quantitation study. The more stable isotopically labeled amides are
also required in order to be used as internal standards in such types of studies [5].
Synthesis of primary amides can be done conventionally by the reaction of
ammonia with the corresponding acids, anhydrides, esters or acyl halides [25]. The
direct reaction of carboxylic acid with ammonia requires harsh conditions which may be
suitable for the synthesis of short chain amides with no double bonds but may result in
the formation of undesired byproducts in the case of amides with reactive double bonds.
Reaction of acid anhydrides with ammonia can also lead to the formation of undesired
imides as byproducts [26]. A number of researchers [27-30] reported the coupling
reaction between acids and amines for the formation of amides under mild conditions,
but no long chain unsaturated or unsaturated primary fatty acid amides were included in
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these studies.

Lipase-catalyzed synthesis of butyramide and oleamide under mild

conditions was studied by Litjens et al. [31]. This method is mild and selective but
takes about 17 days for the formation of amides. Ammonolysis of triacyl glycerol was
also studied by Zoete et al. [32] but 72 h was required to yield oleamide by this method.
Very recently, the use of microwaves has become a popular synthesis device for
synthetic chemists due to the rapidness of the process. Amide syntheses under different
conditions were also studied by several researchers [33-37]. Unfortunately no results
for PFAM’s were reported. In 1989 Arafat et al. [5] reported the synthesis of long
chain primary fatty acid amides by the ammonolysis of corresponding fatty acid
chloride. They used ammonium hydroxide as a source of ammonia, which introduces
water into the system and hence keeps the window open for incomplete conversion and
byproduct formation. Anhydrous ammonia in this case can be a good candidate and in
fact Philbrook [38] reported the formation of lower aliphatic amides using a similar
procedure. In this chapter we have described the synthesis of a wide range of long
chain saturated and unsaturated primary fatty acid amides with high purity and higher
yield. This range also includes geometric and positional isomers of PFAM’s as well as
two isotopically enriched PFAM’s. After synthesis and purification, amides were
characterized by GC/MS and 1H NMR.
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2.3 Experimental
2.3.1 Reagents
Dodecanoic (lauric), tetradecanoic (myristic), hexadecanoic (palmitic), octadecanoic
(stearic), and docosanoic (behenic) acids were purchased from Acros organics (Morris
Plains, NJ); tridecanoic (tridecylic), heptadecanoic (margaric), eicosanoic (arachidic),
hexadecanoic-1

13

C (palmitic-1

13

C) acids and thionyl chloride were purchased from

Aldrich Chemical Co. (Milwaukee, WI); cis-9-tetradecenoic (myristoleic), cis-9hexadecenoic (palmitoleic), trans,trans-9,12-octadecadienoic (linoleladic), trans-11octadecenoic (vaccenic), cis-6-octadecenoic (petroselenic) and trans-9-octadecenoic
(elaidic) acids were purchased from ICN Biomedicals Inc. (Aurora, OH); trans-6octadecenoic
eicosenoic,

(petroselaidic),
cis-11-eicosenoic,

eicosadienoic,

cis-13-octadecenoic,
cis-13-eicosenoic,

cis,cis-9,12-octadecadienoic

cis-10-nonadecenoic,
trans-11-eicosenoic,

(linoleic),

cis-5-

cis-11-14-

cis,cis,cis-9,12,15

octadecatrienoic (α-linolenic), and cis,cis,cis-6,9,12 octadecatrienoic (γ-linolenic) acids
were purchased from Sigma Chemical Co. (St. Louis, MO); Heptadecanoic-D33-acid
was from CDN Isotopes (Quebec, Canada).

Laboratory grade toluene, heptanes,

isopropanol, and ethyl acetate were obtained from Fisher Scientific (Fair Lawn, NJ).
Anhydrous NH3 was supplied by Air Products & Chemicals Inc. (Allentown, PA).

2.3.2 Instrumentation
An Agilent Technologies Network GC/MS system (6890 GC with 5973 mass selective
detector and 7683 series injector) was used for the analysis of synthesized amides. The
column used was an HP-5MS (0.25 mm internal diameter, 0.25 µm film thickness, 30 m
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long, Agilent Technologies Inc., Palo Alto, CA) able to analyze fatty acids and amides
without prior derivatization. The GC/MS method used for analysis was as follows:
starting temperature was 55 ºC, ramped to 150 ºC at 40 ºC per min, held at 150 ºC for
3.62 min, ramped to 300 ºC at 10 ºC per min and finally held at 300 ºC for 2 min.
Electron impact ionization (EI) at 70 eV was used and mass range was kept from 40 to
400 m/z for total ion monitoring (TIM) mode. The fragment ions used for the single ion
monitoring (SIM) mode were m/z 59, m/z 72, m/z 62, and m/z 76. The temperatures of
the injection port and the transfer line were 250 ºC and 280 ºC respectively. Injection
volume was 1 µL splitless [39]. A Varian 500 NMR spectrometer was used to record
the 1H NMR at 500 MHz of the cis and trans isomers.

2.3.3 Synthesis procedure
Synthesis of primary fatty acid amides included two steps.

The 1st step was the

preparation of the acid chlorides from the corresponding acids and the 2nd step was the
formation of amides from the acid chlorides. The 1st step was optimized from Arafat et
al. [5] and the 2nd step was adopted with some modification from Philbrook [38], which
was originally for the synthesis of lower aliphatic amides.

+

R C
OH

Fatty acid

O

Cl

O
O

+

R C
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Cl

Cl
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Cl

Acid chloride
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at the tip of the closed
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Condenser
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N2 inlet, also
connected to a
bubbler
Thionyl
chloride
insertion

Fatty acid
dissolved in
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FIGURE 2-1(a): Set-up for PFAM synthesis 1st step.
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N2 and NH3 outlet through a needle
at the tip of the closed condenser

Condenser
with H2O in
and out

Drop wise
addition of fresh
acid chloride
N2 inlet, also
connected to a
bubbler

Continuous
bubbling of
anhydrous
NH3 from an
NH3 tank

Hot toluene
Hot water
bath

NH3 outlet

Hot plate

FIGURE 2-1(b): Set-up for PFAM synthesis 2nd step.

In order to carry out the 1st step [Figure 2-1(a)], 10 to 500 mg of acid (depending
on the amount available) was dissolved in 5 to 10 mL (depending on the amount of acid
used) of toluene (distilled over CaH2) inside a three-neck round bottom flask, which
was placed in a sand bath attached to a temperature regulator. Two side necks were
sealed using two Sura Seal White-Rubber Septa and the center neck was attached to a
condenser. The top of the condenser was sealed with a Sura Seal White-Rubber Septa
letting a N2 inlet and an outlet. N2 was allowed to pass for several minutes in order to
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achieve an inert environment while the acid was allowed to dissolve in hot toluene.
Thionyl chloride was added to the dissolved acid through a glass syringe needle and the
mixture was allowed to reflux for an hour. When the reaction mixture was semi-cold it
was transferred to a closed, N2 flushed round bottom flask to be used in the 2nd step.
In order to carry out the 2nd step [Figure 2-1(b)] 5 to 10 mL of toluene was
placed through a glass syringe needle in the same three-neck round bottom flask with
condenser attached to it. The flask was then placed in a boiling water bath allowing
toluene to be warmed. At this point anhydrous ammonia was continuously bubbled into
the hot toluene through one side neck and the acid chloride was added drop wise
through the other side neck using a glass syringe needle. After the addition of acid
chloride was complete, NH3 was allowed to bubble through the reaction mixture for 20
additional minutes in order to ensure the complete conversion to acid chloride to the
corresponding amide. N2 was kept on during the entire synthesis time.

2.3.4 Purification procedure
2.3.4.1 Saturated primary amides
The reaction mixture was then cooled on an ice bath, filtered and washed three times
with hot DDI water under vacuum to remove excess thionyl chloride and NH4Cl. The
sample was then dried inside a desiccator under vacuum. The sample was then run by
GC/MS in order to check the purity of the product. In case any other peaks besides the
amide peak were observed, the product was purified by column chromatography
(procedure described at the end of this section).
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2.3.4.2 Unsaturated primary amides
In case of the synthesis of unsaturated fatty acid amides, small amount of acid precursor
was available (10-50 mg). Therefore the amount of amide formed stayed dissolved in
toluene after synthesis. In this case, the reaction product was filtered while hot and the
residue was washed with hot toluene once. The filtrate containing the amide was dried
using a rotary evaporator and kept inside a desiccator under vacuum for further drying.
The purity of the product was checked by GC/MS and similarly if any other peaks
besides amide peak were observed, the product was purified by column

Standard oleic acid

Oleamide and
oleic acid mixture

Standard oleamide

chromatography.

FIGURE 2-2: Separation of oleamide and oleic acid by TLC.
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2.3.4.3 Column chromatography method
Only a small amount of acid was observed with amides in some of the final products.
Therefore, a thin layer chromatographic (TLC) method (Figure 2-2) was developed for
the separation of acids from amides and this method was adapted for the purification of
amides by column chromatography. The products found to contain some acids were
dissolved in isopropanol and loaded onto a silica column (pre-soaked in 80:20;
heptanes: isopropanol). Product was eluted with heptanes: isopropanol: ethyl acetate
(80:16:4) and fractions were collected in 10 mL test tubes. Each fraction was identified
by comparing the spot on a TLC plate to that of a standard amide and acid. Fatty acid
fractions were discarded and the amide fractions were pulled together, dried under
rotary evaporator, and stored inside desiccators under vacuum for further drying.

2.4 Results and Discussion
2.4.1 Optimization of synthesis conditions
A total of seven stearamide syntheses were carried out following the procedure
described in the above section in order to achieve an optimized conversion of acid to
corresponding acid chloride. Optimization parameters are listed in Table 2-I. The
effect of reflux time, amount of toluene and the amount of thionyl chloride required for
maximum yield were studied. It is shown in Table 2-I that percent yield increases from
50% to 85% with the increases of reflux time from 30 min to 60 min and decreases to
52% upon 90 min reflux. The percent yield increases from 85% to 94% by increasing
the amount of SOCl2 from 128 µL (number of moles of SOCl2 required to react with the
number of moles of stearic acid in 0.5 g of acid) to 140 µL (10% excess SOCl2) and
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remained similar by further increasing the amount to 160 µL (20% excess SOCl2).
Decreasing the amount of toluene showed tremendous decrease in yield whereas
increase in toluene amount did not have much effect on the percent yield indicating
proper dissolution of the acid in toluene is a key to better yield.

The optimum

conditions were therefore 10 mL of toluene, 1 h. reflux and 10% SOCl2 above the
stoichiometric amount. These conditions were followed for the syntheses of all of the
other amides. Table 2-II shows the percent yield for 25 amides. Unsaturated amides
were found to have lower yields than saturated and isotopically labeled amides, which
were expected due to the higher reactivity of unsaturated acids. The amides synthesized
by this method were found to be stable over a three year period of time.

TABLE 2-I: Optimization conditions for the 1st step in the synthesis of stearamide
(C18:0).
Optimization

Amount of

Amount of

Amount of

Reflux

Yield

steps

stearic acid

toluene

SOCl2

time

(%)

(g)

(mL)

(µL)

(min)

#1

0.5

10

128

30

50

#2

0.5

10

128

60

85

#3

0.5

10

128

90

52

#4

0.5

10

140

60

94

#5

0.5

10

160

60

91

#6

0.5

5

140

60

64

#7

0.5

15

140

60

91
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2.4.2 Characterization of the synthesized amides
2.4.2.1 Gas chromatography and mass spectrometry (GC/MS)
Upon drying after synthesis, the amides were dissolved in isopropanol and were run by
GC/MS. GC of 16 different amides is shown in Figure 2-3. It can be noticed from the
Figure 2-3 that the detection limit for the unsaturated amides is very high compared to
the saturated ones and the retention time of the amides increase with the increasing
number of carbon in the chain as expected. Unsaturated amides with the same number
of carbons elutes in the same region for example all the unsaturated 18 carbon amides
elute around 16.65 to 16.75 min under the GC/MS method and column conditions
·

described in the previous section. An M+ ion gas chromatogram of ten 18-carbon
(C18) amides is shown in Figure 2-4 where X and Y axes have been shifted for each
peak in order to show these co-eluting amides. A more polar column such as BPX70
(70% cyanopropyl) can be employed for the separation of these amides.

One

disadvantage though is that the derivatization of these amides to their trimethylsilyl
(TMS) ester is required for analysis by this column. Results from this study will be
discussed in Chapter 6.
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TABLE 2-II: Percent product yield for the synthesized amides.
Fatty acid amide

% yield

Scientific symbol *

Lauramide

98

C12:0

Tridecanoamide

68

C13:0

Myristamide

85

C14:0

Myristoleamide

81

C14:19

Palmitamide

97

C16:0

Palmitoleamide

89

C16:19

Palmit-1-13C-amide

95

C16 (13C-1):0**

Heptadecanoamide

75

C17:0

Heptadecano-D33-amide

93

C17D33:0 **

Stearamide

94

C18:0

Oleamide

Commercially available

C18:19

Elaidamide

98

C18:1trans 9

Petroselenamide

80

C18:16

Petroselaidamide

90

C18:1trans 6

vaccenamide

92

C18:1trans 11

Cis-13-octadecenoamide

90

C18:113

linoleamide

77

C18:29,12

linolelademide

84

C18:1trans 9,12

α-linolenamide

98

C18:39,12,15

γ-linolenamide

96

C18:36,9,12

Cis-10-nonadecenoamide

89

C19:110

Eicosanoamide

72

C20:0

Cis-5-eicosenoamide

67

C20:15

Cis-11-eicosenoamide

65

C20:111

Trans-11-eicosenoamide

78

C20:1trans 11

Cis-13-eicosenoamide

90

C20:213

Cis-11,14-eicosadienoamide

75

C20:211,14

Docosanoamide

88

C22:0

Erucamide

Commercially available

C22:113

* Scientific symbols represent the number of carbon atoms in the chain, position and
geometrical configuration of the double bond.
** Shows the carbons or hydrogens in red that are isotopically labeled.
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FIGURE 2-3: Elution profile for C12-C22 amides on a HP-5MS column. The relative
intensities at m/z 59, 72, 62 and 76 are plotted against retention time.

The electron impact ionization MS patterns of four 18-carbon amides are shown
in Figure 2-5 and the structures for the common key fragment ions formed have been
drawn for illustration (also see Scheme 2.1).

All the amides showed similar

fragmentation patterns which included the molecular ion peak, [M]+•; the peak due to
the loss of NH3 and formation of a ketene, [M-17]+; the peak due to the loss of -CH2CH2-CH3, [M-43]+; the peaks due to the consecutive loss of methylene groups (14 u);
and the peaks at m/z 59 and m/z 72 due to the McLafferty rearrangements. The other
fragmentation patterns observed were due to the fragment ions from the C6-C7 cleavage
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and C5-C6 cleavage of the ketene, for example at m/z 97 and m/z 83 respectively for
both oleamide and stearamide [22, 39].

The poly unsaturated fatty acids showed

additional fragment ions from cleavages between C5-C6 and C9-10 (i.e., m/z 55); from
cleavages between C7-C8 and C12-13 (i.e., m/z 67); from cleavages between C5-C6
and C12-13 (i.e., m/z 95).
linolenamide (C18:3

9,12,15

The ions specific for linoleamide (C18:2

9,12

) and

) arises from cleavages between C9-C10 and C15-16 and

from cleavages between C9-C10 and C16-17 (m/z 81 and m/z 95 respectively for
linoleamide and m/z 79 and m/z 93 respectively for linolenamide).

These

fragmentation patterns show that the double bonds are preserved in the fatty acid
amides after their synthesis from corresponding fatty acids. The MS patterns for the
isotopically labeled amides were the same as the naturally abundant amides. The peaks
at m/z 60 and m/z 73 in case of 13C-1-palmitamide [Figure 2-6(a)] and the peaks at m/z
62 and m/z 76 in case of heptadecano-D33-amide [Figure 2-6(b)] were also due to
McLafferty rearrangement. The shift of m/z 59 to m/z 60 for the first one and m/z 62
for the latter are due to one

13

C and two deuterium atoms, respectively. The shifts of

m/z 72 to m/z 73 and m/z 62 respectively can also be explained similarly (Figure 2-6).
Their molecular ion peaks resided at m/z 256 and m/z 302, respectively.
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Scheme 2.1(A)

m/z 72 (Mc Lafferty rearrangement)
O
NH2
m/z 59 (Mc Lafferty rearrangement)
oleamide

.
[M] +
m/z 83

-NH3
O
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Scheme 2.1(B)
m/z 72 (Mc Lafferty rearrangement)
O
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.
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m/z 55
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Scheme 2.1(C)
m/z 72 (Mc Lafferty rearrangement)
O
NH2
m/z 59 (Mc Lafferty rearrangement)

.+

Linolenamide [M]

-NH3
O
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.+

Scheme 2.1(D)
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O
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H2C
HO

+

.

m/z = 59
Scheme 2.1: Mass-spectral (quadrupole) fragmentations for A) oleamide (saturated amides shows
similar patterns), B) linoleamide (C18:2 9, 12) and C) linolenamide (C18:2 9, 12, 15). D) McLafferty
rearrangement ions common to all amides.
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FIGURE 2-4: M+ ion gas chromatogram of ten 18-carbon (C18) amides. X and Y axes
have been shifted for each peak in order to show the co-eluting amides.
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FIGURE 2-5: Mass spectrum patterns of four 18-carbon amides (a) stearamide; C18:0
(b) oleamide; C18:1 (cis-9), (c) linoleamide; C18:2 (cis,cis-9,12) and (d) linolenamide;
C18:3 (cis, cis, cis-9,12,15).
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13

C-1-palmitamide and (b) C17D33-

2.4.2.2 Nuclear magnetic resonance
1

H NMR was used to characterize the cis and trans isomers of some of the amides.

Figure 2-7 shows the NMR spectra of eight C18 amides (including commercially
available cis-9-octadecenamide, C18:19) using benzene d6 as a solvent (7.15 ppm).
Peaks for the synthesized amides were compared with the predicted values and also the
literature values for C18 amides [40, 1]. In all the spectra, peaks due to methyl group
(multiplet, 0.78 to 0.95 ppm), broad peaks due to long alkyl methylene protons
(multiplet, 1.12 to 1.42 ppm), peaks due to CH2-CH2-CO-NH2 (multiplet, 1.42-1.56
ppm), allylic protons (multiplet, 1.58-1.71 ppm), and CH2-CO-NH2 (multiplet, 1.862.10) and peaks due to alkene protons (multiplet, 5.30-5.50 ppm) were observed. The
cis isomers showed a slight downfield shift for all the peaks compared to those for the
trans isomers [Figure 2-7 (a-h)]. As the position of the double bond moves further
away from the carbonyl group, slight upfield shift of the peak of the alkene protons was
observed [Figures 2-7(a), 2-7(c) and 2-7(f)].
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FIGURE 2-7: NMR spectra of C18 unsaturated primary fatty acid amides. Please refer
to Table 2-II for symbol description.

2.5 Conclusions
In conclusion, we have developed an efficient method for the synthesis of primary fatty
acid amides by modifying the simple amide synthesis.

Naturally and isotopically

abundant PFAM’s were synthesized with comparative efficiency. Unsaturated amides
as well as their positional and geometric isomers were also synthesized with similar
efficiency. Amides synthesized by our method were found to be stable over a long
period of time when stored in desiccators at room temperature under N2. Stearamide
was found to be stable over a three year period of time. The trans isomers and the
isotopically enriched amides were more stable than the rest. They also showed higher

99

0

percent yields. Even though some of the unsaturated amides were not separated by HP5MS column, possible use of BPX70 column for their separation will be discussed in
Chapter 6. The synthesized amides were successfully employed in the study of total
lipid profiling by HPTLC [41], amide extraction by SPE [42] and also in the separation
study of the PFAM’s by HPTLC [43], HPLC [44, 45] and GC/MC [manuscript under
preparation].
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Chapter 3
Total lipid profiling of N18TG2 mouse neuroblastoma cells by HPTLC
and quantification of primary fatty acid amides (PFAM’s) by GC/MS

3.1 Abstract
A method for total lipid profiling by HPTLC from a standard lipid mixture was
developed.
precursors

Bioactive primary fatty acid amides (PFAM’s), their biosynthetic
N-acylglycines,

as

well

as

the

cannabinoid

receptor

class

N-

acylethanolamine were included in this profiling as lipid classes. The method was
validated using the extracted lipids from amide spiked N18TG2 mouse neuroblastoma
cells, which have been shown to have catalytic activities necessary to produce PFAM’s.
Extracted lipids were then quantified by comparing with the calibration curve of
standard lipids using Kodak scientific imaging system (SIS). Isolated PFAM spots
were scraped out of the HPTLC plates for quantification by GC/MS and percent
recoveries from GC/MS analysis were found comparable to the results obtained by SIS.
HPTLC is a simple sample clean-up step, which can be useful for analyzing PFAM’s
also in conjunction with LC/MS, and/or CE.
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3.2 Introduction
The analysis of primary fatty acid amides (PFAM’s) is rather troublesome due to their
low abundance in biological samples and higher detection limits for instrumental
analysis. The low volatility of these compounds generally requires the formation of
thermally stable derivatives for gas chromatographic/mass spectrometric (GC/MS)
analysis [1-10]. The absorption of the -CONH2 group at low UV region (~210 nm)
gives rise to poor sensitivity for liquid chromatographic (HPLC) determination [11]
even though a number of researchers have reported successful analysis of PFAM’s by
HPLC [6, 12-17].

Liquid chromatography with tandem mass spectrometry

(LC/MS/MS) [18, 19] as well as capillary electrophoresis with laser induced
fluorescence (CE/LIF) [20, 21] can be good choices for PFAM analysis but sample
clean-up is a crucial factor for any instrumental analysis [22] to increase the detector
lifetime as well as the sensitivity. Since PFAM’s are usually extracted from cells or
tissues along with the other lipids present in the total lipid extract, their complete
isolation from the lipid extract can provide interference free instrumental analysis. The
use of clean samples will generally result in higher sensitivity and lower detection limit.
Thin layer chromatography (TLC) is the oldest technique used for sample clean
up due to its low cost, ease of handling, ability to run multiple samples in parallel and
moderate separation times. The separation of almost any compound from its impurities
can be achieved by modifying the developing solvent. Solid-phase extraction (SPE) is
another sample clean-up technique most recently being used. An advantage of TLC
over column chromatography and SPE is that it can provide a quick profiling of all the
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compounds present in a sample matrix, giving the analyst an idea of the interfering
compounds along with the target analyte. Possible visualization of the TLC plates
under UV light makes any method development rather quick and complication free.
High performance thin layer chromatography (HPTLC) plates use particle sizes less
than ~15 µm, which gives rise to less spot spread and higher resolution in separation
than that regular TLC can offer. HPTLC requires improved analytical techniques for
spotting the plates for quantification purposes. Samples can be spotted at any desirable
amount at constant pressure with minimal spread. The two possible types of TLC
development methods are horizontal and vertical development.

After sample

application TLC plates are placed in a vertical chamber containing developing solvent
at the bottom for vertical development. Horizontal development chambers are flat with
spaces to fit TLC plates of specific dimensions and have solvent chambers on both
sides. This set-up allows TLC development either from one side, which ends at the
other side or from both sides, which ends in the middle of the plate. In the latter case,
sample can be applied on both sides of the plate increasing overall sample throughput.
One disadvantage of horizontal development is that if the surface is not completely
horizontal, uniform separation throughout the plate can not be achieved. The separation
on TLC plate occurs by adsorption mechanism. The samples applied on the plates are
adsorbed on the surface of the silica gel.

Because silica gel is very polar, polar

compounds are bound more strongly than the non-polar compounds. As the plates are
developed by any solvent or mixture of solvents (which are less polar than silica), the
most non-polar compounds travel furthest from the point of sample application. TLC
plates can be visualized under visible or UV light after development depending on the
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absorptivity of the compounds to be analyzed. Colored compounds can be seen with
the unaided eye because they absorb light in the visible region but the colorless
compounds require the help of UV light for visualization. Some specific compounds
such as lipids absorb light in the very low UV region, which are difficult to visualize
even in the UV region. Spraying the TLC plates with certain chemicals in order to form
fluorophore (which fluoresces in the UV region) is useful in such cases for visualization
[23, 24].
The use of TLC in the separation of various lipids from crude lipid extract has
now become common practice in lipid analysis (please see Ref. 25 for review). Many
of these studies are carried out to quantify lipid class spots on the TLC plate itself by
spectrodensitometry [26-35], whereas the remainder were to scrape individual spots and
analyze them by the instrument of choice [36-46]. Quantification of various lipid
classes on TLC plate largely depends on the visualization technique used. Charring the
plates with aqueous ammonium bisulfate, aqueous sulfuric acid, iodine vapors or
sulfuric acid-dichromate reagent are the conventional visualization techniques used.
Some researchers reported better sensitivity with cupric acetate charring [29]
whereas others [30] reported even better sensitivity when cupric sulfate was used.
Cupric acetate was found to react only with the unsaturated species whereas cupric
sulfate was found to react with both saturated and unsaturated species [47]. Rhodamine
6G dye, 2, 7-dichlorofluorescein [24, 40] and a lipophilic dye, primuline, were also used
by some researchers [41, 48]. The advantage of using such dyes is that they are nondestructive and can be removed from the lipids after scraping the spots for further
analysis. It is clear from literature review as well as from personal experience that
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optimum and constant spraying, dipping, or charring is required for reproducible results
by spectrodensitometry. For instrumental analysis it is ideal not to spray the plates
being scraped. Position of the target spot on an untreated plate can be measured by
comparing the spots on a treated plate under the same conditions. This practice reduces
the sample loss by the sample recovery from the spraying reagent, resulting in the
higher percent recovery. The addition of an internal standard (IS) to the sample after
scraping is also crucial for quantitative analyses.
Analysis of PFAM’s by TLC was reported by a number of researchers. Jasperse
et al. [13] could separate the PFAM’s from the fatty nitriles on a TLC plate but the
separation by chain length was achieved only by HPLC. They reported TLC as a quick
scanning technique to assess the method development. Bilyk et al. [49] studied the
separation of free fatty acids, fatty acid amides and fatty acylglycerol on a TLC plate.
They described TLC as a rapid means of identifying the components of fatty mixtures
with highly reproducible separation even though no data on quantification was
available. Kaneshiro et al. [50] have used TLC for the detection of amides while
studying their bioconversion from oleic acid by Bacillus megaterium. They used iodine
vapor for the visualization of unsaturated and sulfuric acid charring at 140 ºC for the
visualization of saturated amides.

Separation of amides was achieved by further

analysis with HPLC and GC. TLC was also used for the identification of oleamide
produced by Streptomyces sp. KK90378, a soil microorganism [51]. After purification
by TLC and column chromatography, the structure of oleamide was confirmed using
GC/MS and NMR.
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In this chapter, we report the inclusion of primary fatty acid amides, Nacylethanolamines and N-acylglycines as lipid classes in total lipid profiling by high
performance thin layer chromatography (HPTLC). The method was validated using the
lipids extracted from N18TG2 cell, a model line, that was found to (i) express
peptidylglycine α-amidating monooxygenase (PAM), (ii) show increased PAM
expression upon differentiation, and (iii) produce both oleamide and anandamide. It is
necessary to add here that the biosynthesis of PFAM’s from N-acylglycines is catalyzed
by PAM in vivo (please see Section 1.5 of Chapter 1 for more information). The total
lipid extract from amide spiked N18TG2 cells was loaded on the HPTLC plates and the
lipid classes were profiled [52-53]. Isolated PFAM’s spots were scraped off the plates
and analyzed by GC/MS free of interference from other lipid classes [54]. Because this
method was validated for isolating and analyzing the amides from amide-spiked N18TG2
cells, it is likely that PFAM’s as well as NAE and NOG can be isolated and analyzed
quantitatively also from any cultured cell type.

3.3 Experimental
3.3.1 Reagents
Oleamide (OM), oleic acid (OA), tristearin (TS), tricaproin (TC), monooleoyl glycerol
(MOG), monopalmitoyl glycerol (MPG), monocaproyl glycerol (MCG), dipalmitin
(DP), phosphatidylcholine (PC), N-oleoylglycine (NOG), N-oleyolethanolamine (NOE),
sphingomyelin (Sph), gangliosides (G) and squalene (Sq) were purchased from Sigma
(St. Louis, MO). Cholesterol (Ch) was purchased from EM Science (Darmstadt,
Germany) and cholesteryl palmitate (ChP) from Janssen Chemical (Geel, Belgium).
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The solvents used for making solutions and mobile phases were purchased as follows:
ACS reagent grade chloroform and methanol from EM Science and EMD (Darmstadt,
Germany) respectively; ACS reagent grade hexanes and glacial acetic acid from Fisher
Scientific (Fair Lawn, NJ); acetone and diethyl ether from Acros Organics (Geel,
Belgium) and Aldrich Chemical Co. (Milwaukee, WI) respectively. Stearamide and
palmitamide were synthesized from the corresponding acids according to the published
protocol [55] modified in our laboratory.

3.3.2 Cells
N18TG2 cells treated under different conditions were provided by our collaborators Dr.
David Merkler and Dr. Kathy Merkler of University of South Florida. The descriptions
are as follows: N18TG2 is a mouse neuroblastoma cell line that was obtained from
DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH;
Braunschweig, Germany).

The N18TG2 cells were grown in Dulbecco's Modified

Eagle's Medium (DMEM, Mediatech Cellgro, Herndon, VA) supplemented with 1%
penicillin-streptomycin (Sigma Chemical Co., St. Louis, MO), 10% fetal bovine serum
(FBS, Atlanta Biological, Atlanta, GA), and 100 mM 6-thioguanine (Sigma) at 37 °C
and 5% CO2 atmosphere. Several conditions were set up: 1) No Tx: no treatment with
differentiation agents, 2) Differentiated (Diff.) Control: Cultures were grown to 60%
confluency and then differentiated for two days in low serum (0.5% FBS) DMEM
containing 200 ng/mL nerve growth factor (NGF, Boehringer Mannheim,
Indianapolis,IN), and 1 mM dibutyryl cAMP (Sigma), 3)

Undiff. + oleic acid:

undifferentiated cells that were at 60% confluency were treated with DMEM + 200 µM
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oleic acid for 2 days and 4) Diff. + oleic/ palmitic / stearic acid: cells at 60% confluency
were treated with low serum DMEM + differentiation agents + 200 µM of a particular
acid for 2 days. The cells were detached from the tissue culture flask using a cell
scraper. The cells were then centrifuged (250 x g) and washed 3 times with Dulbecco's
Phosphate Buffered Saline (DPBS). The pellets were flash frozen in a dry ice/methanol
bath and stored at -80º C.

3.3.3 HPTLC plates
High performance thin layer chromatography plates (HPTLC) were purchased from
Analtech (Newark, DE). These plates were of 10 x 10 cm and with organic binder and
no fluorescence indicator incorporated. Primuline dye, (CI 49000; direct yellow 59)
used for spraying the HPTLC plates, was obtained from Aldrich.

3.3.4 Systems and instruments
Camag Nanomat and capillary dispenser system, purchased from Camag (Muttenz,
Switzerland), was used for easy application of samples on HPTLC plates in the form of
spots with minimal spread, precisely positioned and without damage to the layer. 1 µL
sample was applied at a time with disposable capillary pipettes. Preval power unit
(Precision Valve Corporation, Yonkers, NY) for spraying primuline dye on the HPTLC
plates was purchased from a local hardware store. Fluorescent images were obtained
using Kodak digital science 440 image station (IS440cF, Perkin Elmer, Boston, MA)
and the image analysis was carried out by Kodak 1D scientific image analysis software
(Scientific imaging system; SIS, New Haven, CT). An Agilent Technologies Network
GC/MS system (6890 GC with 5973 mass selective detector and 7683 series injector)
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was used for GC/MS analysis. The column used was an HP-5MS (0.25 mm internal
diameter, 0.25 µm film thickness, 30 meter long, Agilent Technologies Inc., Palo Alto,
CA) able to analyze fatty acids and amides without prior derivatization. The GC/MS
method used for analysis is as follows: Starting temperature was 55 ºC, ramped to 150
ºC at 40 ºC per min, held at 150 ºC for 3.62 min, ramped to 300 ºC at 10 ºC per min and
finally held at 300 ºC for 2 min. Electron impact ionization (EI) at 70 eV was used and
mass range was kept from 40 to 400 m/z for total ion monitoring (TIM) mode. The
fragment ions used for the single ion monitoring (SIM) mode were m/z 59, m/z 72, m/z
62, and m/z 76. The temperatures of the injection port and the transfer line were 250 ºC
and 280 ºC respectively. Injection volume was 1 µL splitless.

3.3.5 Method development
12 lipid markers and their mixtures were used for HPTLC method development. These
lipids include OM, OA, Ch, ChP, TS, MOG, DP, NOG, NOE, PC, Sph and G. HPTLC
mobile phases were made the day before analysis. Solvents were mixed in correct
proportions, sonicated for an hour and kept on the bench top with caps on. 2 µL of each
standard were applied on HPTLC plates 1 cm from the bottom using the Camag
capillary holder. Warm air from a hair dryer was applied continuously for 5 min before
sample application in order to activate the silica gel and for 1 more minute after the
application in order to dry the spots. For plate development, twin trough chambers for
10 x 10 cm plates from Camag were used. HPTLC separation method was modified
from the method used by White, et al. [41] in order to separate PFAM’s as a lipid class.
Firstly, the 10 x 10 cm plates were developed up to 5.5 cm from the bottom in
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chloroform: methanol: acetic acid (95:5:1, v/v/v), dried for 5 min with warm air from a
hair dryer. Secondly, the dried plates were developed in hexanes: diethyl ether: acetone
(60:40:5, v/v/v) up to 8 cm, re-dried. Thirdly and finally, the plates were developed in
hexanes: diethyl ether (97:3, v/v) to 9.5 cm. These plates were then dried for 5 min and
sprayed with a 0.05 % primuline solution (in 80:20, v/v acetone: water) and re-dried.
The dry plates were scanned by Kodak digital Science 440 image station.

3.3.6 Method validation
The developed method was validated using the lipids extracted from N18TG2 cells. Six
different N18TG2 cells were used in this study. Cell 1, differentiated (diff.) cells grown
in oleic acid; cell 2, diff. control; cell 3, diff. cells grown in stearic acid; cell 4, diff.
cells grown in palmitic acid; cell 5, undifferentiated (undiff.) cells grown in oleic acid,
and cell 6, No treatment (No Tx) N18TG2 cells. The cells were stored at -80 ºC upon
arrival in the laboratory. They were taken out just before the extraction and kept on dry
ice until suspending in methanol. Cells 1 and 5 were spiked with oleamide; cells 3 and
4 were spiked with stearamide and palmitamide, respectively, before lipid extraction in
order to be able to see the amides on the HPTLC plates and to analyze percent recovery.
Spiking was done by suspending the cells with 1 mL amide solutions in methanol
(0.947 µmol/mL oleamide, 0.941 µmol/mL stearamide and 1.044 µmol/mL of
palmitamide). Lipid extractions from all the cells were carried out according to White
et al. [41] and Folch-Pi et al. [56] with a little modification. The methanol suspension
was sonicated for 15 min at room temperature and centrifuged at 4500 rpm for 10 min.
The supernatant was separated from the pellet, dried under a stream of N2 in a warm
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water bath at 35-40 ºC. The pellet was re-extracted with 1 mL of 1: 1: 0.1; (v/v/v)
chloroform: methanol: water, sonicated for 10 min, vortexed for 2 min and centrifuged
for 10 min as above. Supernatant from this step was added to the dried supernatant
from the previous step and re-dried the same way.

The total extract was then

partitioned into lipid and non-lipid portions by adding 1.2 mL of chloroform: methanol
(2:1, v/v) and 200 µL of 0.5 M KCl/ 0.08 M H3PO4. This partitioned extract was
sonicated for 2 min, vortexed for 2 min and centrifuged for 10 min at 4500 rpm. The
lower lipid phase was dried under a stream of N2 in a warm water bath at 35-40 ºC. The
dried lipid extract was dissolved in 100 µL of 0.5 mg/mL squalene solution in
chloroform: methanol (2:1, v/v). 2 µL of these final lipid solutions (six solutions for six
different cells) were applied on HPTLC plates so that the amount of each amide applied
on the HPTLC plates is 5.33 µg from the spiked cells.
3.3.6.1 Quantification of lipid classes by KODAK SIS
Because nine different lipid classes were visibly separated in the total lipid extract,
calibration curves of nine lipid markers were prepared. All the standard solutions were
made with a 0.5 mg/mL squalene (an internal standard) solution in chloroform:
methanol (2:1, v/v). Squalene was chosen as an internal standard based on 3 factors: (i)
its good resolution from all the lipid classes (it is a non-polar hydrocarbon), (ii) the
quantity of squalene applied on the HPTLC plates falls within the range of the amount
of lipids applied, and (iii) it can be visualized using primuline dye along with other lipid
classes. The sample spots were quantified by comparing their pixel intensities relative
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to the internal standard to those of the corresponding standard curves (n = 7 to 10).
Kodak 1D scientific imaging software (SIS) was used for this analysis.
3.3.6.2 Quantification of PFAM’s by GC/MS
For GC/MS analysis of PFAM’s, the spots containing amides were scraped off the
HPTLC plates. These plates were not sprayed with primuline and the positions of
PFAM’s were determined by comparing with plates that were sprayed with primuline.
The amides were then treated as follows: (i) amide adsorbed silica-gel was suspended in
2-propanol containing the internal standard (0.8 ng/µL heptadecano-d33-amide) and
sonicated for 5 min to dissolve the amide, (ii) the suspension was then centrifuged and
the supernatant was collected, (iii) any silica particle left in the supernatant was
removed by filtering through 0.2 µm nylon membrane filter (Whatman), and finally (v)
the sample was injected into GC. Quantification of cell amides was done by comparing
their peak areas relative to the internal standard to those of the corresponding standard
curves.

3.4 Results and Discussions
In order to develop a method for total lipid profiling including PFAM’s as a lipid class,
the method described by White et al. [41] was modified. Their method was a multi-step
one dimensional TLC development using 4 different solvent systems. In order to follow
how each lipid moves after development by each solvent system, six different plates (AF) were developed. Besides the four solvent systems used by White et al., 100 %
CHCl3 was included in this method as the first solvent.
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1A

1B

1C

TAG
FFA
1, 3 DAG
1, 2 DAG
Ch
PFAM
MAG

1D

1E

1F

TAG
FFA
1, 3 DAG
Ch
1, 2 DAG
PFAM
MAG

FIGURE 3-1: Step 1 for the method development of the total lipid profiling. The spots
on the plates from left to right are OM, OA, Ch, TS, TC, MOG, mixture of lipids and
DP except on plate E where the spots are OM, OA, Ch, MPG, mixture and DP. For
conditions for each plate, see text.
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Therefore the solvent systems used were (i) 100% CHCl3, (ii) CHCl3: MeOH :
HOAC (90:10:1; v/v/v), (iii) hexanes : diethyl ether : acetic acid (60:40:5; v/v/v), (iv)
hexanes : diethyl ether (97:3; v/v) and (v) 100 % hexanes. The lipids spotted on the
plates to start out are OM, OA, Ch, TS, TC, MOG, DP and a mixture of the standard
lipids. Plate A was developed in solvent (i) to 2.5 cm; plate B in solvent (i) to 2.5 cm
and in solvent (ii) to 4 cm; plate C in solvent (i) to 2.5 cm, in solvent (ii) to 4 cm and in
solvent (iii) to 8 cm; plate D in solvent (i) to 2.5 cm, in solvent (ii) to 4 cm, in solvent
(iii) to 8 cm and in (iv) to 9.5 cm; plate E in solvent (i) to 2.5 cm, in solvent (ii) to 4 cm,
in solvent (iii) to 8 cm, in solvent (iv) to 9.5 cm and in solvent (v) to the top. Plate F
was developed as was plate E except solvent (i) was skipped (see Figure 3-1 for A
through F TLC images).
It was apparent that the lipids were not moving from the loading position very
much with the first solvent. The second solvent was found to be the key solvent that
moved the relatively polar lipids, whereas the third solvents carried the relatively nonpolar lipids further. The fourth solvent did not seem to have too much effect except for
giving better resolution between the lipids. The main point of the use of the fifth
solvent was to wash off any non-polar impurities from the plate. The plate F seemed to
have better separation then E, therefore the first solvent was skipped for the rest of the
study. Figure 3-2 shows the next step taken in the method development. Since the 2nd
solvent moves the relatively polar lipids from the position of load, the distance traveled
by this solvent was changed (plate C) to observe if any further separation between
PFAM and MAG can be achieved. Plate A and B were developed the same way as
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plate F and E respectively from Figure 3-1. Plate C was developed as plate F in Figure
3-1 except the distance traveled by the second solvent was 5 cm instead of 4 cm.

2A

2B

2C

TAG
FFA
1, 3 DAG
1, 2 DAG
Ch
PFAM
MAG

FIGURE 3-2: Step 2 for the method development of the total lipid profiling. The spots
on the plates from left to right are OM, mixture of lipids and MOG except on plate C
where the spots are OA, OM, mixture, MPG and DP.

As shown in Figure 3-2, a better separation between PFAM and MAG was
achieved by the travel of the second solvent to 5 cm. The third step of the study was to
see if a different combination of the second solvent provides better resolution between
OM and MAG. Figure 3-3 shows that the development of the TLC plate by the second
solvent system in a ratio 95:5:1 instead of 90:10:1 indeed gave better separation
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between the polar lipids. Introduction of 3 different MAG (monoacyl glycerol) shows
that MOG moves a little further than MPG and MCG. The next step therefore was to
vary the composition of the second solvent system and the distance traveled by it.

TAG
FA
1, 3 DAG
1, 2 DAG
Ch
PFAM
MAG

FIGURE 3-3: Step 3 for the method development of the total lipid profiling. The
developing solvent for this plate was CHCl3 : MeOH : HOAc (95:5:1 ; v/v/v) to 5 cm.
The spots on the plate from left to right are mixture of lipids, MPG, MCG, Ch, MOG
and mixture of lipids.
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PFAM
MAG
NAE & NAG
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4D

TAG

FFA

1, 3 DAG
Ch
1, 2 DAG

PFAM

MAG

NAE & NAG

PL

4E

4F

TAG
FFA

1, 3 DAG
Ch
1, 2 DAG
PFAM
MAG

Standard lipid mixture

Sphingomyelin
Gangliosides
Phosphatidyl choline

N-oleoylglycine
Dipalmitin

Monooleoyl glycerol
Standard lipid mixture

Tristearin

N-oleoylethanolamine

Tricaproin

Oleamide

Oleic acid
Cholesterol

Standard lipid mixture

Standard lipid mixture

Gangliosides
Phosphatidylcholine

Dipalmitin

Sphingomyelin

Monooleoyl glycerol
Standard lipid mixture
N-oleoylglycine

Cholesterol
Tricaproin
Tristearin
N-oleoylethanolamine

Oleamide

Oleic acid

Standard lipid mixture

PL

FIGURE 3-4: HPTLC method development step 4. Effect of the composition of the
CHCl3: MeOH : HOAc on the total lipid profiling. See text for conditions.

Figure 3-4 shows six different plates A through F with composition of solvent
(ii) varying from 94:6:1, 95:5:1, 96:4:1, 97:3:1, 98:2:1 to 98:2:2 respectively. The
distance traveled by the solvent was 5 cm. All other conditions of the development
were as same as those for plate C of Figure 3-2. Since Figure 3-4 shows that 95:5:1 was
giving comparatively better resolution than the other composition, the distance traveled
by this solvent was varied. Five different distances were tried with all other conditions
the same as the plates in Figure 3-4.
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FIGURE 3-5: HPTLC method development step 5. Effect of the distance traveled by
CHCl3: MeOH : HOAc (95:5:1; v/v/v) on the total lipid profiling. Distances for plates
A-E were 4 cm , 5 cm, 6 cm, 7 cm and 8 cm respectively.

The plates in Figure 3-5 clearly show that 5 cm was the best distance to be used
for optimum lipid class separation. The lipids included in the distance study were OM,
MOG, DP and Ch movement of which were mostly affected by any change in distance
traveled by solvent (ii).

Therefore the optimum method was taken as follows:

123

development in CHCl3 :MeOH : HOAc (95:5:1; v/v/v) to 5 cm, in hexane : diethyl
ether: acetic acid (60:40:5 ; v/v/v) to 8 cm followed by in hexane : diethyl ether (97:3;
v/v) to 9.5 cm.

Sq
CE
TAG

FA
1, 3 DAG
Ch
1, 2 DAG
PFAM

PFAM

NAE

MAG
NAE

NAG

NAG

Standard lipid mixture

N-oleoylethanolamine

Phosphatidyl choline

Gangliosides

Monooleoyl glycerol

Sphingomyelin

Dipalmitin

N-oleoylglycine

Tristearin

Cholesteryl palmitate

Cholesterol

Oleic acid

Oleamide

Standard lipid mixture

PL

FIGURE 3-6: PFAM’s as a lipid class as determined by HPTLC (optimized profiling).
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TAG
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1, 3 DAG
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MAG
NAE & NAG
PL

Standard lipid
mixture

Cell 1 Cell 2

Cell 3

Cell 4

Cell 5

Cell 6

Standard lipid
mixture

FIGURE 3-7: Total lipid profiling of N18TG2 cell lipids.

In this study 12 lipid markers including PFAM’s were successfully included and
separated on a TLC/HPTLC plate (Figure 3-7). The lipid classes profiled were phospho
and glycolipids (polar lipids; PL), monoacyl glycerol (MAG), primary fatty acid amides
(PFAM’s), cholesterol (Ch), diacyl glycerol (1,2 and 1,3 DAG), fatty acids (FA), triacyl
glycerol (TAG) and cholesteryl ester (CE). N-acylglycine and N-acylethanolamine
(NAG and NAE) were also separated from other lipid classes. Because PL do not
migrate from the point of application, the subclasses within this lipid class would have
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to be developed separately [41]. Even though, NAE and NAG are not quite separated
from each other but separation can be easily improved upon further TLC modification.
The spot for NAG and NAE can also be scraped off and separated by LC and/or GC.
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FIGURE 3-8: Elution profile of C12-C22 saturated amides. Relative intensities of m/z
are plotted against the retention time. m/z 59 (blue) and m/z 72 (red) are specific to the
naturally abundant amides whereas m/z 62 (indigo) and m/z 76 (orange) are specific to
the isotopically enriched C17D33 amide used as internal standard (IS).

Our method was equally successful when applied to the separation of lipids
extracted from various N18TG2 cells. The resolved lipid classes in these cells shown in
Figure 3-8 were MAG, PFAM’s, Ch, DAG, FA, TAG and CE. No NAG or NAE were
identified in the cells, which may be due to the high detection limits of these lipids.
Detection limits for the lipid classes are shown in Table 3-I for both KODAK SIS and
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GC/MS. The elution profile for saturated C12 to C22 amides on a HP-5MS column is
shown in Figure 3-8. For GC/MS, detection limits for palmitamide, stearamide and

TABLE 3-I: Detection limits (DL) of the lipids for Kodak SIS and GC/MS.
Lipid classes

DL
SIS (µg)

GC/MS (pg)

PGL

0.08

----

NAG

0.1

----

NAE

0.1

----

MAG

0.36

----

PFAM’s

0.56

C16

25

C18

10

C189

5

Ch

0.05

----

DAG

0.05

----

FFA

0.14

----

TAG

0.09

----

CE

0.02

----

oleamide were found to be 25 pg, 10 pg and 5 pg, respectively. The higher detection
limit of the amides compared to the other lipid classes on the HPTLC plates is why the
spiking was needed in order to be able to see them on the HPTLC plates. In this study
HPTLC was proven be an quick and easy method for profiling and quantifying lipids
including PFAM’s within a specific cell type (see Table 3-II for quantification results)
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and the quantification of PFAM’s were comparable to that obtained by GC/MS (see
Figures 3-9 and 3-10 for standard curves).
GC/MS analysis of the amides scraped off the HPTLC plates is shown in Figure
3-11 which suggests that PFAM’s can be isolated and analyzed free of interaction from
other lipid classes of any cell or tissue type. Percent recoveries of amides (Table 3-III)
obtained by both SIS and GC/MS were found to be comparable within 95 % confidence
level except in case of palmitamide. The reason might be attributed to personal or
instrumental error for that particular case. Low recovery of stearamide and palmitamide
compared to oleamide may be due to the sample loss during the extraction of cells 3 and
4 or due to the sample loss during the isolation of amides from silica particles.

TABLE 3-II: Quantification of lipid classes by KODAK fluorescence imaging system.
See Section 3.3.6 for the description of the cells 1-6 used in this study.
Average mass per cell (ng)
Cell #

MAG

PFAM’s

1,2

Ch

DAG
1

2

3

4

5

6

1,3

FFA

TAG

CE

PL

DAG

3.2

9.8

0.13

0.26

0.25

0.46

0.67

0.17

2

± 0.31

± 0.69

± 0.02

± 0.07

± 0.13

± 0.15

± 0.13

± 0.04

± 0.69

0.14

0.21

0.23

0.23

0.16

0.04

0.93

2.8
± 0.19

----

± 0.02

± 0.06

± 0.08

± 0.05

± 0.02

± 0.02

± 0.32

0.45

0.53

0.03

0.03

0.04

0.06

0.08

0.03

0.27

± 0.06

± 0.21

± 0.004

± 0.01

± 0.01

± 0.01

± 0.01

± 0.01

± 0.10

12.4

10

0.76

0.96

0.76

2.2

1.5

0.32

± 1.8

± 3.5

± 0.17

± 0.21

± 0.34

± 0.35

± 0.29

± 0.23

----

0.29

0.83

0.02

0.02

0.01

0.03

0.06

0.01

0.19

± 0.07

± 0.19

± 0.002

± 0.01

± 0.004

± 0.01

± 0.01

± 0.002

± 0.03

0.05

0.06

0.08

0.1

0.07

0.02

0.48

± 0.01

± 0.03

± 0.04

± 0.02

± 0.01

± 0.01

± 0.12

0.92
± 0.16

-----
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9
8

Intensity, Lipid to IS

7
6
5
4
3
2
1
0
0

1

2

3

4

5

6

7

8

Mass of lipid, µg

Monoacyl glycerol
Cholesterol
Triacyl glycerol

PFAM's
1,3 Diacyl glycerol
Phospho and glycolipids

1, 2 Diacyl glycerol
Free fatty acid
Cholesteryl ester

FIGURE 3-9: Standard curves for the quantification of lipid classes on HPTLC.
Uncertainties are at 95 % confidence level with n = 6.

Both Table 3-II and 3-III show that no amides were detected in cell 2,
differentiated N18TG2 cells and in cell 6, no treatment N18TG2 cells. These cells were
not spiked with amides and extracted in the same fashion as the ones spiked with
amides. The reason that the amides could not be detected by either HPTLC or GC/MS
without a spike was the low cell mass available for this study. Because oleamide is
known to be produced in this cell, it might be possible to detect other PFAM’s as well,
provided a larger sample mass is available.
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1.4

Palmitamide
Intensity, Amide to IS

1.2

Oleamide
Stearamide

1
0.8
0.6
0.4
0.2
0
0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

Amide Mass, ng

FIGURE 3-10: Standard curves for the quantification PFAM’s by GC/MS.
Uncertainties are at 95 % confidence level with n = 6.

TABLE 3-III: Percent recoveries of PFAM’s from amide spiked N18TG2 cells.
Cell #

% Recoveries

Amide spiked
SIS

GC/MS

1

Oleamide

105 ± 8

98 ± 4

2

none

----

----

3

Stearamide

28 ± 12

38 ±1

4

Palmitamide

19 ± 4

36 ± 2

5

Oleamide

80 ± 19

112 ±14

6

none

----

----

Uncertainties are at 95% confidence limit with n = 6 (SIS) and 9 (GC/MS).
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C17D33:0 (IS)
Relative intensity

3000
2500

Cell 1
Cell 3
1500
Cell 4
1000

2000

C16:0

C18:0

500
0
10

C18:19
11

12

13

15

16

17

m/z

18

Retention time, min

2000

C16:0
C18:0
C18:19

72

1500
1000

256

283

m/z

229

202

175

148

121

94

0

67

500
40

Relative intensity

m/z ions due to
Mclafferty
rearrangement

59

FIGURE 3-11: (a) GC of cell 1 oleamide (C18:19), cell 3 stearamide (C18:0) and cell 4
palmitamide (C16:0). Relative intensities of m/z 59, m/z 72, m/z 62 and m/z 76 are
plotted against the retention time. (b) Mass spectra of oleamide, stearamide and
palmitamide recovered from amide-spiked cells. Relative intensities are plotted against
m/z values.
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3.5 Conclusions
We present a method of isolation of the primary fatty acid amide class, which has
recently been recognized for its hormone like activities. After the sample preparation,
instrumental analysis of these biologically active hormones can be done free of
interaction of other lipids. The method was validated by extracting amides from lipid
extracts of N18TG2 cell line, a model for oleamide biosynthesis in vivo. Application of
the validated method to the lipids extracted from rabbit brain, heart and brain acetone
power will be discussed in Chapter 5. Quantification of amides from the biological
sample and their percent recovery will be reported. A solid phase extraction method
was also developed, which will be detailed in the next chapter. Comparison of the
results from HPTLC/GC/MS and SPE/GC/MS of amide isolation can provide strong
milestones for these methods.
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Chapter 4
Solid-phase extraction (SPE) of primary fatty acid amides
4.1 Abstract
Primary fatty acid amides (PFAM’s) were isolated from a standard lipid mixture by
solid-phase extraction (SPE) and the lowest mass of amide to be loaded and recovered
was detected. The method was validated using the lipids extracted from N18TG2 mouse
neuroblastoma cells.

N18TG2 is a model cell line shown to express PAM

(peptidylglycine α-amidating monooxygenase), which is the enzyme for the final step in
PFAM biosynthesis. The cells were spiked with seven different amides before lipid
extraction. The isolated PFAM’s were quantified by GC/MS and percent recoveries
were calculated. The detection limit in the single ion monitoring mode (SIM) were
found to be 30 pg for amides containing 12 to 14 carbons and 10 pg for amides
containing 16 to 22 carbons with the exception of oleamide (C18:19). Oleamide was
found to have a detection limit of 5 pg. Use of SPE for isolating amides from total lipid
extract before analyzing them by GC/MS provides clean detection and interference free
analysis. SPE sample preparation can thus be useful for analyzing PFAM’s also in
conjunction with liquid chromatography/mass spectrometry (LC/MS), and/or capillary
electrophoresis (CE).
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4.2 Introduction
Solid-phase extraction (SPE) implies the adsorption of a target analyte from a mixture
onto a suitable solid phase followed by its elution with a chosen solvent. The objective
of SPE is to isolate the target analyte in pure concentrated form from a rather complex
matrix. The solid phases are so chosen that either the analyte can be selectively
adsorbed on the column while the unwanted compounds can be washed off or the
impurities are retained while the target analyte is selectively eluted with a mobile
solvent of appropriate polarity. The advantages of the SPE over LC includes (i) lower
hazardous solvent handing and consumption, therefore least health and safety risk; (ii)
capability of handling microgram level samples; (iii) shorter sample preparation time;
(iv) increased analyte recovery, as well as (v) less handling and cleaning of glassware.
The variety of solid phases available include silica gel and bonded aminopropyl
(normal phase), octadecylsilyl (reversed phase) or the ion exchange media (bonded
acidic or basic moieties). The one particular characteristic of silica gel used for SPE is
that they have rather larger particle sizes and irregular shapes compared to the
traditional HPLC phases, allowing rapid flow of solvent through the sorbent bed. SPE
particle sizes generally range form 40-100 µm with 60 Å -70 Å pore diameter. Various
bonding techniques and reagents are used by various manufacturers in order to produce
monomeric or polymeric bonded phases on the silica surface.

Monomeric phase

consists of a single bonded silane layer whereas the polymeric phase consists of
multiple layers of bonding reagents polymerized on the silica surface. Depending on
the nature of the bonding reagent, the SPE phases can be termed as normal (polar) or
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reversed (non-polar) phases. The unbonded silica is the most polar phase whereas the
octadecylsilyl (ODS) bonded silica by far is the least polar phase. Silica is used for
extracting relatively polar compounds followed by their selective elution with mobile
phases of increasing polarities, and ODS is mainly used for the extraction of non-polar
compounds followed by their elution with mobile phases of decreasing polarities. The
disadvantage of using silica or ODS is that very polar or very non-polar compounds
respectively can be completely retained by them and therefore become difficult to
recover. Application of the moderately polar phases such as aminopropyl bonded
phases can be used to avoid such difficulties. Ion exchange phases are also used to
selectively extract and elute compounds with cationic or anionic properties. It is a
common practice to condition the columns with solvent of similar polarity as the
loading solvent before loading the sample, which helps to organize the organic moieties
of the bonded silica surface in a regular array, making it more accessible to the analytes
[1, 2].
Lipid extraction by SPE has become popular due to the several facts. Firstly, the
low concentrations of many of the lipids available in samples can be concentrated by
SPE; secondly, any particular class can be selectively extracted and eluted in pure state;
and lastly, sensitivity and the limit of detection of the isolated lipid class is improved for
instrumental analysis due to the removal of interferents. Normal phase silica columns
are the most common types of phases used for lipid extraction even though ODS was
one of the first phase to be used for selective isolation of gangliosides from tissue
extracts [3]. The reason behind the use of ODS in this case was mainly due to the
partition of gangliosides into the Folch upper phase after the Folch extraction of lipids
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[4] from tissues. The Folch upper phase is basically polar and passes through the ODS
leaving the gangliosides behind, which could thus be selectively eluted by chloroform :
MeOH (2:1, v/v). Many other applications for the isolation of various lipid classes as
well as purification of total lipid extracts by ODS columns have been described in the
literature [5-27].
The use of normal phase SPE is pervasive for the isolation of lipid classes [2841] due to its polar nature, which offers selective extraction of different lipid classes
from various sample sources to be available for further instrumental studies. One
example to be mentioned is the separation of N-acylethanolamines (NAE: anandamide,
an endocannabinoid, belongs to this group) and monoacyl glycerol (MAG: 2arachidonyl glycerol, a second endocannabinoid, belongs to this group) from
mammalian tissue lipid extracts by silica columns [42]. One problem associated with
using silica columns is that they tend to show different efficiency from manufacturer to
manufacturer or from batch to batch mostly due to variable water retention. This
problem can be overcome by drying the phases before use or by using solvents with
controlled humidity [43, 44]. The other problem with the silica columns is that the
polar lipids (PL) tend to be retained in this rather polar phase.
The use of aminopropyl bonded columns instead of silica columns is favored in
lipid analysis because these are comparatively less polar than silica and therefore are
less affected by moisture on their capacity for lipid adsorption [45]. Kaluzny et al [46]
were among the first to use the aminopropyl bonded columns for the separation of seven
different lipid classes by piggybacking multiple columns, but unfortunately their
method was not found to be reproducible by other laboratories [for review see Ref 1]
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including this laboratory. Various modifications of this method have been reported
which were better at isolating any particular lipid class [47] or simple lipids [48]. Other
uses of aminopropyl bonded phase for the isolation of lipids include but are not limited
to the separation of acidic and neutral lipids (NL) from Escherichia coli and human
spermatozoa lipid extracts [49], separation of NL and polar lipids (PL) from mixed
microbial cultures [50], rapid separation of lipid classes in different micro organisms
[51], purification of fatty acid ethyl esters from a lipid mixture [52], separation of PL
and various NLs from plasma lipid extract [53], separation of plant membrane lipids
[54], separation of lipid classes from edible oil and mice tissue samples before their
analysis for fatty acid content [55], isolation of chlorinated fatty acids from cell culture
medium and fish lipids [56] as well as isolation of serum lipids [57].
Numerous literature reviews are available discussing the principles of SPE, the
types of phases available for a particular application, and the application of SPE in lipid
analysis [2, 58-61]. The reproducibility of a given SPE method largely depends on the
SPE phase, sorbent conditioning, amount of sample loaded, amount of each mobile
phase used for elution as well as the flow rate of the mobile phase. Therefore, it is
necessary to describe a developed SPE method in detail when publishing in order for
others to be able to reproduce the method. It is also not recommended that a vacuum
manifold be used for carrying out SPE with non polar solvents. Organic solvents tend
to evaporate rapidly under vacuum, which causes partial drying of the stationary phase.
For such cases, normal flow by gravity is preferred, but, if required, positive pressure by
a syringe can be applied [62].
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In the earlier chapters, the biological significance of the primary fatty acid
amides (PFAM’s) was discussed and the potential problems associated with their
analysis were also addressed. It is necessary to point out again that sample clean up
such as by HPTLC described in Chapter 3 or by SPE mentioned above before their
analysis can provide concentration, higher sensitivity as well as the lower limit of
detection. It is important to address that these types of sample preparations not only
improve the analysis but also increase the detector lifetime and save money on
consumables such as injection liners and septa. In this chapter, a method for the
isolation of PFAM’s by SPE has been demonstrated [63] and the validation of this
method by lipid extracts from N18TG2 cells has been described in detail for ease of
reproducibility. The application of this method to the lipids extracted from mammalian
tissues will be reported in Chapter 5.

4.3 Experimental
4.3.1 Reagents
Oleamide (OM), oleic acid (OA), tristearin (TS), monooleoyl glycerol (MOG),
dipalmitin

(DP),

phosphatidylcholine

(PC),

N-oleoylglycine

(NOG),

N-

oleyolethanolamine (NOE), sphingomyelin (Sph) and bovine brain gangliosides (G)
were purchased from Sigma (St. Louis, MO). Cholesterol (Ch) was purchased from EM
Science (Darmstadt, Germany) and cholesterol palmitate (ChP) from Janssen Chemical
(B-2440 Geel, Belgium). The solvents were purchased as follows: ACS reagent grade
hexanes, methanol and glacial acetic acid from Fisher Scientific (Fair Lawn, NJ);
acetone from Acros Organics (manufactured in Geel, Belgium); chloroform and diethyl
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ether from Aldrich Chemical Co. (Milwaukee, WI). Primary fatty acid amides (except
oleamide) were synthesized from the corresponding acids in our laboratory modifying a
published protocol [64, also see Chapter 2]. All the free fatty acids were purchased
from Sigma unless otherwise mentioned. The undifferentiated N18TG2 cells grown in
oleic acid were used, because only this cell type was available in considerable amount
to carry out this study. These cells were donated by David and Kathy Merkler of
University of South Florida.

The cell description is as follows: N18TG2 is a

neuroblastoma cell line that was obtained from DSMZ (Deutsche Sammlung von
Mikroorganismen und Zellkulturen GmbH; Braunschweig, Germany). The N18TG2
cells were grown in Dulbecco's Modified Eagle's Medium (DMEM, Mediatech Cellgro,
Herndon,VA) supplemented with 1% penicillin-streptomycin (Sigma Chemical Co., St.
Louis, MO), 10% fetalbovine serum (FBS, Atlanta Biological, Atlanta, GA), and 100
mM 6-thioguanine (Sigma) at 37 °C and 5% CO2 atmosphere. Undifferentiated cells
that were at 60% confluency were treated with DMEM + 200 µM oleic acid for 2 days
and the cells were detached from the tissue culture flask using a cell scraper. The cells
were then centrifuged (250 x g) and washed 3 times with Dulbecco's Phosphate
Buffered Saline (DPBS). The pellets were flash frozen in a dry ice/methanol bath and
stored at -80 ºC.

4.3.2 SPE phases
Discovery DSC-Si and Discovery DSC-NH2 SPE phases were purchased from Supelco
(Bellefonte, PA). Irregularly shaped and acid washed base silica possessed following
properties: 50 µm particle size, 70 Å pore diameter, 480 m2/g specific surface area and
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0.9 cm3/g pore volume. DSC-Si is the unbonded silica phase, which is basically used as
a normal phase adsorbent whereas DSC-NH2 is the aminopropyl bonded silica which
can be used as either normal phase or the ion-exchange adsorbent. Polypropylene SPE
tubes (empty) of 3 mL volumes with polyethylene frits were also purchased from
Supelco. 500 mg of the phases were packed into the tubes between two frits with hand
pressure in order to carry out SPE.

4.3.3 HPTLC plates
High performance thin layer chromatography plates (HPTLC) from Analtech (Newark,
DE) were used for viewing the lipid contents in different SPE fractions. These plates
were of 10 x 10 cm, with organic binder and no fluorescence indicator incorporated.
Primuline dye (CI 49000; direct yellow 59) used for spraying the HPTLC plates was
obtained from Aldrich Chemical Co. (Milwaukee, WI).

4.3.4 Instrumentation
A Kodak digital Science 440 image station equipped with scientific imaging software
(SIS) was used for scanning the HPTLC plates. An Agilent Technologies Network
GC/MS system (6890 GC with 5973 mass selective detector and 7683 series injector)
was used for GC/MS analysis. The column used was an HP-5MS (0.25 mm internal
diameter, 0.25 µm film thickness, 30 m long, Agilent Technologies Inc., Palo Alto, CA)
able to analyze fatty acids and amides without prior derivatization. The GC/MS method
used for analysis is as follows: Starting temperature was 55 ºC, ramped to 150 ºC at 40
ºC per min, held at 150 ºC for 3.62 min, ramped to 275 ºC at 10 ºC per min and finally
held at 275 ºC for 2 min. Electron impact ionization (EI) at 70 eV was used. The
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temperatures of the injection port and the transfer line were 250 ºC and 280 ºC,
respectively. Mass range was kept from 40 to 400 m/z for total ion monitoring (TIM)
and selected masses were 59, 72, 62 and 76 for single ion monitoring (SIM). Injection
volume was 1 µL splitless.

4.3.5 Method development
12 lipid markers and their mixtures were used for the SPE method development. These
lipids include OM, OA, Ch, ChP, TS, MOG, DP, NOG, NOE, PC, Sph and G. SPE
elution solutions were made by mixing them in correct proportions followed by
sonication for an hour. To start out the method, 100 µL of each lipid (1 mg/mL) were
mixed together, dried under N2 and re-dissolved in 500 µL hexane. 100 µL of this
mixture was loaded into the DSC-Si column so that the total oleamide load onto the
SPE tube is 20 µg (total lipid load was 240 µg). The column was completely solvated
in hexane before the sample load. After the lipids were adsorbed by the silica phase, 4
mL hexane was used for washing the sample, which was considered as fraction one
from DSC-Si column. The lipids were then eluted with 1 mL of each 99:1 hexane:
acetic acid, 90:10 hexane: ethyl acetate, 80:20 hexane: ethyl acetate, 70:30 hexane:
ethyl acetate, 1.5 mL of 2:1 chloroform: 2-propanol, and finally with 2 mL of methanol.
Fraction six was found to contain the amide, monoacyl glycerol, N-acylglycine and the
N-acylethanolamine. This fraction was therefore dried under N2, re-dissolved in 200 µL
of hexane and loaded onto DSC-NH2 column. The sample was allowed to be adsorbed
into the phase and was washed with 2 mL of hexane, which was called fraction one
from DSC-NH2 column. The lipids were then eluted by 2 mL of chloroform, 2 mL of
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2% chloroform in 2-propanol, 1 mL of 2% chloroform in 2-propanol, 2 mL of 3%
chloroform in 2-propanol and finally with 2 mL of methanol. Fraction three from DSCNH2 column was found to contain only amides, which was then dried under N2 and redissolved in 0.25 ng/µL internal standard solution in 2-propanol before injecting into
GC/MS. The internal standard used was deuterated heptadecanoamide (C16D33-CONH2).

4.3.6 Optimization of amide load
In-order to find out the lowest amount of amide to be loaded and isolated by this
method, 9 different oleamide loads were examined. These included 20 µg, 10 µg, 5 µg,
2 µg, 1 µg, 0.5 µg, 0.2 µg, 0.1 µg and 0.02 µg loads. 0.5 µg was found to be the lowest
mass loaded and isolated by this method therefore this amount was used for further
analysis.

4.3.7 HPTLC method for viewing the lipid contents in each SPE fractions
The fractions from both the columns were applied onto the 10 x 10 cm plates and the
plates were developed up to 5.5 cm from the bottom in chloroform: methanol: acetic
acid (95:5:1, v/v/v), dried for 5 min with warm air from a hair dryer. The dried plates
were re-developed in hexane: diethyl ether: acetone (60:40:5, v/v/v) up to 8 cm and redried. The plates were finally developed in hexane: diethyl ether (97:3, v/v) to 9.5 cm.
These plates were then dried for 5 min and sprayed with a 0.05% primuline solution (in
80:20, v/v acetone: water) and re-dried. The dry plates were scanned by Kodak image
station.
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4.3.8 Method validation
4.3.8.1 Lipid extraction
The cells were stored at -80 ºC upon arrival in the laboratory. They were taken out just
before the extraction and kept on dry ice until suspending into 4 mL of methanol. 0.1
µg/µL solution of seven amides was made by dissolving 0.001 g of each amide in 10
mL methanol.

These amides include lauramide, C12:0; tridecanamide, C13:0;

myristamide, C14:0; palmitamide, C16:0; oleamide, C18:19; stearamide, C18:0 and
eicosanamide, C20:0.

5 µL of this solution was spiked into the methanolic cell

suspension so that the amount of each amide spiked into the cell extract was 0.5 µg.
Lipid extraction from all the cells were carried out according to White et al. [65] and
Folch-Pi et al. [4] with a little modification. The methanol suspension was sonicated
for 15 min at room temperature and centrifuged at 4500 rpm for 10 min.

The

supernatant was separated from the pellet, dried under a stream of N2 in a warm water
bath at around 35-40 ºC. The pellet was re-extracted with 4 mL of 1: 1: 0.1; (v/v/v)
chloroform: methanol: water, sonicated for 10 min, vortexed for 2 min and centrifuged
for 10 min as above. Supernatant from this step was added to the dried supernatant
from the previous step and re-dried the same way.

The total extract was then

partitioned into lipid and non-lipid portions by adding 4.8 mL of chloroform: methanol
(2:1, v/v) and 800 µL of 0.5 M KCl/ 0.08 M H3PO4. This partitioned extract was
sonicated for 2 min, vortexed for 2 min and centrifuged for 10 min at 4500 rpm. The
lower lipid phase was dried under a stream of N2 in a warm water bath at around 35-40
ºC. The dried lipid extract was dissolved in 100 µL hexane and loaded into the DSC-Si
so that the amount of each amide loaded is 0.5 µg from the spiked cells. Six different
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extractions were carried out the same way as described above except no amides were
spiked in three extractions (blank).
4.3.8.2 GC/MS analysis of fraction 3 from DSC-NH2
Fraction three containing amides was dried under N2 and re-dissolved in 300 µL of 0.25
ng/µL heptadecano-D33-amide solution in 2-propanol.

1 µL of this sample was

injected into GC. Quantification of cell amides was done by comparing their peak areas
relative to the internal standard to those of the corresponding standard curves.

4.4 Results and Discussion
In order to develop a method for the isolation of primary fatty acid amides from lipid
mixture, the SPE method reported by Kaluzny et al. [46] for lipid separation was
followed to begin with. The method was modified in our own way to isolate amides,
which will be discussed in details in this section and has been shown in Figure 4-1
through Figure 4-8.
In an effort to isolate neutral lipids (NL) form polar lipids (PL), the lipids loaded
into a DSC-NH2 column were eluted with CHCl3:2-propanol (2:1), 2% acetic acid in
diethyl ether and finally with methanol. TLC of the collected fractions (Figure 4-1)
shows that all the neutral lipids in 1st fraction, free fatty acid (FFA) and polar lipids in
3rd fraction with no lipids eluting in 2nd fraction. This result is slightly different from
what Kaluzny et al. had observed (they found FFA in fraction 2), which is acceptable
provided the phase and the solvents were purchased from different vendors. Re-load of
the neutral fraction into a separate NH2 column and their elution with 15% ethyl acetate
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in hexane elutes CE and TAG and 2:1 CHCl3: MeOH elutes the rest of the neutral lipids
(Figure 4-2).

CE
TAG

FFA

1, 3 DAG
Ch
1, 2 DAG

PFAM’s
MAG
NAG & NAE

Standard lipid mixture

Oleamide

Fraction 1

Fraction 2

Fraction 3

N-oleoylglycine

Monooleoyl glycerol

N-oleoylethanolamine

PL

FIGURE 4-1: SPE method development step 1 using a DSC-NH2 column. Fraction 1:
elution by 1 mL of 2:1 CHCl3: 2-propanol; Fraction 2: elution by 1 mL of 2% acetic
acid in diethyl ether; Fraction 3: elution by 1 mL of MeOH.
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In order to separate amides from the rest of the neutral lipids five separate
elution skims were tried with 12% 2-propanol in CHCl3, 3% 2-propanol in CHCl3, 0.5%
2-propanol in CHCl3, 0.2% 2-propanol in CHCl3 and 0.1% 2-propanol in CHCl3 (Figure
4-3) followed by a MeOH wash after each skim. The results show that the first skim
eluted all the lipids, second, third, and fourth skims all eluted amides partially. The
fifth skim did not elute any amides.

CE
TAG

FFA
1, 3 DAG
Ch
1, 2 DAG

PFAM’s
MAG
NAE & NAG

Standard lipid mixture

Fraction 3

Fraction 2

Fraction 1

Standard oleamide

Standard lipid mixture

PL

FIGURE 4-2: SPE method development step 2 using a DSC-NH2 column. Fraction
1: elution by 1 mL of 15% ethyl acetate in hexane; Fraction 2: elution by 1 mL of
2:1 CHCl3: MeOH; Fraction 3: elution by 1 mL of MeOH.
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This situation led us to try a different type of phase with which we can separate
just the PFAMs, MAG, NOE and NOG out in one fraction and load them into NH2
column to isolate amides. The use of three different phases to elute NL, PL and FFA is
shown in Figure 4-4 which indicates that DSC-Si could be the type of phase we are
looking for because it is missing some of the non-polar lipids, which are lost in the
CHCl3 wash before elution. Using a DSC-Si column, it was possible to elute all TAG
and CE, most FFA and DAG and some Ch by 1 mL of 60:40:5 hexane: diethyl ether:
acetone. 1 mL of 95: 5:1 CHCl3: MeOH: acetic acid (HOAc) eluted the rest of the FFA,
Ch and some DAG. 2:1 CHCl3: MeOH (1 mL) was found to elute all the amide, MAG,
NOE and NOG with a small amount of DAG and Ch. Finally 2 mL MeOH eluted the
polar lipids (PL) (see Figure 4-5).

B

A

C
CE
TAG

FFA
1, 3 DAG
Ch
1, 2 DAG
PFAM’s
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Fraction 2

Fraction 1

Standard lipid mixture

Fraction 2

Fraction 1

Standard lipid mixture

Fraction 1

Standard lipid mixture

MAG
NAG & NAE
PL

D

E

CE
TAG

FFA

1, 3 DAG
Ch
1, 2 DAG

PFAM’s
MAG
NAE & NAG

Fraction 3

Fraction 2

Fraction 1

Standard lipid mixture

Fraction 2

Fraction 1

Standard lipid mixture

PL

FIGURE 4-3: SPE method development step 3 using DSC-NH2 columns. A) Fraction 1:
elution by 1 mL of 12% 2-Propanol in CHCl3. B) Fraction 1: elution by 1 mL of 3% 2Propanol in CHCl3; Fraction 2: elution by 1 mL of MeOH. C) Fraction 1: elution by 1
mL of 0.5% 2-Propanol in CHCl3; Fraction 2: elution by 1 mL of MeOH. D) Fraction 1:
elution by 1 mL of 0.1% 2-Propanol in CHCl3; Fraction 2: elution by 1 mL of MeOH.
E) Fraction 1: elution by 1 mL of 0.2% 2-Propanol in CHCl3; Fraction 2: elution by 1
mL 2% HOAc in diethyl ether; Fraction 3: elution by 1 mL of MeOH.
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CE
TAG

FFA
1, 3 DAG
Ch
1, 2 DAG
PFAM’s
MAG
NAE & NAG

DSC-Diol
A

DSC-CN
B

Fraction 3

Fraction 2

Fraction 1

Fraction 3

Fraction 2

Fraction 1

Fraction 3

Fraction 2

Fraction 1

Standard lipid mixture

PL

DSC-Si
C

FIGURE 4-4: SPE method development step 4. A) Using DSC-Diol column, B) Using
DSC-CN column and C) Using DSC-Si column. Fraction 1: elution by 1 mL of 2:1
CHCl3: 2-propanol; Fraction 2: elution by 1 mL of 2% acetic acid in diethyl ether and
Fraction 3: elution by 1 mL of MeOH.
Several attempts in between the 95: 5:1 CHCl3: MeOH: HOAc and the 2:1
CHCl3: MeOH fractions in order to isolate amides in a separate fraction using varying
solvent polarity were not very successful. Lipids dissolved in hexane were therefore
loaded into a DSC-Si column solvated in hexane and eluted with 1 mL of each hexane,
99:1 hexane: HOAc, 90: 10 hexane: ethyl acetate, 80: 20 hexane: ethyl acetate, 70: 30
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hexane: ethyl acetate, 2:1 CHCl3: MeOH and finally, with 1 mL of MeOH. Figure 4-6
showed that hexane wash did not elute any lipids as expected neither did the second
elution. The third fraction contained the TAG and CE lipids whereas the next two
fractions contained FFA, DAG and Ch.

CE
TAG

FFA
1, 3 DAG
Ch
1, 2 DAG
PFAM’s
MAG
NAE & NAG

Standard lipid mixture

Fraction 6

Fraction 5

Fraction 4

Fraction 3

Fraction 2

Fraction 1

Standard lipid mixture

PL

FIGURE 4-5: SPE method development step 5 using DSC-Si column. Fraction 1:
MeOH wash of the DSC-Si phase before sample load; Fraction 2: hexane wash after
sample load; Fraction 3: elution by 1 mL of 60:40:5 hexane: diethyl ether: acetone;
Fraction 4: elution by 1 mL of 95:5:1 CHCl3: MeOH: HOAc; Fraction 5: elution by 1
mL of 2:1 CHCl3: MeOH; Fraction 6: elution by 1 mL of MeOH.
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CE
TAG

FFA
1, 3 DAG
Ch
1, 2 DAG
PFAM’s

MAG
NAE & NAG

Standard lipid mixture

Fraction 7

Fraction 6

Fraction 5

Fraction 4

Fraction 3

Fraction 2

Fraction 1

Standard lipid mixture

PL

FIGURE 4-6: SPE method development step 6 using DSC-Si column. Fraction 1: 1 mL
hexane wash after sample load; Fraction 2: elution by 1 mL of 99:1 hexane: HOAc;
Fraction 3: elution by 1 mL of 90:10 hexane: ethyl acetate; Fraction 4: elution by 1 mL
of 80:20 hexane: ethyl acetate; Fraction 5: elution by 1 mL of 70:30 hexane: ethyl
acetate; Fraction 6: elution by 1 mL of 2:1 CHCl3: MeOH; Fraction 7: elution by 1 mL
of MeOH.
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A

B
CE
TAG

FFA
1, 3 DAG
Ch
1, 2 DAG
PFAM’s
MAG
NAE & NAG

Standard lipid mixture

Fraction 5

Fraction 4

Fraction 3

Fraction 2

Fraction 1

Standard lipid mixture

Standard lipid mixture

Fraction 7

Fraction 6

Fraction 5

Fraction 4

Fraction 3

Fraction 2

Fraction 1

Standard lipid mixture

PL

FIGURE 4-7: SPE method development step 7 using DSC-NH2 columns. A) Fraction 1:
1 mL CHCl3 wash after sample load; Fraction 2: elution by first 1 mL of 2% 2-propanol
in CHCl3; Fraction 3: elution by second 1 mL 2% 2-propanol in CHCl3; Fraction 4:
elution by third 1 mL 2% 2-propanol in CHCl3; Fraction 5: elution by first 1 mL of 3%
2-propanol in CHCl3; Fraction 6: elution by second 1 mL 3% 2-propanol in CHCl3;
Fraction 7: elution by third 1 mL 3% 2-propanol in CHCl3. B) Fraction 1: 1 mL CHCl3
wash after sample load; Fraction 2: elution by first 1 mL of 3% 2-propanol in CHCl3;
Fraction 3: elution by second 1 mL 3% 2-propanol in CHCl3; Fraction 4: elution by first
1 mL 4% 2-propanol in CHCl3; Fraction 5: elution by second 1 mL of 4% 2-propanol
in CHCl3.
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A

B
CE
TAG

FFA
1, 3 DAG
Ch
1, 2 DAG
PFAM’s
MAG
NAE & NAG

Standard lipid mixture

Fraction 6

Fraction 5

Fraction 4

Fraction 3

Fraction 2

Fraction 1

Standard oleamide

Standard lipid mixture

Standard lipid mixture

Fraction 7

Fraction 6

Fraction 5

Fraction 4

Fraction 3

Fraction 2

Fraction 1

Standard lipid mixture

PL

FIGURE 4-8: Optimized SPE method for the isolation of amides by A) DSC-Si and B)
DSC-NH2 columns. A) Fraction 1: 4 mL hexane wash after sample load; Fraction 2:
elution by 1 mL of 99:1 hexane: HOAc; Fraction 3: elution by 1 mL of 90:10 hexane:
ethyl acetate; Fraction 4: elution by 1 mL of 80:20 hexane: ethyl acetate; Fraction 5:
elution by 1 mL of 70:30 hexane: ethyl acetate; Fraction 6: elution by 1.5 mL of 2:1
CHCl3: 2-propanol; Fraction 7: elution by 2 mL of MeOH. B) Fraction 1: 2 mL hexane
wash after sample load; Fraction 2: elution by 2 mL CHCl3; Fraction 3: elution by 2 mL
of 2% 2-propanol in CHCl3; Fraction 4: elution by 1 mL 2% 2-propanol in CHCl3;
Fraction 5: elution by 1 mL 3% 2-propanol in CHCl3; Fraction 6: elution by 2 mL of
MeOH.
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The sixth fraction contained the desired lipids amide, MAG, NAE and NOG.
Because DSC-NH2 column was already tried for the separation of amide in a different
fraction, fraction 6 was dried under N2, re-dissolved in hexane and loaded into DSCNH2 column to carry out further study. This column was therefore eluted with different
proportions of 2-propanol in CHCl3. Figure 4-7 shows that the solution that isolated
amides from MAG, NOE and NOG was 2 mL of 2% 2-propanol.
Depending on the other tests performed, the final SPE method for the isolation
of primary fatty acid amides (Figure 4-8) was taken as the method described in the
experimental section. This method was optimized for the lowest mass of amides that
could be loaded and isolated successfully from a lipid mixture. The amide loads tried
were 20 µg, 10 µg, 5 µg, 2 µg, 1 µg, 0.5 µg, 0.2 µg, 0.1 µg and 0.02 µg while keeping
the mass of other lipids constant. Figure 4-9 shows the percent recovery of some of the
amide loads, which indicates that the lowest possible mass to be loaded and isolated by
this method (500 mg packing in a 3 mL tube) is 0.5 µg. The low percent recovery
below this mass was due to the scattering of amides in different fractions, which could
be improved using a smaller sorbent mass. This 0.5 µg amount was therefore used for
the method validation using N18TG2 cell lipids. The isolated amides from the total lipid
extract were separated and detected by GC/MS, providing a nice and clean detection
(Figure 4-10 and Figure 4-11). The large peak that comes around 19 min in Figure 4-11
is due to erucamide (C22:113) which was eluted from the polypropelene SPE tubes used
for the solid phase packing.
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FIGURE 4-9: Percent recoveries of the decreasing mass of amides by SPE.
Uncertainities are at 95% confidence limit (n = 9).

As mentioned in Chapter 2 that erucamide, oleamide (C18:19), palmitamide
(C16:0) and stearamide (C18:0) are used as slip additives in plastics. Therefore, in this
study, a parallel blank was run for each sample. Trace amounts of eicosanoamide
(C20:0), stearamide and oleamide were also detected in blank. The quantitation of the
amides was carried out by subtracting blank data from sample data. The percent
recoveries of the seven different amides are displayed as bar graph in Figure 4-12. The
results indicate that the shorter chain amides are more difficult to recover and/or
quantify in trace level. The reason might be the low extractability of the relatively polar
short chain amides by the aminopropyl phase. The detection limits for the amides show
(Table 4-I) that the shorter chain amides have higher detection limit than that of the
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longer chain ones. The instrument response (Figure 4-13) was found linear over a range
of around 48 fmol (~5 pg) to 6000 fmol (2500 pg) of amides.

A

B
CE
TAG

FFA
1, 3 DAG
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1, 2 DAG
PFAM’s
MAG
NAE & NAG

Standard lipid mixture
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Standard lipid mixture

Standard lipid mixture
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Fraction 3

Fraction 2

Fraction 1

Standard oleamide

Standard lipid mixture
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FIGURE 4-10: SPE fractions of the lipids extracted from amide spiked N18TG2 cells
A) DSC-Si column and B) DSC-NH2 column.
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FIGURE 4-11: Separation of PFAM’s isolated from amide spiked N18TG2 cells. The
relative intensities at m/z 59, 72, 62 and 76 are plotted against retention time.

TABLE 4-I: Detection limits (DL) of different amides in single ion monitoring mode
(SIM).
Amides

DL, pg

C12:0

30

C13:0

30

C14:0

30

C16:0

10

C17:0

10

C18:19

5

C18:0

10

C20:0

10

C22:0

10
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FIGURE 4-12: Percent recoveries of PFAM’s from amide spiked N18TG2 cells.
Uncertainities are at 95% confidence level (n=9).
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FIGURE 4-13: Mass spectrometer response in terms of the concentration of oleamide
(48 femto mol/µL to 6000 femto mol/µL). Uncertainties are at 95% confidence level
(n=3).

4.5 Conclusions
This chapter included the discussion of the isolation of the primary fatty acid amides by
solid-phase extraction and their quantification by GC/MS. As mentioned earlier, SPE is
a simple sample clean up/preparation procedure useful in analyzing compounds, which
are not abundant, have higher detection limits and/or are difficult to be quantified in
presence of other interfering compounds. The method was validated using the lipids
extracted from N18TG2 cells and percent recoveries of seven different amides were
successfully calculated. Application of this method for the isolation of amides from
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mammalian tissues will be discussed in the following chapter with emphasis on
quantification. Comparison of the results obtained from this method to that of the
HPTLC/GC/MS method can provide strong milestones for these methods.
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Chapter 5
Distribution of primary fatty acid amides in mammalian tissues

5.1 Abstract
Primary fatty acid amides (PFAM’s) were isolated and quantified from the lipid extracts
of frozen and powdered rabbit tissues. These biologically active hormones are found in
mammals in a very low concentration and their detection limits are relatively higher.
High performance thin layer chromatography (HPTLC) and solid-phase extraction
(SPE) were used for their isolation prior to the analysis by GC/MS. HPTLC or SPE
provided the complete separation of amides from total lipid extract and allowed their
concentration for interference free and quantitative detection. These types of sample
preparation techniques can also be useful for analyzing PFAM’s in conjunction with
liquid chromatography/mass spectrometry (LC/MS), matrix-assisted laser desorption
ionization (MALDI)/MS, and/or capillary electrophoresis (CE).
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5.2 Introduction
Fatty acid amides comprise one of the important classes of bioactive lipids found in
mammals. N-acylethanolamines (NAE) and primary fatty acid amides (PFAM’s) are
two important families of this class [1]. Members of both of these families consisting of
long chain saturated and unsaturated fatty acids are considered as bioregulators due to
their hormone like activities [2]. They became recognized as a signaling class of lipid,
when anandamide (N-arachidonylethanolamine) was identified in 1992 as a natural
product that binds to the cannabinoid receptors in the brain [3]. It was found to mimic
all the activities of delta-9-tetrahydrocannabinol (∆-9-THC) and was thought to be a
potent neuromodulator besides its other hormonal activities.

Within three years

researchers discovered that oleamide, a primary fatty acid amide, is synthesized in the
cerebrospinal fluid of sleep deprived cats [4]. Since then the PFAM’s were studied
widely in various biochemical and pathological ways. They were first identified in
human luteal phase plasma [5] even though neither their function nor their bio-synthetic
pathway was recognized at them time.
Various reported hormonal-activities of oleamide and the controversy about its
biosynthetic pathways were discussed in Section 1.5 of Chapter 1. Quantification of
PFAM’s by instrumental analysis is problematic due to their presence in biological
samples in low concentration as well as due to the interference from other lipids present
in lipid extracts of the sample of interest. The peak suppression during trace analysis of
PFAM’s due to the tailing of -NH2 group gives rise to higher detection limits, which
seems to be more prominent in the presence of other non-volatile lipids. Because of this
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reason, PFAM’s are usually derivatized to stable, amide deactivated compounds for
higher sensitivity before GC/MS analysis. These problems can be solved by isolating
the PFAM’s from interfering lipids followed by diluting the isolate to a preferred
concentration. Therefore it is possible to analyze the PFAM’s quantitatively from
biological samples of interest by the instrument of choice without any interaction from
other lipid classes.
Sample preparation by HPTLC and SPE for the study of lipids was discussed in
Chapters 3 and 4. Analysis of brain and plasma lipids after clean up by HPTLC or SPE
are the long known techniques used by numerous researchers. Mascala et al. [6] have
separated neutral and acidic lipids from rat and human brain using a DEAE-Sephadex
column and then further separated into individual lipid classes by applying them into
separate HPTLC plates. They used two solvent systems for the development of the
plates.

The quantification of the lipid classes was obtained using a scanning

densitometer equipped with a Shimadzu CR1A data processor. They reported that the
use of an internal standard minimized the variation from plate to plate. The use of
cupric acetate for charring was found to be more sensitive than the conventional sulfuric
acid-dichromate reagent. Entezami et al. [7] on the other hand reported similar analysis
of brain lipids by single solvent system HPTLC and found that cupric sulfate charring
was more sensitive than cupric acetate charring.
Separation of cholesterol, N-acyl glycerol and N-butyl palmitamide was
achieved by Bilyk et al. [8] on a TLC plate with 2 solvent systems and aqueous sulfuric
acid charring. They described TLC as a rapid means of identifying the components of
fatty mixtures with highly reproducible separation but neither any quantification data
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were published, nor the percent recovery results were mentioned. Alvarez et al. [9]
reported the quantitation of amniotic fluid lipids by HPTLC and reflectance
spectrodensitometry with percent recoveries ranging from 82-95%.

The detector

response was found to be linear over a range of 20 ng/mL (detection limit) to 2 µg/mL.
TLC was also employed for the separation of the polar lipids from rabbit tissues by
Baldoni et al. [10], but the method was used for only qualitative study. Dreyfus et al.
[11] reported the quantitative analysis of lipid classes extracted from pig and rat tissues
by HPTLC and found the percent recoveries around 90-97% for different lipid classes.
It is clear from literature review that HPTLC/TLC is an ideal technique for quick
profiling of lipid classes present in a sample of interest. With proper developing
solvent, it is possible to isolate the target lipid class in higher recoveries from other
classes. The isolated lipid can be brought to any desired concentration for further
instrumental analysis.
SPE is the most recently used technique for the isolation of a specific lipid class
from the crude lipid extract.

Two different SPE phases usually employed by

researchers, namely, un-bonded silica phases and aminopropyl bonded silica. So far the
latter phase has become more popular in lipid analysis due to its comparatively lower
polarity than silica and hence less capability of retaining polar lipids. Kaluzny et al. [12]
had first reported the use of such column for the separation of seven lipid classes from
bovine adipose tissue extract with percent recoveries ranging from around 96-101%.
They reported that about 10 mg of lipid can be loaded on a 500 mg column. According
to literature both types of columns were successfully used in lipid analysis by numerous
authors [13-17].
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A very few studies were actually done for the isolation of PFAM’s from crude
lipid extract by HPTLC or SPE. In 1994, before oleamide was identified as a sleep
inducing agent, Kaneshiro et al. [18] reported the isolation of PFAM’s from Bacillus
Megaterium cell extracts using silica column chromatography (similar to SPE) followed
by HPLC and GC analysis for their separation and identification. TLC was used as a
primary means of identification of the presence of amides in those cells by comparing
with the standard amides. Cravat et al. [4] in 1995 isolated a compound from the
cerebrospinal fluid (CSF) of sleep-deprived cat and identified it as cis-9octadecenoamide (oleamide), which fueled the later PFAM studies. Bisogno et al. [19,
20] had reported the existence of both oleamide and anandamide in N18TG2 mouce
neuroblastoma cells, human breast cancer cells and rat adrenal pheochromocytoma
cells. They employed a series of sample preparation steps such as TLC, SPE and
column chromatography for quantitative determination of these amides. Hanuš et al.
[21] had also determined the presence of oleamide in rat plasma and CSF quantitatively
by GC/MS. They reported the difficulties of analyzing oleamide by electrospray MS
without prior chromatography due to the presence many compounds in body fluids. In
their case oleamide was analyzed by GC/MS after derivatization in order to increase the
peak sensitivity and therefore to lower the detection limit. Oleamide was also identified
to be produced in a soil microorganism by Ho Jeong et al. [22]. They successfully used
preparative TLC before GC/MS in order to obtain oleamide in pure form allowing
contaminant free analysis. These types of studies indicate that it is crucial to isolate the
target lipid class from other lipid classes present in the complex lipid matrix for
interference free analysis [23].
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Together all these data suggest that sample preparation before instrumental
separation and detection is the key to obtain better and reliable quantitation. It is
necessary to point out again that sample clean up such as by HPTLC and/or by SPE
mentioned above before their analysis can provide concentration, higher sensitivity as
well as the lower limit of detection. This type of interference free analysis results not
only in lower peak suppression lowering the detection limit for PFAM’s but also
provides longer detector lifetime and save money on consumables such as injection
liners and septa. The addition of internal standards (IS) to the sample before and after
isolation is also crucial for quantitative instrumental analysis. In this study, we report
the isolation of PFAM’s from rabbit tissues using both HPTLC and SPE followed by
quantitative analysis by GC/MS [24]. Rabbit brain and whole heart tissues are known
to express PAM, the enzyme for the last step of PFAM biosynthesis (see Chapter 1 for
more information). Because heart atrium but not ventricle expresses PAM, atrium
removed heart were used in this study as control. The rabbit tissues were chosen for the
application of HPTLC and SPE sample preparation methods because of their low cost
and commercial availability at the time of this study.

5.3 Experimental
5.3.1 Reagents
ACS reagent grade hexanes, ethyl acetate, methanol, 2-propanol and glacial acetic acid
were purchased from Fisher Scientific (Fair Lawn, NJ); acetone, palmitic acid and
stearic acid were purchased from Acros Organics (Morris plains, NJ); chloroform and
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diethyl ether, heptadecanoic acid and eicosanoic acid were obtained from Aldrich
Chemical Co. (Milwaukee, WI); heptadecaoic-D33-acid was purchased from CDN
Isotopes (Quebec, Canada). Palmitamide, stearamide, heptadecanoamide, deuterated
heptadecanoamide and eicosanoamide were synthesized from the corresponding acids
in our laboratory modifying a published protocol [25, also see Chapter 2]. Oleamide
(OM) and erucamide were purchased from Sigma (St. Louis, MO).

5.3.2 Tissues
Rabbit whole heart (atrium removed), rabbit whole brain (stripped) and rabbit brain
acetone powder were purchased from Pel-Freez Biologicals (Rogers, AR).

5.3.3 HPTLC plates
High performance thin layer chromatography plates (HPTLC) from Analtech (Newark,
DE) were used for viewing the lipid contents in different SPE fractions. These plates
were of 10 x 10 cm, with organic binder and no fluorescence indicator incorporated.
Primuline dye (CI 49000; direct yellow 59) used for spraying the HPTLC plates was
obtained from Aldrich Chemical Co. (Milwaukee, WI).

5.3.4 SPE phases
Discovery DSC-Si and Discovery DSC-NH2 SPE phases were purchased from Supelco
(Bellefonte, PA). Irregularly shaped and acid washed base silica possessed following
properties: 50 µm particle size, 70 Å pore diameter, 480 m2/g specific surface area and
0.9 cm3/g pore volume. DSC-Si is the base silica phase which is basically used as a
normal phase adsorbent whereas DSC-NH2 is the aminopropyl bonded silica which can
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be used as either normal phase or the ion-exchange adsorbent. SPE tubes (empty) of 3
mL volumes with polyethylene frits were also purchased from Supelco. 500 mg of the
phases were packed into the tubes between two frits applying hand pressure in order to
carry out SPE.

5.3.5 Instruments
A Kodak digital Science 440 image station equipped with scientific imaging software
(SIS) was used for scanning the HPTLC plates. An Agilent Technologies Network
GC/MS system (6890 GC with 5973 mass selective detector and 7683 series injector)
was used for GC/MS analysis. The column used was an HP-5MS (0.25 mm internal
diameter, 0.25 µm film thickness, 30 m long, Agilent Technologies Inc., Palo Alto, CA)
able to analyze fatty acid amides without prior derivatization. The GC/MS method used
for analysis is as follows: Starting temperature was 55 ºC, ramped to 150 ºC at 40 ºC per
min, held at 150 ºC for 3.62 min, ramped to 275 ºC at 10 ºC per min and finally held at
275 ºC for 2 min.

Electron impact ionization (EI) at 70 eV was used and the

temperatures of the injection port and the transfer line were 250 ºC and 280 ºC,
respectively. Mass range was kept from 40 to 400 m/z for total ion monitoring (TIM)
and selected masses were 59, 72, 62 and 76 for single ion monitoring (SIM). Injection
volume was 1 µL splitless.

5.3.6 Lipid extraction from rabbit brain and heart tissues
The samples were stored at -80 ºC upon arrival. Right before lipid extraction, samples
were taken out of the freezer and placed at dry ice temperature. They were then cut into
pieces and weighed before extracting lipids. The lipids were extracted from the tissues
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(26, 27) as follows: The weighed tissues/acetone powder were suspended into 20 times
of its volume of chloroform: methanol (2:1; v/v) and completely homogenized using a
glass-to-glass homogenizer (Kontes Glass Co., Vineland, NJ). The tissue homogenate
was then sonicated for 10 min at 1500 g. Before sonication the specific gravity of the
homogenate was lowered using 0.2 times of its volume (20%) of methanol.

The

supernatant was separated from the pellets and chloroform was added to the supernatant
in order to adjust the proportion of chloroform: methanol to 2:1 (for example if the total
volume of the homogenate was 20 mL, 4 mL methanol was added before sonication and
8 mL of chloroform was added to the supernatant after sonication). To the total amount
of supernatant, 0.2 times of its volume of aqueous 0.88% KCl was added (for example
if the total volume of the supernatant was 20 mL, 4 mL of aqueous 0.88% KCl was
added). The sample was then vortexed for 2 min and allowed to sit for separation into
two phases. The upper phase mostly contains proteins and non-lipid contaminants and
the lower phase contains the lipid extract. The upper phase was discarded and the lower
lipid phase was completely dried under a stream of N2. The dried lipid extract was
dissolved in 4 mL hexane to be loaded onto either HPTLC plates or into the SPE
columns. Three separate extractions and three blanks were carried out for this study.
An internal standard, heptadecanoamide (C17), was spiked into the tissue suspension as
well as into the blanks before homogenization in order to calculate percent recovery.
The glass-to-glass homogenizer was silanized using 10% TMS in toluene before use in
order to minimize the amide adsorption on the silica surface.
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5.3.7 Quantitation of amides from rabbit brain and heart tissues by HPTLC
5.3.7.1 Isolation of amides from TLC plates
30 µL of extracted lipids were applied onto HPTLC plates and the plates were
developed as follows: firstly up to 5.5 cm from the bottom in chloroform: methanol:
acetic acid (95:5:1, v/v/v), dried for 5 min with warm air from a hair dryer; secondly,
the dried plates were developed in hexane: diethyl ether: acetone (60:40:5, v/v/v) up to
8 cm, re-dried and finally, the plates were developed in hexane: diethyl ether (97:3, v/v)
to 9.5 cm. Two separate plates were developed at the same time, one of which was
sprayed with primuline for visualization. Amide spots adsorbed in silica were scraped
off the plate not sprayed with primuline by comparing to the spot position on the
sprayed one.
5.3.7.2 Analysis of scraped amides by GC/MS
The scraped silica containing amides was suspended in isopropanol containing the
deuterated internal standard, sonicated for 10 min for the transfer of amide to
isopropanol from silica. The samples were filtered through 0.2 µm filter paper and 1 µL
of the sample was injected into GC/MS.

5.3.8 Quantitation of amides in rabbit brain and heart tissues by SPE
5.3.8.1 Isolation of amides from lipid extract
SPE elution solutions were made by mixing them in correct proportions followed by
sonication for an hour. The DSC-Si column was completely solvated in hexane before
the sample load. After the lipids were loaded, 4 mL hexane was used for washing the
sample, which was considered as fraction one from DSC-Si column. The loads for
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brain, heart, and brain acetone powder were 50 µL, 100 µL and 200 µL, respectively.
The lipids were then eluted with 1 mL of each 99:1 hexane: acetic acid, 90:10 hexane:
ethyl acetate, 80:20 hexane: ethyl acetate, and 70:30 hexane: ethyl acetate, 1.5 mL of
2:1 chloroform: methanol, and finally with 2 mL of methanol. Fraction six was found
to contain the amides, monoacyl glycines, N-acylglycines and the N-acylethanolamines.
This fraction was therefore dried under N2, re-dissolved in 200 µL of hexane and loaded
onto DSC-NH2 column. The sample was adsorbed onto the phase and then washed with
2 mL of hexane, which was called fraction one from DSC-NH2 column. The lipids
were then eluted by 2 mL of chloroform, 2 mL of 2% chloroform in 2-propanol, 1 mL
of 2% chloroform in 2-propanol, 2 mL of 3% chloroform in 2-propanol and finally with
2 mL of methanol. Fraction three from DSC-NH2 column was found to contain only
amides.
5.3.8.2 GC/MS analysis of fraction 3 from DSC-NH2
Fraction three containing amides was dried under N2 and re-dissolved in 300 µL of 0.25
ng/µL heptadecano-d33-amide solution in 2-propanol. 1 µL of this sample was injected
into GC. Quantification of amides was done by comparing their peak areas relative to
the internal standard to those of the corresponding standard curves.

5.3.9 HPTLC method for viewing the lipid contents in each SPE fraction
The fractions from both the columns were applied onto the 10 x 10 cm plates and the
plates were developed up to 5.5 cm from the bottom in chloroform: methanol: acetic
acid (95:5:1, v/v/v), dried for 5 min with warm air from a hair dryer. The dried plates
were re-developed in hexane: diethyl ether: acetone (60:40:5, v/v/v) up to 8 cm and re-
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dried. The plates were finally developed in hexane: diethyl ether (97:3, v/v) to 9.5 cm.
These plates were then dried for 5 min and sprayed with a 0.05 % primuline solution (in
80:20, v/v acetone: water) and re-dried. The dry plates were then scanned by Kodak
scientific imaging system.

5.4 Results and Discussion
The total lipid profiling of the rabbit tissues shows the separation of 9 different lipid
classes with higher amount of phospholipids and cholesterol present in brain tissues
whereas higher amount of triacyl glycerol and fatty acids present in heart tissues (Figure
5-1 and Figure 5-2). N-acylglycine (NAG) and N-acylethanolamine (NAE), monoacyl
glycerol (MAG), primary fatty acid amides (PFAM’s), diacyl glycerol (DAG), free fatty
acids (FA), triacyl glycerol and cholesteryl esters (CE) were the other classes
recognized by comparing to the standard lipids. PFAM’s were detectable on a TLC
plate (Figure 5-1) upon overloading the plate whereas optimum loading provided nice
separation between the classes (Figure 5-2) with PFAM’s beyond the detection limit by
TLC.
After scraping off amide spots and analysis by GC/MS, three different amides
were identified, which as shown in Figure 5-3 and Figure 5-4 includes palmitamide,
stearamide, and oleamide. The amides were identified by comparing their retention
times and mass spectral patterns with those of the standard amides. The other amides
observed in these figures are heptadecanoamide and deuterated heptadecanoamide used
as internal standards added to the samples before and after extraction, respectively. The

180

presence of erucamide was also observed due to their elution from polypropylene vials,
which was confirmed by running blanks under the same conditions as the samples.

CE
TAG

FA

1, 3 DAG
Ch
1, 2 DAG

PFAM’s
MAG
NAE & NAG

Standard lipid mixture

Brain acetone
powder lipid extract

Rabbit heart lipid extract

Rabbit brain lipid extract

Standard oleamide

Standard lipid mixture

PL

FIGURE 5-1: Total lipid profiling of rabbit tissues (overloading the HPTLC plate).
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CE
TAG

FA
1, 3 DAG
Ch
1, 2 DAG
PFAM’s
MAG
NAE & NAG

Standard lipid mixture

Brain acetone
powder lipid extract

Heart lipid extract

Brain lipid extract

Standard oleamide

Standard lipid mixture

Standard lipid mixture

Brain acetone
powder lipid extract

Heart lipid extract

Brain lipid extract

Standard oleamide

Standard lipid mixture

PL

FIGURE 5-2: Total lipid profiling of rabbit tissues (two sets of optimized lipid load on
the HPTLC plate).

The HPTLC of the SPE fractions of the rabbit brain and heart tissues are shown
in Figure 5-5 and Figure 5-6. The analysis of fraction three from the DSC-NH2 column
by GC/MS (Figure 5-7 and Figure 5-8) confirmed the presence of palmitamide,
stearamide and oleamide.

Again heptadecanoamide (C17) and deuterated

heptadecanoamide (C17D33) were used as internal standards added to the samples
before and after extraction, respectively.

The presence of erucamide as well as

eicosanoamide was also observed, which largely eluted from SPE polypropylene vials.
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For most of the cases of GC/MS analysis reported here, the GC method was edited so
that the runs end before the erucamide elution in order to increase the sensitivity of the
other peaks.

Relative intensity
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C22:113

C18:0
C18:19

700

C20:0

C17:0

600
C17D33:0

500
400

C16:0

300
200
100
0
10

12

14

16

18

20

22

24

Retention time, min

FIGURE 5-3: GC of rabbit brain amides isolated by HPTLC. The relative intensities at
m/z 59, 72, 62 and 76 (see Chapter 2 for fragmentation patterns) are plotted against
retention time.

The ions monitored under SIM were m/z 59 and m/z 72 for the naturally
abundant amides as well as m/z 62 and m/z 76 for the isotopically enriched amides
(Figures 5-3, 5-4, 5-7, 5-8, 5-9 and 5-10). These ions correspond to the fragmentations
due to McLafferty rearrangement (see Chapter 2 for description). It is noticeable that
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the relative intensities of the amides isolated by SPE (Figures 5-7 and 5-8) are higher
than that isolated by HPTLC (Figures 5-3 and 5-4). The reason is the larger sample
capacity of SPE. The optimized amount of the lipid extract that could be loaded on the
HPTLC plate was only around 1-30 µL (total mass unknown for the rabbit tissue lipid
load).
C17D33:0
C22:113
C17:0

400

C18:19
C18:0

Relative intensity

350
300
250
C16:0

200
150
100
50
0
10

12

14

16

18

20

22

Retention time, min

FIGURE 5-4: GC of rabbit heart amides isolated by HPTLC. The relative intensities at
m/z 59, 72, 62 and 76 (see Chapter 2 for fragmentation patterns) are plotted against
retention time.

On the other hand, the amount that could be loaded on SPE was in the order of
1-300 µL (total mass unknown for the rabbit tissue lipid load). The loads for brain,
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heart, and brain acetone powder were 50 µL, 100 µL and 200 µL, respectively, onto
SPE columns. In order to optimize the amount of load, different loads of the same
sample were carried out by SPE and the fraction were visualized by HPTLC until
optimal resolution was obtained. The reason only 50 µL load was sufficient for brain
compared to 200 µL for brain acetone powder is that (i) amount of brain tissue used was
higher than brain acetone powder in our case and (ii) brain contained much higher lipid
amount than brain acetone powder (see Table 5-I and 5-II). The later could be due to
the lipid loss that might occur during drying the tissues under acetone [28].
Table 5-I and 5-II shows the quantification of amides by both HPTLC/GC/MS
and SPE/GC/MS. The percent recoveries of the internal standard (C17) spiked before
the lipid extraction was found to be comparable at 95% confidence limit (n=9) for SPE,
although this was not the case for HPTLC analysis. Not only the percent recovery of
the spiked standard was uncomparable at 95% confidence limit but also the amount of
amides found in tissue sample was randomly different from that obtained by SPE.
Lower recovery by HPTLC was observed in most cases compared to that by SPE except
in some case where larger values were obtained. The larger values could be resulted
from possible contamination from TLC developing solvents (or due to peroxide
formation) whereas lower values could be the result of sample loss during separation of
amides from silica after scraping the spots. Therefore, it is clear from the results that
HPTLC is valuable for quick profiling of the total lipids and SPE is more reliable for
quantification. Even though it was assumed that no PFAM’s would be found from
atrium-removed heart, palmitamide, stearamide and oleamide were detected in heart as
in brain. This suggests that PFAM’s are probably carried into the ventricle by blood.
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TABLE 5-I: Quantitation of PFAM’s in rabbit tissues by HPTLC/GC/MS.
Amount of amides, µg/g of rabbit tissue

Percent recovery
of spiked standard

C16

C18

C18:19

C17

Brain

7.2 ± 0.8

3.5 ± 0.2

28 ± 2

85 ± 3

Heart

1.6 ± 0.2

2.0 ± 0.1

4.5 ± 0.4

82 ± 4

Brain-acetone powder

3.6 ± 0.5

1.8 ± 0.1

5.8 ± 0.1

91 ± 3

Blank

----

0.005 ± 0.001

0.0136 ± 0.0001

98 ± 6

Uncertainties are at 95% CL with n = 9.

TABLE 5-II: Quantitation of PFAM’s in rabbit tissues by SPE/GC/MS.
Amount of amides, µg/g of rabbit tissue

Percent recovery
of spiked standard

C16

C18

C18:19

C17

Brain

3.2 ± 0.2

4.4 ± 0.2

23 ± 1

104 ± 9

Heart

1.9 ± 0.1

1.4 ± 0.1

7.5 ± 0.5

92 ± 5

Brain-acetone powder

2.7 ± 0.4

1.7 ± 0.1

15.7 ± 0.8

95 ± 9

Blank

----

0.007 ± 0.001

0.031 ± 0.002

102 ± 7

Uncertainties are at 95% CL with n = 9.
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PFAM’s
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NAE & NAG

Standard lipid mixture

Fraction 6

Fraction 5

Fraction 4

Fraction 3

Fraction 2

Fraction 1

Standard oleamide

Standard lipid mixture

Standard lipid mixture

Fraction 7

Fraction 6

Fraction 5

Fraction 4

Fraction 3

Fraction 2

Fraction 1

Standard oleamide

Standard lipid mixture

PL

FIGURE 5-5: SPE fraction from rabbit brain lipid load onto A) DSC-Si and B) DSCNH2 columns. Note: SPE method for the isolation of amides by A) DSC-Si and B)
DSC-NH2 columns. A) Fraction 1: 4 mL hexane wash after sample load; Fraction 2:
elution by 1 mL of 99:1 hexane: HOAc; Fraction 3: elution by 1 mL of 90:10 hexane:
ethyl acetate; Fraction 4: elution by 1 mL of 80:20 hexane: ethyl acetate; Fraction 5:
elution by 1 mL of 70:30 hexane: ethyl acetate; Fraction 6: elution by 1.5 mL of 2:1
CHCl3: 2-propanol; Fraction 7: elution by 2 mL of MeOH. B) Fraction 1: 2 mL hexane
wash after sample load; Fraction 2: elution by 2 mL CHCl3; Fraction 3: elution by 2 mL
of 2% 2-propanol in CHCl3; Fraction 4: elution by 1 mL 2% 2-propanol in CHCl3;
Fraction 5: elution by 1 mL 3% 2-propanol in CHCl3; Fraction 6: elution by 2 mL of
MeOH.

187

188

NH2 columns. (Please see the NOTE under Figure 5-5 for clarification).
Standard lipid mixture

Fraction 6

Fraction 5

Fraction 4

Fraction 3

Fraction 2

Fraction 1

Standard oleamide

Standard lipid mixture

Standard lipid mixture

Fraction 7

Fraction 6

Fraction 5

Fraction 4

Fraction 3

Fraction 2

Fraction 1

Standard oleamide

Standard lipid mixture

A
B
B

CE

TAG

FFA

1, 3 DAG
Ch
1, 2 DAG

PFAM’s

MAG
NAE & NAG
PL

FIGURE 5-6: SPE fraction from rabbit heart lipid load onto A) DSC-Si and B) DSC-
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FIGURE 5-7: GC of rabbit brain amides isolated by SPE. The relative intensities at m/z
59, 72, 62 and 76 (see Chapter 2 for fragmentation patterns) are plotted against retention
time.

The amount of palmitamide and oleamide isolated from human luteal phase
plasma [5] were in the order of 3.9 µg/mL and 31.7 µg/mL, respectively, and the
amount of oleamide extracted from N18TG2 cells [20] was 0.0155 µg (55.0 ± 9.5 pmol;
mean ± SD, n=2)/107 cells. Hanuš et al. [21] reported the amount of oleamide analyzed
as TMS ester to be 9.9 ± 1.0 ng/mL in rat plasma and 44 ± 3.0 ng/mL in rat CSF. They
[21] concluded that the higher microgram amount of PFAM’s extracted from human
plasma was probably due to the contamination coming from the use of plastic
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containers. It is to be mentioned that the PFAM’s are used as slip additives in plastics
in order to improve their surface properties [29-32].
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FIGURE 5-8: GC of rabbit heart amides isolated by SPE. The relative intensities at m/z
59, 72, 62 and 76 (see Chapter 2 for fragmentation patterns) are plotted against retention
time.

The amount of palmitamide (3.2 ± 0.2 µg/g) and oleamide (23 ± 1 µg/g) found
in brain by SPE in this study is in accordance with the amounts of those reported by
Arafat et al. [5]. The comparison was done by assuming that the specific gravity of
tissue is the same as the specific gravity of water, therefore the weight of 1 mL of tissue
can be taken as 1 g. Even though polypropelyne vials and tubes were used for lipid
extraction and SPE purposes in this study, a parallel blank as described above was run
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in this case and was subtracted from the sample in order to compensate for any
contamination (Figure 5-9). The standard curves for PFAM’s were found to be linear in
the range of 5 pg/µL to 2.5 ng/ µL at 95% confidence limit (Figure 5-10).

300

C17:0

Relative intensity

250

C17D33:0
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FIGURE 5-9: GC of blank of the lipid extraction process. The relative intensities at m/z
59, 72, 62 and 76 (see Chapter 2 for fragmentation patterns) are plotted against retention
time.
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FIGURE 5-10: Standard curves for PFAM’s. Uncertainties are at 95% confidence limit
(n=3).

One other point to address from the results that the oleamide peak observed in
GC could also be the result of the co-elution of different C18 unsaturated amides, which
were not separated on a HP-5MS column (Figure 5-11). The fact that, Arafat et al. [5]
also found palmitoleamide (C16:19; 4.4 µg/mL), elaidamide (C18:1trans9; 3.7 µg/mL)
and linoleamide (C18:29, 12; 2.2 µg/mL) besides palmitamide and oleamide in human
plasma, even strengthen this point. In our case, this assumption is still to be proven
using a relatively polar column capable of separating unsaturated fatty acids and
amides, which will be discussed in Chapter 6.
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unsaturated amides
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FIGURE 5-11: Elution profile for standard C12-C22 amides on a HP-5MS column. The
relative intensities at m/z 59, 72, 62 and 76 (see Chapter 2 for fragmentation patterns)
are plotted against retention time.

5.5 Conclusions
The application of the HPTLC and SPE sample preparation methods for the isolation of
the primary fatty acid amides from tissue lipid extracts prior to their analysis by GC/MS
has been established. These sample preparation techniques have been proven to be
useful for obtaining clean amide samples free from interfering components. The clean
detection techniques gave rise to higher sensitivity and lower detection limits for the
amides. Concentration of the samples was also achieved providing the quantitation of
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these trace lipid amides in mammalian tissues. The HPTLC method has been proven to
be efficient for quick profiling of the total lipid extract whereas the SPE method was
found to be efficient in reliable quantification at 95% confidence limit. The amount of
palmitamide and oleamide was found in the same order of the amount of those observed
by Arafat in human plasma. Nearly 100 % recovery of the spiked internal standard by
SPE makes the method reliable for quantitative recovery of the amides from any cell or
tissue type. Next chapter will emphasis on the use of a very polar BPX70 column for
the separation of any unsaturated amides if co-eluting with the oleamide peak.
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Chapter 6
Separation of unsaturated fatty acid amides by argentation-HPTLC
and BPX70 column

6.1 Abstract
Unsaturated primary fatty acid amides were separated by silver-ion high performance
thin layer chromatography (argentation-HPTLC) as well as by a BPX70 GC column.
The separated amides were all eighteen carbon analogs of cis-9-octadecenoamide
(oleamide). The separation was achieved in terms of number of double bonds by
argentation-HPTLC whereas clear resolutions between geometric and positional
isomers were obtained using the BPX70 column. Synthesized standard PFAM’s were
used for this separation analysis and PFAM’s isolated from rabbit brain and heart
tissues by solid phase extraction (SPE) were used for the application. The goal of this
method was to separate and identify individual peaks if co-eluting with the oleamide
peak.

Separation of unsaturated amides with same number of carbon cannot be

achieved by a less polar column such as HP-5MS. Separation of rabbit brain and heart
amides shows that oleamide is the only major C18 unsaturated amides isolated from
heart tissues. Trace amounts of linoleamide (C18:29,12) and eicosenoamide (C20:113)
were also identified in brain besides oleamide.

197

6.2 Introduction
Primary fatty acid amides (PFAM’s) are one of the most recently emerging classes of
bio-active compounds. Long chain amides (C12-C22), isolated from biological samples
and assigned different hormonal activity so far, are oleamide (cis-9-octadecenoamide),
erucamide

(cis-13-docosenoamide),

anandamide

(cis,cis,cis,cis-5,8,11,14

eicosatetraenoamide), and linoleamide (cis,cis-9,12 octadecadienoamide) [1-17].
Numerous different PFAM’s can be synthesized from commercially available free fatty
acids (FFA) in vitro and no assumption can be made yet how many different PFAM’s
are synthesized in vivo. For a list of fatty acids refer to Table 6-1 [18]. The next step of
the isolation of PFAM’s from tissues and samples is their identification followed by
quantification. In order to identify each and every single amide present in a sample,
they need to be completely separated from each other.

Normal phase liquid

chromatography (TLC/HPLC) and gas chromatography are the most widely used
separation techniques for fatty acids, their derivatives and PFAM’s separations [19-48].
Separation of the cis and trans isomers of FFA as their methyl esters has been achieved
using mainly argentation HPTLC/HPLC and highly polar GC columns. Solid-phase
extraction (SPE) and supercritical fluid chromatography in Ag-ion mode can also be
used [49, 50]. Numerous publications and application notes from various laboratories
as well as from different manufacturers are available, which discuss theories and
techniques behind these separations [19-48].
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TABLE 6-1: Systematic names and selected properties of some of the more important
fatty acids of five or more carbon atoms [18].

Mr: molecular weight,

tm: melting point in °C,

S: aqueous solubility at 20 °C in units of grams of solute per solute per 100 g of water.
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Silver ion chromatography depends on the formation of weak, reversible,
charge-transfer complexes of Ag+ with unsaturated organic molecules. The mechanism
for this type of reaction involves 1) the formation of a sigma bond between the occupied
bonding π2p electrons of the double bond and free 5s and 5p orbitals of Ag+ as well as 2)
the formation of a weaker π accepter backbone between the antibonding π*2p electrons
of the double bond and the occupied 4d orbitals of the Ag+ [51]. The FFA derivatives
such as unsaturated FAMEs can be separated on Ag impregnated silica phase based on
the number of double bonds present, geometric configuration of the double bonds
(cis/trans) as well as the position of the double bond. Stronger retention is obtained for
the higher degree of unsaturation and for the larger the separation between the double
bond (i.e., polyunsaturated fatty acids will retain stronger than diunsaturated ones and
methylene interrupted unsaturated fatty acids will retain stronger than conjugated ones).
As the double bond position moves away from the carbonyl group of the fatty acids,
longer retention is observed. The trans isomers are found to retain less strongly than
the cis isomers [for review see Ref. 52].
Successful separation by silver ion chromatography such as Ag-HPTLC depends
on the optimum impregnation of stationary phase with silver.

A “dynamic

impregnation” technique proposed by Aitzetmueller et al. is generally used which
includes the development of the TLC plates in 10-20% AgNO3 in acetonitrile [23]. In
this process, as the development progresses, Ag gradually travels upwards on the plates
with a decreasing concentration. Better separation is usually achieved with such a
gradient in silver content on the stationary phase. Even though the earlier works show
that 10 to 30% AgNO3 solution are necessary for better resolution [53, 54], recent work
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indicates that retention and resolution are not affected at all by impregnating plates with
more than 5% AgNO3 solution [55, 57]. Moreover, excellent separation was achieved
by developing the plates in 0.5% methanolic AgNO3 [52, 58, 59]. The solvents used for
the separation of lipids by Ag-TLC are mainly non polar solvents such as benzene,
toluene, chloroform, dichloromethane, diethyl ether, etc. Mixtures of different solvents
are also employed depending on the unsaturation of the lipids to be separated. Usually
a larger excess of aliphatic hydrocarbons are employed with varying amounts of polar
solvents in the mixture [for a review see Ref. 23]. Because the separation profile of
FFA/FAME is similar to that of PFAM’s as in other chromatographic techniques, AgHPTLC could be successfully employed in their separation. A given recipe for FAME
might not work for PFAM’s in which case method development will be necessary.
Separation and detection of fatty acids by gas chromatography is a long known
and probably the most used technique. The analysis of fatty acids in different lipids
(such as in triacylglycerols) is done by transesterification of the fatty acids into their
methyl esters followed by GC/MS analysis. Earlier work mostly shows the separation
in terms of chain length or at best in terms of unsaturation, whereas the recent analyses
are concentrated on separation in terms of configuration and position of the unsaturation
[35-48]. The later was possible due to the development of polar columns that are
capable of separating the positional and geometric isomers of FAMEs. These columns
are routinely used in various laboratories for FFA analysis in food, vegetable and fish
oil, dairy products, plastics, paints and varnishes, geochemical supplies, biological
samples and many others.

As mentioned above, PFAM’s tend to show similar

chromatographic behavior as FFA/FAME. The separation of derivatized PFAM’s in
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terms of the number of carbon has been achieved using non polar columns [35-37]. In
some cases, separation by the number and position of unsaturation was achieved (38,
39) but separation in terms of geometrical and most positional isomers have yet to be
accomplished. Use of a polar column for the separation of PFAM’s was also described
but only a few unsaturated ones were separated, which probably due to the poor column
performance [43]. In recent years the development of polar columns has reached
tremendous goals of achieving more stable and lower bleed profile. Temperatures as
high as 260 °C can be employed, even with the most polar phases (such as cyanopropyl
incorporated dimethyl polysiloxane) without breakage of the phase. The bonded phase
feature (cross linking) allows such a column to be rinsed to remove contaminants.
Employing such a column could result the desired PFAM separation with higher
sensitivity and lower detection limit, provided PFAM’s are proper derivatized prior to
the analysis [see Section 6.4.2 for more discussion on polar columns and derivatization
techniques].
In this study, we have employed argentation HPTLC (Ag-HPTLC] [60] and a
polar column (BPX70; 70% cyanopropyl dimethyl polysilphenylenesiloxane) to explore
the separation of unsaturated PFAM’s. The BPX70 column was also used in the
separation of amides isolated from rabbit brain and heart tissues. Different pros and
cons of the techniques used have been mentioned and areas for further development are
discussed in the following sections.
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6.3 Experimental
6.3.1 Reagents
PFAM’s were synthesized from the corresponding acids (see Chapter 2) unless
otherwise mentioned.

The PFAM’s used in this study were octadecanoamide

(stearamide; C18:0), cis-9-odecenoamide (oleamide; C18:19), trans-9-octadecenoamide
(elaidamide; C18:1trans9), cis,cis-9,12-octadecadienoamide (linoleamide; C18:29,12),
trans,trans-9,12-octadecadienoamide (linoleladamide; C18:1trans9,12), cis,cis,cis-9,12,15octadecatrienoamide (α-linolenamide; C18:39,12,15), cis,cis,cis-6,9,12-octadecatrienoamide

(γ-linolenamide;

C18:36,9,12),

trans-11-octadecenoamide

(vaccenamide;

C18:1trans11), cis-6-octadecenoamide (petroselenamide; 18:16), trans-6-octadecenoamide
(petroselaidamide; C18:1trans6), cis-13-octadecenoamide (C18:113), cis-5-eicosenoamide
(C20:15), cis-11-eicosenoamide (C20:111), trans-11-eicosenoamide (C20:1trans11), and
cis-13-eicosenoamide (C20:113). The corresponding acids were purchased from Sigma
Chemical Co. (St. Louis, MO). Oleamide is commercially available and was purchased
also from Sigma.

All chemicals and solvents used were of ACS reagent grade.

Chloroform and methanol were obtained from EM Science and EMD (Darmstadt,
Germany) respectively; acetonitrile, ethyl acetate, hexanes, isopropanol, glacial acetic
acid and sodium thiosulfate were all purchased from Fisher Scientific (Fair Lawn, NJ);
acetone was from Acros Organics (Geel, Belgium); diethyl ether and silver nitrate were
from Aldrich Chemical Co. (Milwaukee, WI).
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6.3.2 Tissues
Rabbit whole heart (atrium removed), rabbit whole brain (stripped), and rabbit brain
acetone powder were purchased from Pel-Freez Biologicals (Rogers, AR).

6.3.3 HPTLC plates
High performance thin layer chromatography plates (HPTLC) from Analtech (Newark,
DE) were of 10 x 10 cm, with organic binder and no fluorescence indicator
incorporated. Primuline dye (CI 49000; direct yellow 59) used for spraying the HPTLC
plates was obtained from Aldrich Chemical Co. (Milwaukee, WI). PrevalTM power unit
(Precision Valve Corporation, Yonkers, NY) for spraying primuline dye on the HPTLC
plates was purchased from a local hardware store.

6.3.4 SPE phases
Discovery DSC-Si and Discovery DSC-NH2 SPE phases were purchased from Supelco
(Bellefonte, PA). Irregularly shaped and acid washed base silica possessed following
properties: 50 µm particle size, 70 Å pore diameter, 480 m2/g specific surface area and
0.9 cm3/g pore volume. DSC-Si is the base silica phase which is basically used as a
normal phase adsorbent whereas DSC-NH2 is the aminopropyl bonded silica which can
be used as either normal phase or the ion-exchange adsorbent. SPE tubes (empty) of 3
mL volumes with polyethylene frits were also purchased from Supelco. 500 mg of the
phases were packed into the tubes between two frits applying hand pressure in order to
carry out SPE.

204

6.3.5 Instrumentation
Camag Nanomat and capillary dispenser system, purchased from Camag (Muttenz,
Switzerland), was used for easy application of samples on Ag incorporated HPTLC
plates.

1 µL sample was applied at a time with disposable capillary pipettes.

Fluorescent images were obtained using Kodak digital science 440 image station
(IS440cF, Perkin Elmer, Boston, MA). An Agilent Technologies Network GC/MS
system (6890 GC with 5973 mass selective detector and 7683 series injector) was used
for the analysis of derivatized amides. The column used was a polar BPX70 column
(0.25 mm internal diameter, 0.25 µm film thickness, 60 m long, SGE incorporate,
USA). The composition of the column is 70% cyanopropyl polysilphenylenesiloxane.
The GC/MS method used for analysis was as follows: starting temperature was 60 ºC,
ramped to 170 ºC at 50 ºC per min with 5 min hold time, ramped to 200 ºC at 4 ºC per
min with 5 min hold time and finally ramped to 225 ºC at 50 ºC per min with 4.5 min
hold time. The total run time was 24.70 min [61]. Electron impact ionization (EI) at 70
eV was used and mass range was kept from 40 to 400 m/z. The m/z values 67, 81, 122,
124, 136 and 138 were used for single ion monitoring (SIM). The temperatures of the
injection port and the transfer line were 250 ºC and 280 ºC respectively. Injection
volume was 1 µL splitless

6.3.6 Separation of PFAM’s by Ag-HPTLC
6.3.6.1 Preparation of HPTLC plates
HPTLC plates were allowed to develop in either a 10% AgNO3 solution in acetonitrile
or a 0.5% AgNO3 solution in methanol to the top in a vertical development chamber.
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The silver actually travels up to the half of the plate with its concentration gradually
decreasing. The Ag impregnated plates were dried at 100 ºC for 5 min.
6.3.6.2 HPTLC method for plate development
Solvents were mixed in correct proportions, sonicated for an hour and kept on the bench
top with caps on. 5 µL of each PFAM standard (1 µg/µL) were applied on HPTLC
plates 1 cm from the bottom using the Camag capillary holder. Warm air from a hair
dryer was continuously applied during sample application in order to dry the spots. For
plate development, horizontal chambers for 10 x 10 cm plates from Camag were used.
HPTLC separation method is as follows: the 10 x 10 cm plates were developed twice up
to 10 cm in hexane: diethyl ether: acetone (40:35:15, v/v/v). The plates were developed
in the same direction as Ag was developed and were dried in between runs.
6.3.6.3 HPTLC plate visualization
The developed plates were then dried at 100 ºC for 5 min. Ag was removed by dipping
the plates into a saturated solution of sodium thiosulfate followed by dipping into
double distilled water. The plates were dried at 100 ºC for 5 min and sprayed with a
0.05 % primuline solution (in 80:20, v/v acetone: water) and re-dried. The dry plates
were scanned by Kodak digital Science 440 image station for visualization.

6.3.7 Separation of PFAM’s by BPX70 column
6.3.7.1 Derivatization of amides
50 µL of each PFAM standards (1 µg/µL) were placed in separate vials and completely
dried under N2. The dried amides were then placed inside a glove bag and 50 µL N, N-
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bis-trimethylsilyltrifluoroacetamide (N, N-BSTFA) was added to each amide.

The

reaction mixture was then heated at 95 ºC for 15 min and allowed to cool. After the
products were cold, 300 µL acetonitrile was added to each vial and 1 µL of each of
these solutions were injected into GC/MS.
6.3.7.2 Identification of amides
Individual amides were run by GC/MS in order to identify their retention time and mass
spectral patterns. Once this goal was established, a mixture of derivatized amides was
injected into the GC/MS and the elution profile was observed. Different amides, in a
mixture, were therefore identified by comparing their retention times and MS patterns
with those of the corresponding individual amide.

6.3.8 Separation of rabbit brain and heart PFAM’s by BPX70 column
6.3.8.1 Extraction of lipids from rabbit brain and heart
The samples were stored at -80 ºC upon arrival. Right before lipid extraction, samples
were taken out of the freezer and placed at dry ice temperature. They were then cut into
pieces and weighed before extracting lipids. The lipids were extracted from the tissues
(62, 63) as follows: The weighed tissues/acetone powder were suspended into 20 times
of its volume of chloroform: methanol (2:1; v/v) and completely homogenized using a
glass-to-glass homogenizer (Kontes Glass Co., Vineland, NJ). The tissue homogenate
was then sonicated for 10 min at 1500 g. Before sonication the specific gravity of the
homogenate was lowered using 0.2 times of its volume (20%) of methanol.

The

supernatant was separated from the pellets and chloroform was added to the supernatant
in order to adjust the proportion of chloroform: methanol to 2:1 (for example if the total
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volume of the homogenate was 20 mL, 4 mL methanol was added before sonication and
8 mL of chloroform was added to the supernatant after sonication). To the total amount
of supernatant, 0.2 times of its volume of aqueous 0.88% KCl was added (for example
if the total volume of the supernatant was 20 mL, 4 mL of aqueous 0.88% KCl was
added). The sample was then vortexed for 2 min and allowed to sit for separation into
two phases. The upper phase mostly contains proteins and non-lipid contaminants and
the lower phase contains the lipid extract. The upper phase was therefore discarded and
the lower lipid phase was completely dried under a stream of N2. The dried lipid extract
was dissolved in 4 mL hexane to be loaded onto SPE columns. Blanks (no tissues)
were prepared following the same procedure as samples.

The glass-to-glass

homogenizer was silanized using 10% TMS in toluene before use in order to minimize
the amide adsorption on the silica surface.
6.3.8.2 Extraction of amides from total lipid extract by SPE
SPE elution solutions were made by mixing them in correct proportions followed by
sonication for an hour. The DSC-Si column was completely solvated in hexane before
the sample load. After the lipids were loaded, 4 mL hexane was used for washing the
sample, which was considered as fraction one from DSC-Si column. The loads for
heart, and brain acetone powder were 100 µL of the lipid extract in each case. The
lipids were then eluted with 1 mL of each 99:1 hexane: acetic acid, 90:10 hexane: ethyl
acetate, 80:20 hexane: ethyl acetate, and 70:30 hexane: ethyl acetate, 1.5 mL of 2:1
chloroform: 2-propanol, and finally with 2 mL of methanol. Fraction six containing the
amides, monoacyl glycines, N-acylglycines and the N-acylethanolamines was dried
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under N2, re-dissolved in 200 µL of hexane and loaded onto DSC-NH2 column. The
sample was adsorbed onto the phase and then washed with 2 mL of hexane, which was
called fraction one from DSC-NH2 column. The lipids were then eluted by 2 mL of
chloroform, 2 mL of 2% chloroform in 2-propanol, 1 mL of 2% chloroform in 2propanol, 2 mL of 3% chloroform in 2-propanol and finally with 2 mL of methanol.
Fraction three from DSC-NH2 column containing amides was dried under N2 and
derivatized with BSTFA as described above before injecting 1 µL sample into GC/MS.

6.4 Results and Discussion
6.4.1 Separation of PFAM’s by argentation-HPTLC
In order to develop a method for the separation of primary fatty acid amides by AgHPTLC, free fatty acid (FFA) were tried to begin with. The reason behind this is that
fatty acid methyl esters are the mostly studied lipid class by Ag-HPTLC (see Section
6.2). The goal was to optimize a method for the separation of FFA and include amides
into the method. To start out the method, HPTLC plates were developed in 10%
solution of AgNO3 in acetonitrile. Four C18 acids were loaded onto the plates and were
developed in various solvents (such as hexane, diethyl ether, methanol, tetrahydrofuran
etc) in order to follow how the acids move. These acids were stearic acid (no double
bond), oleic acid (one double bond), linoleic acid (two double bonds) and linolenic acid
(three double bonds). Unfortunately, FFAs were not found to be separated by a single
solvent system. It was clear from the literature review that the fatty acid methyl esters
are well separated by developing with a mixture of solvents containing a large portion
of nonpolar one.

Different solvent systems were therefore tried which included
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hexane:diethyl ether (97:3), hexane:diethyl ether:acetone (60:40:5) and hexane:diethyl
ether:acetone (40:30:15). FFAs were found to be separated by developing the plates in
the latter solvent up to 10 cm of the plates (Figure 6-1).
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FIGURE 6-1: HPTLC Plate developed A) in hexane: ether: acetone (60:40:5 v/v/v) up
to 10 cm, B) twice in hexane: ether: acetone (60:40:5 v/v/v) to the top and C) in hexane:
ether: acetone (40:35:15 v/v/v) up to 10 cm.
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It is clear from the picture that they are separated based on their number of
double bonds, with the most unsaturated one being strongly retained by Ag. These
plates were visualized under UV light (254 nm) by spraying primuline after reducing
the Ag on the plates (see Section 6.3.6.3).
Similar solvent systems were therefore tried for the separation of ten different
C18 PFAM’s. Figure 6-2(A) shows that a slight separation of amides occurs using the
same solvent system and under the same conditions as those used for the separation of
acids. An improved separation was observed by developing the plates in same solvent
system twice upto 7 cm [Figure 6-2 (B)].

The amides with higher number of

unsaturation were more strongly retained by Ag.

For example, linolenamide

(C18:39,12,15) with 3 sites of unsaturation did not move from the origin at all. Due to the
comparatively higher polarity of the amides than acids, the resolution between the
amides was not satisfactory. Even though a slight separation between cis and trans
isomers (cis being strongly retained) was observed when separately run, a mixture was
not separated. A slight increase in retention strength was also observed for the amides
with double bonds closer to the amide functional group (i.e., C18:16 was strongly
retained than C18:19, which was again strongly retained than C18:113). These plates
were also Ag impregnated by dipping them into 10% AgNO3 solution in acetonitrile.
One problem that was encountered during the above procedure was the presence of
higher percentage of Ag on the plate. Even though the Ag was being reduced, the
dipping procedure in some cases tended to wash the acids off too. Also the reduced
portion of the Ag quenched the primuline fluorescence making the visualization
difficult. It was therefore necessary to use a lower percent of AgNO3 solution for the
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plate impregnation. Literature review indicates that AgNO3 contents higher than 5% in
the layer have no effect on retention or resolution, more over 0.5% methanolic AgNO3
solution was found to show excellent resolution for fatty acid methyl esters and triacyl
glycerols [see Section 6.2].
HPTLC plates were therefore developed in 0.5% methanolic AgNO3 solution.
After 10 different C18 amides were loaded onto the HPTLC plates, the plates were
developed in the same solvent as before [see Figure 6-3(a)]. Developing the plates
twice in hexane:ether:acetone (40:35;15; v/v/v) did not improve the resolution except
moving them collectively away from the origin [Figure 6-3(B)]. The washing steps
were found to be easier in this case with no problem in getting rid off Ag. The
detection of the amides improved to a much higher degree due to the presence of lower
amount of Ag. One problem observed with this lower percentage of Ag was though the
lesser degree of resolution between the amides than that observed with higher silver
content [see Figures 6-2(A) and 6-3(A)]. Therefore it will be necessary to optimize the
silver content on the plate for the optimum resolution as well as for optimum detection
of the primary fatty acid amides.
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FIGURE 6-2: Separation of C18 unsaturated primary fatty acid amides by ArgentationHPTLC. The plates were impregnated by dipping them in 10% AgNO3 in acetonitrile.
Plate development A) in hexane: ether: acetone (40:35:15; v/v/v) up to 10 cm, B) twice
in hexane: ether: acetone (40:35:15; v/v/v) to 7 cm, and C) in chloroform: methanol:
acetic acid (95:5:1; v/v/v) to 5 cm, in hexane: ether: acetone (60:40:05; v/v/v) to 7 cm
and finally in hexane: ether (97:3; v/v) up to 10 cm.
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FIGURE 6-3: Separation of C18 unsaturated primary fatty acid amides by ArgentationHPTLC. The plates were impregnated by dipping them in 0.5% AgNO3 in methanol.
Plate development A) in hexane: ether: acetone (40:35:15; v/v/v) up to 10 cm, B) twice
in hexane: ether: acetone (40:35:15; v/v/v) up to 10 cm.
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6.4.2 Separation of PFAM’s by BPX70 column
6.4.2.1 Some insight into polar columns
It was discussed in previous chapters that unsaturated PFAM’s with the same number of
carbons can not be separated by a non polar column like HP-5MS (see Figure 6-4).
This was not unexpected because the amides are relatively polar and there is a tight
margin between their polarities. Because BPX70 is a highly polar column, it can be
utilized for their separation. There are a number of columns available from different
manufacturers which have similar polarities as BPX70, but none of them have ever been
used in conjunction with a mass spectrometer. The reason behind this is their high
bleed profile, which can saturate the detector. These are mainly the highly polar
columns with low temperature limit and mostly being used with FID.

There are

numerous literature/application notes available about these columns being successfully
used in the separation of long chain geometric and positional isomers of fatty acid
methyl esters (FAME) in very short time. But it is important to point out that most of
these separations were carried out with H2 as carrier gas and FID as a detector. Both of
these conditions are not used in majority of the separation laboratories. A very few
cases of He use as a carrier gas were mentioned where the separations were rather
sloppy and required longer time. BPX70 is the only polar column which has been found
to be used with a MS [61] for the separation of FAME. This column was therefore used
in this study for the separation of derivatized PFAM’s. One crucial requirement for the
analysis of PFAM’s by the polar column is that they must be derivatized prior to the
analysis in order to lower the retention time as well as to increase sensitivity. It is
necessary to add here that analysis of non-volatile compounds by GC/MS requires prior
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derivatization, but FFA and PFAM’s can be analyzed by some non-polar columns (such
as HP-5MS) with high sensitivity without derivatization.

Derivatization is often

required in trace analysis in order to increase the sensitivity. At low concentration,
underivatized acids and amides tend to show lower sensitivity due to the tailing by their
polar functional groups even on a non-polar column (HP-5MS is only 5% polar). This
tailing problem is severe with polar columns and results in very poor sensitivity even
when analyzing them at higher concentration. The underivatized compounds can be
detected at higher concentration but the resolution between peaks is unacceptable.
Therefore in order to analyze the primary fatty acid amides by polar columns, the NH2
group needs to be deactivated through derivatization
6.4.2.2 Derivatization of PFAM’s by BSTFA and analysis by GC/MS
A number of different techniques are available in the literature for the derivatization of
the amides (39, 64). The most commonly used one is the derivatization by N, NBSTFA. The protocol was optimized in this laboratory and can be successfully used for
the derivatization of fatty acids and amides. In this study the PFAM’s were derivatized
with N, N-BSTFA at 95 ºC for 5 min and cooled at room temperature before acetonitrile
was added. The derivatized amides were then run by GC/MS and individual mass
spectral patterns were observed.
Derivatizing with BSTFA involves the replacement of one hydrogen from the
amide by trimethylsilyl group forming trimethylsilyl-amide (TMS-derivative). While
analyzing the mass spectra of the amides derivatized according to the protocol described
above, it was observed that instead of TMS derivatives, nitrile derivatives were formed.
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The reason might be the use of acetonitrile as a solvent which quickly converted TMS
derivatives to nitrile derivatives in gas phase on-column. Figure 6-5 shows the mass
fragmentation patterns of nine C18 amides.
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FIGURE 6-4: Elution profile for C12-C22 amides on a HP-5MS column. The relative
intensities at m/z 59, 72, 62 and 76 are plotted against retention time. Refer to Chapter 2
for the description of the fragment ions.
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FIGURE 6-5: Mass spectrum patterns of nitrile derivatives of C18 amides (a) stearamide;
C18:0, (b) petroselenamide; C18:16, (c) petroselaidamide; C18:1trans6 , (d) oleamide; C18:19 ,
(e) elaidamide; C18:1trans9, (f) Vaccenamide; C18:1

trans11

, (g) cis-13 octadecenamide;

C18:113, (h) linoleamide; C18:19,12, and (i) linoleladamide; C18:1trans9,12 . See scheme 6.1 for
illustration of the patterns.

The structures for the common key fragment ions formed have been drawn for
illustration in Scheme 6-1. All the amides (both saturated and unsaturated) showed
·

similar fragmentation patterns which included the molecular ion peaks ([M]+ ); the
peaks due to the loss of -CH3, ([M-15]+); the peaks due to the loss of -CH2-CH2-CH3,
[M-43]+ ion; and the peaks due to the consecutive loss of methylene groups (14 u).
Stearamide which is a saturated amide showed peaks at m/z 124 and m/z 138
[Figure 6-5(a)] due to the formation of (C8H14N)+ and (C9H16N)+ ions from C8-C9 and
C9-C10 cleavages respectively. Stearamide also showed peaks at m/z 57 (base peak),
m/z 70, and m/z 82 due the formation of (C4H9)+ (C5H10)+ and (C5H8N)+ ions
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respectively [see Scheme 6-1(A)].

All the mono unsaturated amides showed

characteristic peaks at m/z 122 and m/z 136 due to the (C8H12N)+ and (C9H14N)+
fragment ions. The other intense fragmentation patterns observed at m/z 55, m/z 69,
m/z 83 and m/z 97 were due to the cleavage of the nitrile [see Scheme 6-1(B)]. For
petroselenamide (C18:16) and petroselaidamide (C18:1trans 6) with a double bond at sixth
carbon, the base peak was observed at m/z 122. The intensities of the peaks at m/z 55,
m/z 69, m/z 83 and m/z 97 were much lower than those observed for other
monounsaturated amides [see Figure 6-5(b)-(c)]. This is most probably due to the
position of the double bond, which was included in the most frequently formed peak at
m/z 122 [see Scheme 6-1(C)]. The diunsaturated PFAM’s did not show any fragment
ions at m/z 69, m/z 83 and m/z 97, instead intense peaks at m/z 55, m/z 67, m/z 81, m/z
95 were observed [see Figure 6-5 (h)-(i)] due to the presence of an additional double
bond. The other characteristic peaks resided at m/z 120 and m/z 134 due to the
formation of (C8H10N)+ and (C9H12N)+ ions, respectively [see Scheme 6-1(D)]. These
fragmentation pattern shows that the double bonds are preserved in the fatty acid
amides after their synthesis from corresponding fatty acids.
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Scheme 6-1(C)
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Scheme 6-1(D)

m/z 134
m/z 120

m/z 67

N

m/z 246
[M-15]

m/z 55
m/z 95
m/z 81

m/z 218
[M-43]

Nitrile derivatized linoleamide, m/z 261, [M]
Scheme 6-1 Mass-spectral (quadrupole) fragmentations for A) stearamide; C18:0, B) oleamide
C18:19 (all the unsaturated amides shows similar patterns), C) petroselaidamide C18:1trans6, and
D) linoleamide; C18:2 9,12.

225

6.4.2.3 Separation of derivatized standard PFAM’s
Once the identity and the retention time of the each derivatized amides was confirmed,
a mixture of amides was run by GC/MS. Before the analysis, argon (a non- retained
gas) was injected into the column and the average linear velocity was calculated to be
27 cm/sec for He carrier gas. Because the amides had high capacity factor, k´, at 27
cm/sec gas velocity, optimization needed to be done.

In order to optimize the

separation and lower the elution time, separation was carried out at 30 cm/sec, 35
cm/sec, and 40 cm/sec, average He gas linear velocities. At the latter velocity, elution
profile was found to be shorter, which is better for the higher carbon amides. It was
found that the amides from C20 to C22 elute near the maximum temperature limit of the
column. They are therefore difficult to recognize and often co-elute with column bleed
peaks. But the resolution between the C18 amides at this velocity was not satisfactory.
A slightly better separation was observed using the velocity at 35 cm/sec than that using
the velocity at 40 cm/sec, whereas 30 cm/sec provided the best resolution and elution
profile among the four velocities tried.
Separation of nine C18 amides is shown in Figure 6-6 indicating excellent
resolution between positional and geometric isomers, which was not achieved on a HP5MS column. The trans isomers eluted at least a min before the cis isomers. The
amides with double bond closer to the carbonyl carbon eluted earlier than those
containing double bonds further away from the carbonyl carbon. Even though most of
the monounsaturated amides showed nice separation from the unsaturated ones, C18:113
was found to co-elute with C18:29,12 most probably due to the close position of their
double bonds. Because the fragments for C18:113 (m/z 122 and m/z 136) are different
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from those for C18:29,12 (m/z 67, m/z 87, m/z 120, m/z 134), it will be possible to
separate them by monitoring those ions only (see Figure 6-6).
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C18:1

C18:1trans 9, 12

trans6
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C18:19, 12
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FIGURE 6-6: Separation of derivatized unsaturated C18 amides on a BPX70 column.
The relative intensities of m/z 67, m/z 81, m/z 122, m/z 124, m/z 136, and m/z 138 are
plotted against retention time (see Figure 6.5 for fragmentation patterns). Average linear
velocity of He was 30 cm/sec. Co-elution of C18:113 and C18:2

trans 9, 12

occurs in this

separation but still can be separately identified due to the m/z 122, and m/z 134 specific
for C18:113 which are not formed by C18:2 trans 9, 12 (m/z 67 and m/z 81 are specific for
linoleladmide).

The separation between four C20 amides was also achieved. Table 6-II shows
their retention times in two different linear velocities. The retention times indicate that
the elution profile for C20 amides follows similar trend as C18 amides in terms of
geometric and positional isomers. The trans amides elute before the cis amides and as
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the position of the double bond moves further away from the carbonyl carbon, the
retention time increases. The problem with these higher molecular weight amides is
that they elute near the maximum temperature of the column and are often accompanied
column bleed peaks. They were not included in this study because base line resolution
was not achieved for them. It is important to add that this separation indicates not only
the position of the double bonds but also the stereochemistry of the bonds was
preserved after the synthesis of the amides from their corresponding acids.
TABLE 6-II: Retention time of four C20 unsaturated amides at different average linear
velocity of He carrier gas.
Amides

Retention time, min at different
He gas average linear velocity
30 cm/sec

40 cm/sec

C20:15

22.97

20.84

C20:1trans 11

23.37

22.12

11

23.81

22.47

C20:113

23.92

22.59

C20:1

6.4.2.4 Separation of PFAM’s from rabbit brain and heart
The analysis of the derivatized amides isolated from rabbit brain and heart shows that
oleamide is the only major unsaturated fatty acid amide present in those tissues (see
Figure 6-7).

Trace amounts of linolemide and cis-13- eicosenoamide were also

observed besides oleamide, stearamide and palmitamide in brain tissues [Figure 6-7(a)].
Heart tissues contained only stearamide and palmitamide besides oleamide [Figure 67(b)].
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FIGURE 6-7: Separation of derivatized unsaturated C18 amides from a) rabbit brain
acetone powder and b) rabbit heart on a BPX70 column. The relative intensities of m/z
67, m/z 81, m/z 122, m/z 124, m/z 136, and 138 are plotted against retention time. (see
Figure 6.5 for fragmentation patterns). Average linear velocity of He was 30 cm/sec for
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(a) and 40 cm/sec for (b). Peaks in figure (a) therefore eluted around 1.5 min later than
those in (b).

Beacuse fatty acid amides are used as slip additives in plastics and can
contaminate the sample upon the use of such containers, a method blank was run and
subtracted from each sample spectrum. This method therefore could be an excellent
way of identifying the types of amides present in different parts of mammalian tissues.
It was basically a qualitative study to identify the unsaturated amides that are co-eluting
with the oleamide peak. The quantitation is the next step that needs to be done. Also
the tissues that were used in this study are available in larger quantities in which case
detection is not an issue, but mapping the amides in different parts of tissue will be
critical.

For example, concentration of amides in different brain parts such as in

hypothalamus, neocortex, basal ganglia, hippocampus, amygdale, cerebellum, brain
stem and spinal cord could be in the order of picograms. Sensitivity will definitely be
an issue for amide identification and quantitation in these types of samples using a polar
column. One solution might be to find a better derivatizing agent for producing more
stable derivatized amides for better sensitivity as well as lower detection limit.

6.5 Conclusions
In conclusion, we have developed an efficient method for the separation of primary
fatty acid amides by BPX70 column. Unsaturated C18 amides were separated with
excellent resolution in terms of the number, position and stereochemistry of the double
bonds. In this study, the C20-C22 unsaturated amides were not employed due to the
incapability of the high bleed, polar BPX70 column to provide baseline resolution for
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these amides. An argentation-HPTLC method was also studied for the separation of
C18 unsaturated amides. A nice resolution between the saturated and the unsaturated
amides were observed in this case. A satisfactory resolution between the geometric and
the positional isomers could not be achieved. As discussed in the results and discussion
section, optimization of the amount of silver might help improve these types of
separation. Even though the amides isolated from rabbit tissues were successfully
separated by the BPX70 column, quantification still needs to be carried out for these
tissues as well as other tissues known to express PAM. As discussed in earlier chapters,
PAM is the catalyst for the final step of oleamide biosynthesis. Tissues known not to
express PAM (such as kidney) will also be analyzed and will be a good control for
future studies.
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